Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3015322	s-alfa-1	g/l (g/l)	10254	22739	0.00%
3015322	s-alfa-1	— (—)	1802	2369	100.00%	Distribution not available
3015322	alfa1-glob	g/l (—)	683	2715	100.00%	Distribution not available
3015322	s-a1glob	g/l (—)	410	876	100.00%	Distribution not available
3015322	s-alfa-1-fraktio	g/l (—)	310	372	100.00%	Distribution not available
3015322	alfa-1	g/l (—)	113	347	100.00%	Distribution not available
3015322	alfa-1-glo	g/l (—)	84	95	100.00%	Distribution not available
3015322	s-alfa1-globuliini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Finngen Rheumatological endpoints

2682

6671

2.34

308.72

2.1

2.3

2.99

2.84

g/l

10.78

2441

5980

ILD medications

3985

7218

3.10

307.65

2.9

1.6

3.01

2.85

g/l

14.67

3643

6360

Other bacterial diseases

3478

8581

2.83

307.65

2.9

2.0

3.19

2.82

g/l

62.60

3159

7618

Inflammatory bowel disease treatment related agents

3782

8301

2.63

307.65

2.1

2.3

3.04

2.86

g/l

18.14

3447

7352

Autoimmune diseases excluding thyroid diseases

3233

7703

2.35

307.65

1.9

2.4

3.01

2.90

g/l

7.06

2960

6834

Multiple myeloma, including Hilmo

654

554

18.37

307.65

16.6

1.4

2.57

3.05

g/l

18.33

637

480

Implicit Sepsis

2801

7986

2.76

307.65

2.5

2.1

3.06

2.89

g/l

13.61

2467

7122

Tramadol

2609

6002

2.76

307.65

2.3

1.9

3.01

2.87

g/l

8.20

2347

5338

All pneumoniae

3120

9065

2.37

307.65

3.1

1.9

3.10

2.85

g/l

29.25

2830

8096

Metabolic disorders

2936

7734

2.38

307.65

2.4

2.1

2.95

2.91

g/l

1.02

2652

6905

Liquid cancers, helper endpoint

2591

4490

5.66

307.65

6.4

1.3

2.81

2.96

g/l

8.72

2418

3916

Pneumonias (Asthma/COPD co-morbidities)

3106

9043

2.37

307.65

3.1

1.9

3.11

2.85

g/l

29.29

2818

8075

Bacterial infection, other or unspecified

2521

6799

3.32

307.65

3.2

2.1

3.30

2.83

g/l

67.69

2282

5959

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

860

587

26.37

307.65

7.1

1.3

2.60

3.02

g/l

15.29

800

508

Other soft tissue disorders, not elsewhere classified

2850

7206

2.38

307.65

2.3

2.92

2.95

g/l

0.67

2597

6409

Other and unspecified polyneuropathies, also in other diseases

1347

2690

5.78

307.65

2.0

2.3

2.63

3.00

g/l

31.73

1209

2376

General symptoms and signs

3157

6353

2.56

307.65

2.4

2.0

2.98

2.85

g/l

8.06

2863

5668

Multiple myeloma and malignant plasma cell neoplasms

655

629

15.85

307.65

16.6

1.5

2.56

3.05

g/l

18.49

638

554

Acute renal failure

1132

2887

4.29

307.65

2.8

2.2

3.24

2.92

g/l

16.44

1032

2507

Pain in limb

2600

7102

2.53

307.65

2.1

2.3

2.96

2.95

g/l

0.12

2365

6317

L04AX Other immunosuppressants

2153

7253

3.12

307.65

5.1

1.7

3.04

2.90

g/l

7.22

2002

6476

Other anaemias

2533

5835

4.53

307.65

2.5

2.2

3.04

2.96

g/l

3.13

2263

5083

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4636

8004

4.24

307.65

2.5

2.1

3.02

2.88

g/l

12.12

4200

7106

Infections, IBD-co-morbidities

569

586

7.32

307.65

4.3

2.1

2.97

2.95

g/l

0.16

517

528

All chronic kidney diseases

2819

5784

4.29

307.65

2.4

2.2

3.08

2.89

g/l

14.91

2596

5072

Bacterial infection, other or unspecified

2379

6540

3.35

307.65

3.3

2.0

3.32

2.84

g/l

64.21

2149

5728

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2821

7222

2.44

307.65

3.1

1.8

3.09

2.86

g/l

21.34

2560

6431

Dialysis, with operation codes

741

1437

5.82

307.65

3.9

2.1

3.24

2.89

g/l

13.34

695

1287

Other bacterial diseases

3525

8318

2.79

307.65

2.8

2.0

3.15

2.80

g/l

55.99

3203

7376

Chronic kidney disease

1982

4238

5.14

307.65

2.4

2.2

3.09

2.93

g/l

8.11

1823

3649

Implicit bacterial Sepsis

1754

5386

3.05

307.65

2.8

2.1

3.20

2.91

g/l

21.14

1546

4732

Polyarthropathies

2581

5530

3.18

307.65

2.4

2.3

3.12

2.90

g/l

18.00

2372

4931

Aplastic and other anaemias

2649

6123

4.41

307.65

2.5

2.2

3.04

2.96

g/l

3.32

2368

5347

Implicit bacterial Sepsis

1887

5724

3.01

307.65

2.7

2.1

3.20

2.91

g/l

21.32

1662

5040

Renal failure

2717

5929

4.45

307.65

2.5

2.2

3.13

2.92

g/l

18.12

2484

5150

Polyneuropathies and other disorders of the peripheral nervous system

1453

3073

5.38

307.65

2.3

2.63

3.01

g/l

35.03

1308

2717

ILD medications: prednisolone, methylprednisolone, prednisone

3807

7191

3.07

307.65

2.2

1.6

3.05

2.85

g/l

20.20

3464

6333

Pneumonia, organism unspecified

2878

8638

2.41

307.65

3.0

1.9

3.13

2.85

g/l

30.97

2595

7714

First line medication for Crohn's disease

3641

7106

2.86

307.65

3.0

1.6

3.02

2.84

g/l

15.96

3344

6263

Influenza and pneumonia

3163

8917

2.32

307.65

3.1

1.9

3.08

2.85

g/l

23.61

2862

7975

Other systemic involvement of connective tissue (FG)

1207

2899

4.43

307.65

1.8

2.5

3.13

2.87

g/l

11.45

1073

2531

ILD medications: immunosuppressive drugs

2691

6325

4.18

307.65

4.4

1.7

3.04

2.84

g/l

16.68

2514

5601

Condition for Implicit Sepsis (Organ dysfunction codes)

2910

8094

2.56

307.65

2.4

2.1

3.00

2.88

g/l

7.67

2605

7259

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

595

1042

6.76

307.65

3.4

2.3

3.17

3.01

g/l

2.15

537

918

Autoimmune diseases excluding thyroid diseases, strict definition

3118

7436

2.36

307.65

1.9

2.4

3.01

2.90

g/l

6.78

2853

6593

Condition for Implicit Sepsis (Organ dysfunction codes)

2861

8265

2.53

307.65

2.4

2.1

3.03

2.88

g/l

10.17

2542

7403

Other systemic involvement of connective tissue

1232

3680

3.59

307.65

1.8

2.3

3.13

2.92

g/l

8.02

1096

3238

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

448

316

24.97

307.65

19.5

1.5

2.60

3.09

g/l

11.16

437

269

Primary_lymphoid and hematopoietic malignant neoplasms

1623

3335

5.53

307.65

8.3

1.4

2.85

2.98

g/l

4.28

1547

2906

Second line medication for Crohn's disease

2179

7436

3.07

307.65

5.0

1.7

3.04

2.89

g/l

7.96

2026

6644

Anaemias

956

576

11.55

307.65

2.4

1.2

3.00

2.72

g/l

6.80

891

534

Malaise and fatigue

1905

5027

3.19

307.65

2.2

2.1

3.08

2.87

g/l

13.46

1672

4430

Implicit Sepsis

2921

8224

2.70

307.65

2.5

2.1

3.04

2.88

g/l

11.00

2579

7362

All kidney diseases

3672

8402

3.11

307.65

2.4

2.2

3.04

2.86

g/l

16.60

3350

7471

Examination and observation for other reasons

1974

3868

3.06

307.65

2.3

2.1

3.05

3.03

g/l

0.36

1814

3495

Other and unspecified anaemias

2519

5795

4.55

307.65

2.5

2.2

3.04

2.96

g/l

2.91

2250

5048

Heart failure, not strict

2821

7159

2.80

307.65

2.5

2.3

3.09

2.86

g/l

22.86

2556

6358

Renal tubulo-interstitial diseases

3521

8505

3.23

307.65

2.5

2.2

3.08

2.87

g/l

25.35

3183

7556

2821

7222

2.44

307.65

3.1

1.8

3.09

2.86

g/l

21.34

2560

6431

Systemic connective tissue disorders

1643

4773

3.70

307.65

1.8

2.3

3.20

2.91

g/l

17.54

1475

4200

Fever of other and unknown origin

2079

5616

3.44

307.65

3.7

2.1

3.19

2.86

g/l

30.12

1914

4986

Oral corticosteroids

3704

8249

2.76

307.65

2.1

2.3

3.04

2.86

g/l

18.27

3383

7304

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3042

9127

2.34

307.65

3.1

2.0

3.11

2.85

g/l

30.49

2759

8151

Bacterial Sepsis

1978

5850

3.05

307.65

3.0

2.1

3.20

2.91

g/l

24.14

1750

5156

Multiple myeloma

448

316

24.97

307.65

19.5

1.5

2.60

3.09

g/l

11.16

437

269

Glomerular diseases

924

2368

4.27

307.65

2.7

2.3

3.04

2.94

g/l

1.95

861

2129

Gout

1232

3404

3.40

306.00

3.1

2.4

3.11

2.94

g/l

6.53

1127

2986

Osteopathies and chondropathies

1967

7487

2.55

299.76

3.0

2.1

2.99

2.94

g/l

1.20

1695

6675

Persons encountering health services for specific procedures and health care

3068

8721

2.16

295.75

2.6

2.1

2.96

2.90

g/l

2.21

2814

7745

Heart failure,strict

1952

5549

2.60

288.59

2.2

2.3

3.16

2.88

g/l

24.35

1755

4866

Oedema, not elsewhere classified

1160

3742

3.21

274.82

2.2

2.1

3.04

2.89

g/l

4.68

1040

3296

Codeine

2534

6147

2.29

274.55

2.1

1.9

2.91

2.87

g/l

1.22

2293

5477

Heart failure and antihypertensive medication

941

1627

4.00

273.21

2.1

2.4

3.15

2.84

g/l

11.93

855

1441

Abnormal findings on examination of blood, without diagnosis

1750

6514

2.58

271.56

2.7

2.3

3.03

2.93

g/l

3.36

1586

5807

Unspecified kidney failure

597

1258

5.33

271.24

2.5

2.1

3.21

2.94

g/l

7.32

548

1090

Asthma, unspecified (mode), excluding more controls

1497

4107

2.81

267.27

2.1

1.8

2.97

2.83

g/l

5.69

1356

3666

Erysipelas

2231

7595

2.31

266.08

2.1

2.0

3.13

2.81

g/l

35.34

2011

6705

Disorders of lipoprotein metabolism and other lipidaemias

2521

7261

2.21

258.33

2.3

2.2

2.97

2.92

g/l

1.32

2267

6456

Glomerular disorders in diseases classified elsewhere

631

1447

4.85

258.03

2.7

2.3

3.06

2.95

g/l

1.63

585

1311

Other heart diseases

1180

2465

3.21

255.83

2.3

2.0

3.00

2.78

g/l

8.72

1089

2250

Nutritional anaemias

1763

7157

2.47

253.58

2.0

2.3

3.10

2.95

g/l

7.66

1539

6301

Nephropathy related operations

649

1545

4.67

252.97

4.0

2.2

3.25

2.93

g/l

10.82

612

1389

Gout, FINNGEN

1232

4404

2.96

250.53

3.1

2.3

3.11

2.92

g/l

8.43

1127

3855

Other and unspecified iron deficiency

1270

4668

2.86

244.57

2.0

2.3

3.14

2.94

g/l

8.16

1111

4109

Septicaemia

1490

5513

2.64

243.78

3.1

2.0

3.18

2.85

g/l

23.60

1329

4810

Reimbursement for rheumatic diseases

1845

8048

2.36

243.24

1.7

2.4

3.15

2.90

g/l

19.93

1698

7114

Iron deficiency anaemia

1533

6113

2.58

241.91

2.0

2.3

3.12

2.94

g/l

8.09

1334

5381

Autoimmune diseases related-to ILD

2468

10276

2.11

241.19

2.0

2.3

3.08

2.89

g/l

15.18

2247

9144

Care involving dialysis

472

902

5.94

240.43

2.5

2.0

3.19

2.92

g/l

5.17

439

818

Implicit viral Sepsis

1110

3834

3.05

240.37

2.8

2.1

3.02

2.91

g/l

2.72

987

3379

Explicit Sepsis

1521

5712

2.59

240.00

3.1

2.1

3.18

2.90

g/l

17.23

1358

5036

Opioids

2530

6180

2.17

238.81

2.5

1.9

2.96

2.87

g/l

3.69

2291

5508

Hypertension, essential

2054

5080

2.35

236.96

2.2

2.96

2.82

g/l

6.93

1882

4555

Asthma, unspecified (mode)

1553

4653

2.59

236.80

2.0

1.8

2.97

2.85

g/l

4.58

1404

4147

Heart failure, strict

2112

6809

2.28

235.58

2.2

2.4

3.17

2.91

g/l

22.64

1895

5957

Certain infectious and parasitic diseases

2579

6136

2.15

234.97

2.5

1.8

3.01

2.80

g/l

16.48

2357

5425

Hypertensive diseases (excluding secondary)

1246

2493

2.98

230.21

2.2

2.0

2.95

2.77

g/l

6.87

1155

2268

Pure hypercholesterolaemia

2276

6990

2.19

229.90

2.2

2.97

2.92

g/l

1.02

2041

6207

Dental caries

927

2832

3.31

229.25

3.8

2.1

3.08

2.97

g/l

2.17

848

2552

Osteoporosis

1103

3649

3.01

226.58

2.2

2.97

2.99

g/l

0.35

906

3188

All-cause Heart Failure

2057

6720

2.25

222.64

2.2

2.4

3.16

2.91

g/l

21.81

1845

5875

Codeine or tramadol medication

3134

9021

1.94

222.48

2.1

2.3

2.94

2.92

g/l

0.34

2828

8033

Pain in joint

1661

4398

2.47

221.61

2.0

2.2

2.93

2.96

g/l

0.62

1495

3910

Covid-19 confirmed case

1328

5292

2.63

217.60

2.8

2.2

3.11

2.94

g/l

6.78

1187

4676

Other arthritis (FG)

997

3430

3.03

216.38

2.2

2.5

3.19

2.84

g/l

18.93

911

3060

Other diseases of blood and blood-forming organs, wide

903

2958

3.26

216.06

3.1

2.3

3.02

2.93

g/l

1.62

834

2638

Diseases of arteries, arterioles and capillaries (FINNGEN)

798

1558

3.71

215.37

2.3

2.2

3.19

2.79

g/l

17.18

729

1399

Asthma, excluding more controls

1887

4272

2.35

215.13

2.0

1.8

2.94

2.83

g/l

4.58

1720

3823

Hypertensive diseases

1999

5120

2.25

211.10

2.2

2.96

2.82

g/l

6.43

1839

4589

Hypertension

1995

5119

2.25

209.68

2.2

2.96

2.82

g/l

6.43

1835

4589

Medical observation and evaluation for suspected diseases and conditions

1789

3914

2.39

209.53

2.3

2.1

2.91

3.03

g/l

4.01

1578

3530

Caries of dentine

825

2530

3.34

207.60

3.8

2.1

3.06

2.96

g/l

1.61

752

2285

Codes for special purposes

1634

7293

2.31

205.19

2.8

2.1

3.08

2.91

g/l

8.57

1462

6497

Provisional assignment of new diseases of uncertain etiology

1632

7284

2.31

204.95

2.8

2.1

3.08

2.91

g/l

8.54

1461

6488

Abnormalities of breathing

2311

6569

2.08

203.51

2.3

2.1

2.92

2.93

g/l

0.20

2087

5890

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3065

8962

1.90

203.15

2.1

2.3

2.91

2.95

g/l

1.31

2820

7922

Diseases of oesophagus, stomach and duodenum

2901

9247

1.91

202.55

2.1

2.3

2.90

2.94

g/l

0.96

2578

8297

Autoimmune diseases

2893

7731

1.94

201.84

2.0

2.4

2.95

2.90

g/l

1.92

2628

6858

Oxycodone

1278

4639

2.59

201.26

4.6

2.0

3.12

2.91

g/l

8.34

1131

4076

GASTRO-related operations

1890

4226

2.28

200.09

2.3

1.9

2.97

2.82

g/l

7.24

1712

3795

Any gastric operation

1890

4226

2.28

200.09

2.3

1.9

2.97

2.82

g/l

7.24

1712

3795

Other septicaemia

1297

5089

2.55

200.05

2.7

2.0

3.18

2.85

g/l

20.63

1155

4432

Used for control exclusion in common control thyroid runs

2723

7102

1.97

199.48

2.1

2.4

2.95

2.90

g/l

1.50

2471

6308

Dyspnoea

2578

10013

1.95

197.18

2.3

2.2

2.98

2.92

g/l

1.93

2310

8929

Cardiovascular diseases (excluding rheumatic etc)

1274

2791

2.67

195.02

2.2

1.9

2.97

2.77

g/l

8.27

1192

2551

Asthma

1989

4847

2.20

194.01

2.0

1.8

2.94

2.85

g/l

3.42

1815

4330

Diverticular disease of intestine

2211

7014

2.07

192.90

2.5

2.2

3.00

2.93

g/l

2.24

1965

6250

Polymyalgia rheumatica

662

1934

3.75

192.85

1.7

2.4

3.31

2.97

g/l

9.13

572

1676

Erysipelas

1708

6991

2.23

192.66

2.2

2.0

3.15

2.83

g/l

29.61

1540

6159

Other specific joint derangements/joint disorders

1861

5587

2.20

192.36

2.0

2.3

2.89

g/l

0.06

1675

5021

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

384

460

6.27

189.72

2.3

2.2

3.13

2.97

g/l

1.79

359

408

Transplanted organ and tissue status

469

1086

4.74

188.75

5.4

2.1

2.89

2.94

g/l

0.45

450

980

Asthma (mode)

1951

4887

2.18

188.52

2.0

1.8

2.93

2.85

g/l

2.61

1785

4368

Pain, not elsewhere classified

835

2819

3.08

187.06

2.6

2.1

2.92

2.83

g/l

1.62

765

2513

Asthma (only as main-diagnosis), excluding more controls

1682

4272

2.30

187.06

2.0

1.8

2.94

2.83

g/l

4.21

1537

3823

Acute tubulo-interstitial nephritis

1762

7190

2.17

186.49

2.3

2.2

3.13

2.88

g/l

16.72

1548

6330

Ulcer of lower limb, not elsewhere classified

678

2065

3.56

184.44

2.2

3.34

2.95

g/l

17.39

613

1809

Other specified/unspecified arthritis

888

3137

2.95

183.92

2.2

2.4

3.20

2.89

g/l

12.66

806

2785

Cerebrovascular diseases (FINNGEN)

846

1954

3.17

182.83

2.4

2.2

3.03

2.78

g/l

8.40

765

1765

Diabetic nephropathy, excluding more controls

617

1415

3.88

181.61

1.8

2.1

3.00

2.94

g/l

0.70

568

1237

Other heart diseases, wide

2259

7025

2.00

181.49

2.3

2.2

2.98

2.85

g/l

6.75

2068

6313

L04AA Selective immunosuppressants

787

2651

3.13

178.51

1.8

2.3

3.12

2.91

g/l

6.14

745

2398

Other diseases of intestines

2639

8062

1.89

177.40

2.4

2.1

2.90

2.92

g/l

0.24

2377

7239

Low back pain

2005

7196

2.04

175.70

2.6

2.1

2.90

2.97

g/l

2.24

1811

6406

Other disorders of skin and subcutaneous tissue

2076

9500

1.99

175.40

2.2

2.3

3.04

2.92

g/l

5.25

1858

8415

Persons encountering health services in other circumstances, wide

3104

9006

1.81

175.02

2.2

2.3

2.90

2.95

g/l

1.48

2844

7953

Exposure to unspecified factor

2651

10518

1.85

173.43

2.1

2.3

3.00

2.91

g/l

4.53

2350

9428

Gout, idiopatic and unspecified

1006

3934

2.71

173.13

2.0

2.4

3.17

2.94

g/l

10.04

916

3468

Spondylopathies

2236

6913

1.98

170.83

2.5

2.1

2.86

2.98

g/l

5.93

2029

6130

Viral Sepsis

760

2577

3.11

170.63

3.3

2.1

3.01

2.93

g/l

1.29

676

2269

Headache

1542

5683

2.21

169.99

2.1

2.0

2.82

2.85

g/l

0.39

1394

5067

Certain infectious and parasitic diseases

1851

4393

2.15

169.80

2.4

1.8

3.01

2.81

g/l

11.19

1697

3882

Implicit viral Sepsis

758

2576

3.11

169.50

3.3

2.1

3.01

2.93

g/l

1.29

674

2268

Pain in throat and chest

2123

6506

2.00

168.24

2.2

2.1

2.91

2.93

g/l

0.36

1928

5828

Complications of surgical and medical care, not elsewhere classified

2688

10277

1.83

167.36

2.2

2.3

3.00

2.91

g/l

4.37

2399

9169

L04AD Calcineurin inhibitors

451

1109

4.40

167.16

2.5

3.09

2.92

g/l

2.56

434

1017

Continuous positive airway pressure

654

1683

3.43

166.63

2.2

2.4

3.14

2.90

g/l

5.81

577

1517

Rheumatoid arthritis

1034

3710

2.60

163.65

1.8

2.4

3.17

2.90

g/l

11.66

946

3260

Enlarged lymph nodes

543

1543

3.71

162.21

2.1

2.2

3.00

2.87

g/l

2.04

511

1382

Small fibre neuropathy

230

322

8.85

162.19

2.5

2.4

2.70

3.05

g/l

4.41

205

287

Asthma (only as main-diagnosis)

1746

4847

2.13

161.90

2.0

1.8

2.95

2.85

g/l

3.87

1592

4330

Symptoms and signs involving cognition, perception, emotional state and behaviour

2583

9811

1.83

161.64

2.0

2.3

2.87

2.94

g/l

2.54

2288

8813

Non-Hodgkin lymphoma, all, including Hilmo

584

1768

3.57

160.14

3.0

1.4

3.12

2.94

g/l

3.37

552

1536

Other disorders of fluid, electrolyte and acid-base balance

1051

4121

2.53

158.97

2.5

2.2

3.08

2.97

g/l

2.31

930

3603

Coagulation defects, purpura and other haemorrhagic conditions

714

2437

3.10

158.58

2.5

2.2

3.01

2.96

g/l

0.54

652

2176

Symptoms and signs involving the skin and subcutaneous tissue

1955

10067

1.95

157.18

2.3

2.2

2.83

2.95

g/l

6.38

1761

8959

Cardiovascular diseases

1087

2269

2.62

156.88

2.2

1.8

2.96

2.77

g/l

6.26

1012

2084

Syncope and collapse

1254

4761

2.32

155.44

2.3

2.2

2.93

2.87

g/l

1.15

1081

4197

Preparatory care for dialysis

288

528

6.42

155.11

2.2

2.8

3.21

2.91

g/l

4.34

270

480

Neurological diseases, wide definition

554

688

4.12

155.09

2.1

2.0

2.85

2.95

g/l

1.05

514

622

Gout, strict definition

763

2769

2.95

152.73

2.1

2.5

3.21

2.94

g/l

10.16

697

2446

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1972

9391

1.93

151.51

2.5

2.3

2.97

2.94

g/l

0.73

1776

8302

Disorders resulting from impaired renal tubular function

246

396

7.37

151.30

2.2

2.7

3.13

2.96

g/l

1.44

235

360

Disturbances of skin sensation

823

3095

2.76

151.18

2.0

2.2

2.72

2.92

g/l

9.31

752

2803

Diseases of the skin and subcutaneous tissue

2509

6932

1.85

151.16

2.2

2.94

2.92

g/l

0.32

2269

6163

Diseases of arteries, arterioles and capillaries

2052

8105

1.92

150.13

2.0

2.4

3.15

2.92

g/l

17.63

1838

7143

Gout, unspecified

827

3155

2.79

149.88

2.1

2.3

3.15

2.94

g/l

7.84

761

2781

Heart failure and bmi 25plus

1118

3189

2.47

148.04

2.1

2.5

3.20

2.92

g/l

14.27

992

2748

Disorders of thyroid, IBD co-morbidities

394

603

4.72

147.95

2.0

2.1

2.94

2.93

g/l

0.06

354

541

Fall on same level

2812

8882

1.76

147.07

2.2

2.3

2.97

2.89

g/l

3.65

2444

8119

Other pulmonary diagnosis

1923

4895

2.00

147.01

2.6

1.8

2.98

2.85

g/l

5.74

1754

4374

Dorsalgia

2453

7290

1.83

146.94

2.3

2.1

2.87

2.97

g/l

4.57

2215

6488

COPD/asthma related infections

2574

7222

1.81

146.87

3.0

1.8

3.00

2.86

g/l

8.25

2339

6431

COPD/asthma/ILD related infections

2574

7222

1.81

146.87

3.0

1.8

3.00

2.86

g/l

8.25

2339

6431

Symptoms and signs involving the nervous and musculoskeletal systems

1663

8554

2.00

143.90

2.0

2.3

2.73

2.97

g/l

20.84

1513

7583

Symptoms and signs concerning food and fluid intake

406

1028

4.21

143.63

1.9

2.2

2.86

2.95

g/l

0.92

369

903

Hypertensive heart and/or renal disease

896

2609

2.67

143.60

2.0

2.4

3.14

2.88

g/l

9.90

811

2263

Type 2 diabetes, wide definition

2256

7999

1.85

142.67

2.0

2.5

2.99

2.91

g/l

2.59

2021

7114

Excluding asthma or asthma-COPD overlap

1904

4895

1.98

141.59

2.5

1.8

2.98

2.85

g/l

5.84

1741

4374

Atrial fibrillation and flutter

797

1867

2.85

140.92

2.6

2.1

3.03

2.79

g/l

7.29

739

1684

Other necrotizing vasculopathies (FG)

300

615

5.42

140.60

1.4

3.0

3.63

2.84

g/l

19.32

271

543

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

733

1205

3.11

139.17

2.2

1.9

2.94

2.86

g/l

0.89

676

1094

COPD differential diagnosis

1890

4887

1.97

138.29

2.6

1.8

2.98

2.85

g/l

5.67

1731

4368

ILD differential diagnosis

1890

4887

1.97

138.28

2.6

1.8

2.98

2.85

g/l

5.67

1731

4368

Non-ischemic cardiomyopathy

1090

3857

2.38

138.03

2.2

2.4

3.14

2.92

g/l

9.48

966

3350

Seropositive rheumatoid arthritis

774

2950

2.72

137.50

1.8

2.6

3.14

2.86

g/l

10.37

711

2577

Lower back pain or/and sciatica

2688

10424

1.71

133.56

2.4

2.2

2.90

2.94

g/l

0.98

2424

9297

Asthma (diagnoses ohter than nonallergic)

2241

10634

1.78

133.24

2.0

2.3

2.95

2.93

g/l

0.65

2021

9467

Glomerulonephritis

422

1166

3.91

133.11

2.9

2.3

3.02

2.97

g/l

0.49

399

1056

Symptoms and signs involving the urinary system

2125

9103

1.82

132.52

2.1

2.3

2.95

2.94

g/l

0.12

1872

8103

Malignant immunoproliferative diseases

137

134

16.05

131.89

9.7

2.2

2.74

3.05

g/l

1.98

132

121

Follow-up examination after treatment for conditions other than malignant neoplasms

1118

3292

2.30

129.33

2.3

2.2

2.98

3.02

g/l

0.68

1013

2978

Benign neoplasm of colon, rectum, anus and anal canal

1901

9137

1.85

128.59

2.3

2.4

3.00

2.94

g/l

1.49

1667

8101

Diabetic nephropathy

620

2178

3.01

128.50

1.8

2.1

3.01

2.98

g/l

0.29

570

1929

Care involving use of rehabilitation procedures

1658

8098

1.92

128.12

2.4

2.1

2.91

g/l

0.02

1567

7168

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

925

2382

2.50

127.61

2.3

2.1

2.93

2.77

g/l

4.12

857

2167

Disorders of calcium metabolism

311

712

4.82

127.44

3.9

2.3

2.96

2.97

g/l

0.06

270

642

Disorders of mineral metabolism

363

931

4.23

127.36

3.6

2.3

2.94

2.96

g/l

0.11

317

838

Other CVD (FINNGEN)

418

866

3.97

127.31

2.9

2.3

2.96

2.83

g/l

1.67

362

761

Pain (limb, back, neck, head abdominally)

1772

4620

1.95

126.70

2.3

2.2

2.93

2.96

g/l

0.52

1613

4083

Other dorsopathies, not elsewhere classified

2416

7296

1.76

126.26

2.3

2.1

2.84

2.97

g/l

7.58

2176

6494

Abnormalities of gait and mobility

520

1705

3.29

125.30

1.9

2.3

2.94

2.99

g/l

0.62

473

1519

Asthma-related infections

1559

8052

1.94

124.49

2.2

2.3

3.03

2.93

g/l

3.36

1414

7119

Asthma, hospital admission 2, infections

1559

8052

1.94

124.49

2.2

2.3

3.03

2.93

g/l

3.36

1414

7119

Other necrotizing vasculopathies

351

903

4.29

123.55

1.6

2.7

3.61

2.92

g/l

17.41

319

809

Parasetamol

1656

4305

1.98

123.44

2.4

1.9

2.98

2.87

g/l

3.68

1504

3905

Endocrine, nutritional and metabolic diseases

1699

4455

1.96

123.34

2.2

2.3

2.95

2.89

g/l

1.36

1555

4030

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2387

9160

1.72

121.81

2.7

2.1

2.93

g/l

0.03

2155

8235

Constipation

2352

9602

1.73

121.59

2.7

2.2

2.88

2.95

g/l

2.83

2050

8604

Osteoporosis with pathological fracture (FG)

323

790

4.48

121.30

1.8

2.6

2.96

2.88

g/l

0.62

252

670

Other and unspecified dermatitis

1401

7209

1.99

121.23

2.1

2.3

2.88

2.95

g/l

1.59

1268

6397

Soft tissue disorders

2410

7244

1.74

120.39

2.2

2.3

2.89

2.95

g/l

2.07

2189

6442

Dermatitis and eczema

2739

10407

1.66

119.26

2.1

2.3

2.86

2.95

g/l

4.58

2481

9269

Purpura and other haemorrhagic conditions

506

1675

3.21

119.12

2.5

2.4

2.93

2.96

g/l

0.24

464

1503

Symptoms and signs involving the circulatory and respiratory systems

2282

6577

1.76

119.09

2.2

2.1

2.91

2.93

g/l

0.33

2078

5898

Bleeding

2246

9379

1.74

118.92

2.2

2.3

3.04

2.92

g/l

6.09

2000

8336

Any reimbursement code in KELA

1076

2361

2.32

118.66

2.5

1.5

2.97

2.73

g/l

10.37

1007

2093

Cardiac arrhythmias

1294

4122

2.08

116.75

2.4

2.3

2.94

2.85

g/l

2.32

1191

3742

Rheumatoid arthritis, including avohilmo

1145

5595

2.11

115.37

1.8

2.4

3.15

2.93

g/l

9.21

1047

4923

Dermatitis

1613

8823

1.86

114.06

2.1

2.3

2.87

2.95

g/l

2.30

1458

7836

Other special examinations and investigations of persons without complaint or reported diagnosis

1512

3914

1.99

114.03

2.2

2.1

2.82

3.03

g/l

10.66

1369

3530

Asthma, hospital admissions 3, pneumonia

1103

5328

2.13

113.81

2.3

2.2

3.12

2.95

g/l

5.62

1010

4641

Asthma-related pneumonia or sepsis

1103

5328

2.13

113.81

2.3

2.2

3.12

2.95

g/l

5.62

1010

4641

Asthma-related pneumonia

1100

5320

2.13

113.15

2.3

2.2

3.12

2.95

g/l

5.65

1007

4633

Diseases of the musculoskeletal system and connective tissue

1074

2414

2.26

112.43

2.3

2.1

2.97

2.90

g/l

1.23

987

2156

Extracorporeal dialysis

295

718

4.56

112.06

2.6

2.5

3.20

2.92

g/l

3.83

272

657

Chronic lymphocytic leukaemia

199

351

6.76

112.05

2.0

1.4

2.85

3.03

g/l

1.51

187

302

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

199

351

6.76

112.05

2.0

1.4

2.85

3.03

g/l

1.51

187

302

Chronic lymphocytic leukaemia, helper endpoint

199

351

6.76

112.05

2.0

1.4

2.85

3.03

g/l

1.51

187

302

Spinal stenosis

1487

5994

1.93

111.93

2.2

2.83

3.00

g/l

8.90

1313

5270

Haemorrhage from respiratory passages

1032

4390

2.18

111.63

2.2

2.3

3.03

2.97

g/l

1.31

927

3858

Nephrotic syndrome

184

299

7.09

111.51

2.8

2.6

3.02

2.94

g/l

0.42

179

271

Intestinal infectious diseases

2320

10632

1.68

111.33

2.9

2.1

3.00

2.91

g/l

3.77

2097

9478

ILD medications: azathioprine

397

1175

3.52

111.12

1.8

1.5

3.10

2.82

g/l

5.46

366

1055

Depression medications

449

618

3.71

110.74

1.8

1.2

2.93

2.72

g/l

3.24

433

575

Atrial fibrillation and flutter with reimbursement

668

1589

2.76

110.55

2.6

2.2

3.09

2.80

g/l

8.42

612

1425

Intestinal infectious diseases

2830

10142

1.62

110.32

2.7

2.1

2.98

2.92

g/l

2.17

2553

9036

Neurological diseases

1909

5380

1.81

108.53

2.1

2.4

2.85

3.04

g/l

11.98

1714

4846

Neoplasms

1509

4179

1.94

107.99

2.7

1.2

2.92

2.90

g/l

0.20

1400

3747

Valvular heart disease excluding rheumatic fever

1296

4781

2.01

107.93

2.4

2.3

3.06

2.88

g/l

7.33

1150

4225

Diarrhoea and gastroenteritis of presumed infectious origin

1738

8887

1.79

107.67

2.7

2.0

3.00

2.92

g/l

2.58

1571

7898

Amyloidosis, other/unspecified

152

213

8.95

107.49

8.2

2.4

2.69

3.02

g/l

2.99

146

192

Other disorders of urethra and urinary system

1765

7197

1.80

107.02

2.2

2.3

2.95

2.92

g/l

0.69

1584

6401

Heart failure and coronary heart disease

1396

5216

1.96

106.50

2.0

2.5

3.17

2.95

g/l

11.43

1254

4535

Chronic gastritis

897

4122

2.26

106.45

2.1

2.4

3.00

2.99

g/l

0.05

783

3637

Non-rheumatic valve diseases

1290

4772

2.00

106.38

2.4

2.3

3.05

2.88

g/l

7.20

1144

4216

Persons encountering health services for examination and investigation

1496

3914

1.95

106.25

2.2

2.1

2.92

3.03

g/l

3.29

1351

3530

Complications of medical and surgical care

1922

10388

1.73

105.94

2.4

2.3

3.01

2.92

g/l

3.50

1720

9244

Complications of procedures, not elsewhere classified

2045

10069

1.71

105.76

2.1

2.3

2.99

2.91

g/l

2.73

1833

8976

Amyloidosis

165

256

7.78

105.65

7.8

2.3

2.71

3.05

g/l

3.61

157

232

Cardiomyopathy

588

2247

2.74

105.47

2.6

2.2

3.08

2.88

g/l

4.56

539

1975

Non-follicular lymphoma

414

1327

3.38

103.98

2.6

2.5

3.16

2.96

g/l

2.95

392

1187

Hypothyroidism (congenital or acquired)

393

601

3.75

103.21

2.4

1.2

2.79

2.73

g/l

0.44

369

558

Bacterial pneumoniae

1149

5114

2.03

102.99

3.7

2.0

3.13

2.87

g/l

13.12

1069

4511

Hypertensive Renal Disease

202

386

5.87

102.87

1.7

2.6

3.08

2.94

g/l

0.92

193

339

Bacterial pneumonia, not elsewhere classified

1109

4872

2.06

102.83

3.7

2.0

3.14

2.88

g/l

13.01

1039

4285

Hyperlipidaemia, other/unspecified

1133

5283

2.03

101.77

2.3

2.2

3.01

2.95

g/l

1.10

1000

4644

Other disorders of white blood cells

259

615

4.65

101.49

2.1

2.6

3.01

2.96

g/l

0.29

234

557

Antihypertensive medication - note that there are other indications

1032

2542

2.18

100.80

2.1

2.92

2.81

g/l

2.36

955

2305

Lymphoid leukaemia

279

706

4.39

100.78

2.7

2.88

3.01

g/l

1.15

263

630

Hypothyroidism, levothyroxine purchases

388

600

3.72

100.56

2.4

1.2

2.79

2.72

g/l

0.53

364

557

Hypothyroidism and >3 levothyroxin purchases

388

600

3.72

100.56

2.4

1.2

2.79

2.72

g/l

0.53

364

557

Genitourinary diseases

1258

3162

2.03

99.92

2.1

2.2

2.95

2.91

g/l

0.68

1161

2849

STROKE

1415

5174

1.90

99.61

2.5

2.4

2.96

2.88

g/l

2.33

1263

4612

Other diseases of urinary system

2418

8407

1.64

99.56

2.2

2.3

2.95

2.91

g/l

1.07

2178

7541

Benign neoplasm: Colon

1595

8683

1.80

99.49

2.3

2.4

3.01

2.95

g/l

1.71

1389

7709

Other antidepressants

2524

8047

1.63

99.28

2.1

2.3

2.89

2.94

g/l

1.32

2225

7248

Certain disorders involving the immune mechanism

600

2402

2.61

97.84

2.7

2.2

2.86

2.94

g/l

0.96

561

2161

Disorders of other endocrine glands

1123

5676

1.99

97.37

2.3

2.2

2.90

2.95

g/l

0.80

1003

5034

Fracture of lumbar spine and pelvis

742

3272

2.36

97.22

2.2

3.02

3.00

g/l

0.11

600

2848

Other and unspecified diseases of blood and blood-forming organs

167

284

6.88

97.17

5.1

2.6

3.03

2.98

g/l

0.21

159

261

Dizziness and giddiness

1915

9067

1.70

97.01

2.0

2.4

2.86

2.94

g/l

2.92

1705

8107

Spondylosis

1437

6475

1.85

96.30

2.1

2.2

2.86

2.98

g/l

5.35

1291

5738

Arthropathies

1951

5789

1.73

96.01

2.1

2.3

2.94

2.89

g/l

1.28

1781

5182

Diseases of liver

983

4873

2.08

95.28

1.8

2.4

2.98

2.93

g/l

1.05

862

4387

2761

9173

1.58

94.89

3.1

2.0

2.95

2.92

g/l

0.53

2499

8137

Chronic lower respiratory diseases

2808

9671

1.57

94.65

2.0

2.3

2.98

2.91

g/l

3.47

2543

8633

Malignant neoplasm, wide definition for exclusion

2041

7200

1.69

94.61

3.7

1.4

2.98

2.89

g/l

2.80

1886

6410

Need for other prophylactic measures

254

627

4.42

94.28

2.3

2.5

3.09

2.97

g/l

1.08

248

567

Disorders of parathyroid gland

698

3005

2.40

94.28

2.3

2.2

2.90

3.01

g/l

2.32

612

2618

Diaphragmatic hernia

1085

5603

2.00

93.80

2.3

3.02

2.96

g/l

1.11

949

4941

Adjustment and management of implanted device

649

2751

2.47

93.78

2.6

2.1

3.16

2.97

g/l

5.36

591

2369

1076

5474

1.99

93.76

2.3

2.2

2.99

2.92

g/l

1.61

977

4864

Dorsopathies

2323

7301

1.64

93.39

2.3

2.1

2.85

2.97

g/l

5.98

2100

6498

Secondary hypertension

254

617

4.29

93.20

2.3

2.2

3.08

2.82

g/l

3.26

239

552

Myelodysplastic syndrome, including Hilmo

184

357

5.95

92.98

2.3

1.4

3.00

3.02

g/l

0.07

168

305

Malignant neoplasm

1999

7114

1.69

92.94

3.9

1.4

2.97

2.89

g/l

2.34

1842

6327

Injuries to the abdomen, lower back, lumbar spine and pelvis

1096

5626

1.98

92.70

2.3

2.2

2.99

2.95

g/l

0.58

919

4981

Gastrointestinal diseases

1186

3003

2.01

92.01

2.5

1.9

2.96

2.92

g/l

0.65

1083

2721

Hypothyroidism, drug reimbursement

269

450

4.32

91.65

2.4

1.3

2.84

2.73

g/l

0.88

253

412

Other/unspecified dorsalgia

956

4706

2.06

91.49

2.7

2.1

2.90

2.99

g/l

1.97

851

4153

Use of hypnotics and sedatives

2555

9415

1.58

90.72

2.6

2.2

2.91

2.93

g/l

0.33

2278

8447

Azathioprine

397

1335

3.09

90.03

1.8

2.5

3.10

2.84

g/l

4.93

366

1204

Abnormal findings on diagnostic imaging of lung

1407

7651

1.81

89.40

2.4

2.3

3.01

2.95

g/l

1.50

1254

6743

Sicca syndrome [Sjögren]

328

999

3.52

89.16

1.8

2.6

2.85

2.92

g/l

0.67

295

891

Other intervertebral disc disorders

1952

7112

1.68

88.99

2.2

2.1

2.81

2.97

g/l

9.21

1763

6317

Acquired haemolytic anaemia

158

278

6.67

88.94

3.5

2.1

2.91

3.04

g/l

0.76

149

248

Other disorders of kidney and ureter

476

1794

2.81

88.53

2.3

2.99

2.96

g/l

0.33

452

1608

Myalgia

604

2535

2.45

88.14

2.0

2.2

2.85

2.95

g/l

1.69

539

2265

Sulfasalazine

702

3145

2.29

87.92

1.7

2.4

3.16

2.85

g/l

12.64

644

2797

Hypertensive Heart Disease

716

2489

2.33

87.88

2.1

2.4

3.16

2.88

g/l

9.14

637

2155

389

1315

3.08

87.59

2.2

2.3

3.14

2.92

g/l

3.74

352

1184

Kidney transplant status

214

490

4.76

87.51

1.7

2.4

3.19

2.85

g/l

4.12

207

452

Chronic apical periodontitis

2656

9871

1.55

87.46

2.4

2.2

2.92

2.93

g/l

0.29

2355

8851

Haemolytic anaemias

180

360

5.61

87.26

3.3

2.2

2.92

3.05

g/l

0.87

170

320

Nerve, nerve root and plexus disorders

2571

10257

1.56

86.77

2.2

2.3

2.82

2.96

g/l

9.26

2315

9141

Other joint disorders

1840

5786

1.70

85.77

2.0

2.3

2.88

2.89

g/l

0.12

1664

5179

Weight loss

374

1262

3.16

85.55

2.0

2.4

2.87

2.98

g/l

1.22

340

1128

Infections of the skin and subcutaneous tissue

1374

7764

1.78

85.24

2.4

2.2

3.03

2.91

g/l

4.19

1256

6981

Other medical care

1226

6084

1.85

84.28

3.4

2.1

3.18

2.94

g/l

10.21

1119

5313

SLE (Finngen)

160

296

5.98

84.15

1.8

2.3

3.16

2.94

g/l

1.40

149

272

Venous thromboembolism

1499

8516

1.74

83.67

2.6

2.2

3.05

2.95

g/l

3.53

1348

7489

Gastro-oesophageal reflux disease

1663

8636

1.69

83.11

2.0

2.3

2.83

2.94

g/l

4.55

1445

7750

Cerebrovascular diseases

1988

8728

1.63

83.07

2.3

3.02

2.94

g/l

2.85

1729

7791

Disorders of choroid and retina

2097

9456

1.60

82.10

2.3

2.96

2.95

g/l

0.17

1839

8429

Other and unspecified disorders of white blood cells

200

460

4.84

81.96

2.0

2.7

2.99

g/l

0.03

184

415

Thrombocytopenia, unspecified

290

864

3.62

81.88

2.0

2.5

2.91

2.97

g/l

0.41

261

781

Abnormal weight loss

354

1189

3.18

81.81

1.9

2.4

2.85

2.98

g/l

1.50

322

1064

Bacterial pneumonia (organism specified)

1228

6210

1.83

81.70

3.9

2.1

3.14

2.93

g/l

9.23

1143

5425

Disorders of eyelid, lacrimal system and orbit

2100

10178

1.59

80.89

2.4

2.3

2.87

2.95

g/l

2.85

1851

9080

Intracranial trauma

1166

4432

1.88

80.85

2.2

2.3

2.88

3.03

g/l

4.74

1019

4007

Other functional intestinal disorders

1132

5733

1.87

80.78

2.5

2.2

2.83

2.94

g/l

3.34

997

5070

Viral pneumonia

405

1470

2.88

80.39

3.7

1.9

3.02

2.88

g/l

1.73

375

1304

Disorders of lens

1734

6553

1.68

80.11

2.5

2.3

2.97

2.94

g/l

0.73

1542

5955

Periodontitis

2344

10229

1.55

79.99

2.3

2.98

2.92

g/l

2.12

2070

9173

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1580

7585

1.71

79.92

2.1

2.5

3.00

2.94

g/l

1.56

1401

6688

Seronegative rheumatoid arthritis

353

1194

3.10

79.71

2.1

2.8

3.22

2.84

g/l

7.31

323

1065

Chronic periodontitis, including avohilmo

2337

10225

1.55

79.63

2.3

2.98

2.92

g/l

2.18

2062

9170

Diseases of the respiratory system

1458

4160

1.78

79.14

2.6

1.9

3.01

2.87

g/l

5.02

1326

3699

Injuries to the head

2554

10434

1.52

78.52

2.2

2.3

2.95

2.92

g/l

0.75

2242

9380

COPD (mode)

832

3220

2.09

78.35

1.8

1.9

3.26

2.86

g/l

22.78

728

2826

Other diseases of blood and blood-forming organs

275

817

3.63

77.99

4.1

2.5

2.99

2.95

g/l

0.29

252

742

Any event in cancer register

2057

7672

1.60

77.79

3.6

1.5

2.96

2.89

g/l

2.26

1886

6853

All influenza

667

3083

2.23

77.60

4.4

1.9

2.94

2.86

g/l

1.09

596

2728

Hypercalcemia

217

555

4.36

77.56

4.4

2.6

2.92

3.00

g/l

0.41

194

491

Other external causes of accidental injury

1834

5610

1.66

77.32

2.1

2.3

2.95

2.90

g/l

1.24

1624

5137

Cough

989

4969

1.92

77.20

2.5

2.2

2.93

2.95

g/l

0.34

884

4410

Streptococcal septicaemia

307

979

3.32

77.14

4.3

2.1

3.18

2.82

g/l

6.35

276

859

Pruritus

360

1258

3.01

76.90

2.0

2.4

2.77

3.01

g/l

5.28

328

1129

Explicit bacterial Sepsis

352

1216

3.04

76.74

4.4

2.1

3.19

2.93

g/l

4.09

318

1082

Symptoms and signs involving the digestive system and abdomen

2328

7565

1.56

76.61

2.3

2.2

2.89

2.95

g/l

2.24

2111

6721

Other bacterial intestinal infections

658

3046

2.23

76.59

3.7

2.1

3.02

2.95

g/l

0.93

585

2688

Diseases of the eye and adnexa

1616

4789

1.71

76.54

2.2

2.1

2.88

2.93

g/l

1.18

1490

4364

Other disorders involving the immune mechanism, not elsewhere classified

152

295

5.76

76.15

2.1

2.6

2.97

2.94

g/l

0.12

144

271

Paroxysmal tachycardia

475

1571

2.59

75.67

1.8

2.2

2.95

2.79

g/l

2.54

427

1408

Viral infections characterized by skin and mucous membrane lesions

1981

10874

1.58

75.63

2.8

2.2

2.88

2.94

g/l

1.74

1781

9723

Gonarthrosis [arthrosis of knee](FG)

1709

6053

1.67

75.55

2.0

2.5

2.96

2.84

g/l

4.62

1534

5399

Other diseases of pleura

1306

6652

1.76

75.38

2.5

2.3

3.14

2.94

g/l

9.97

1166

5852

Giant cell arteritis

210

536

4.37

75.30

1.5

2.8

3.72

2.96

g/l

11.74

186

473

Peripheral artery disease

1300

5986

1.77

75.11

2.0

2.4

3.20

2.93

g/l

15.55

1163

5228

Hypo-osmolality and hyponatraemia

541

2319

2.41

74.99

2.7

2.1

3.03

2.99

g/l

0.32

481

2000

Dialysis

169

363

5.11

74.96

2.3

2.0

3.18

2.89

g/l

2.39

162

333

Isolated proteinuria

145

275

5.93

74.65

3.1

2.6

2.88

2.96

g/l

0.38

137

247

Injuries to the hip and thigh

1307

6905

1.75

74.47

2.1

2.3

3.05

2.96

g/l

2.35

1056

6142

Diabetes, varying definitions

2306

8882

1.54

74.18

2.0

2.4

2.97

2.90

g/l

2.41

2071

7931

Diarrhoea and gastroenteritis of presumed infectious origin

2322

10121

1.53

74.15

2.5

2.1

2.98

2.92

g/l

2.02

2092

9018

Diabetes mellitus

2312

8887

1.54

74.00

2.0

2.4

2.97

2.90

g/l

2.17

2076

7937

Seropositive rheumatoid arthritis, wide

774

3864

2.07

73.94

1.8

2.3

3.14

2.93

g/l

6.23

711

3405

DVT of lower extremities and pulmonary embolism

1179

6700

1.80

73.94

2.7

2.3

3.04

2.96

g/l

1.94

1056

5888

Hard cardiovascular diseases

1988

7558

1.59

73.61

2.3

2.4

2.96

2.90

g/l

2.01

1805

6759

Asthma, including avohilmo

2696

10275

1.49

73.55

2.0

2.3

2.95

2.92

g/l

0.76

2442

9152

Accidents

1814

5610

1.64

73.30

2.2

2.3

2.94

2.90

g/l

0.92

1606

5137

Falls/tendency to fall

2355

7748

1.54

73.03

2.2

2.3

2.93

2.90

g/l

0.74

2077

7099

Unspecified haematuria

1165

5463

1.81

73.00

2.2

2.4

3.03

2.95

g/l

1.79

1035

4852

Bronchitis

2481

10500

1.51

72.73

3.2

2.0

2.96

2.92

g/l

1.09

2245

9344

General examination and investigation of persons without complaint and reported diagnosis

1316

3907

1.78

72.35

2.3

2.1

2.67

3.03

g/l

25.94

1163

3525

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

753

3756

2.07

72.15

1.9

2.3

3.13

2.94

g/l

5.47

691

3312

Benign neoplasms

2146

7676

1.56

71.94

2.3

2.2

2.90

2.94

g/l

1.01

1935

6912

Other/unspecified seropositive rheumatoid arthritis

763

3828

2.06

71.91

1.8

2.3

3.14

2.94

g/l

5.93

700

3374

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1537

9361

1.65

71.39

2.2

2.3

3.02

2.92

g/l

3.21

1378

8306

Viral hepatitis, IBD co-morbidity

120

194

6.42

71.30

1.9

1.6

2.99

2.84

g/l

0.78

109

182

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2298

9785

1.52

71.29

2.4

2.2

2.96

2.92

g/l

0.83

2067

8745

Sciatica+with lumbago

1180

6227

1.77

71.17

2.0

2.2

2.89

2.97

g/l

2.03

1072

5548

Systemic lupus erythematosus

160

344

5.13

71.02

1.8

2.1

3.16

2.89

g/l

2.10

149

317

Factors influencing health status and contact with health services

667

1494

2.28

70.99

2.4

1.9

2.95

3.01

g/l

0.64

602

1338

Insulin medication

1499

7695

1.67

70.91

2.1

2.4

3.01

2.93

g/l

2.20

1346

6828

Statin medication

1392

4580

1.73

70.73

2.1

2.4

2.94

2.86

g/l

1.73

1277

4079

Other bacterial intestinal infections

541

2392

2.35

70.68

3.8

2.1

3.02

2.97

g/l

0.50

483

2108

Implicit fungal Sepsis

257

778

3.54

70.68

2.7

2.4

3.08

2.96

g/l

0.99

226

697

Other arrhythmias

1407

6341

1.70

70.65

2.1

2.2

2.87

2.86

g/l

0.15

1251

5677

Idiopathic gout

353

1287

2.92

70.40

2.0

2.3

3.19

2.93

g/l

4.11

316

1140

Pulmonary heart disease, diseases of pulmonary circulation

935

5056

1.90

70.35

2.5

2.3

3.09

2.95

g/l

3.97

845

4438

Type 2 diabetes

2260

8745

1.53

70.06

2.0

2.4

2.98

2.91

g/l

2.39

2028

7802

Obesity related asthma

865

4568

1.94

69.74

1.9

2.4

2.92

2.90

g/l

0.16

774

4111

Cystitis

1949

7450

1.58

69.39

2.2

2.3

2.95

2.92

g/l

0.74

1726

6636

Hyperparathyroidism

582

2653

2.26

68.76

2.4

2.2

2.90

3.02

g/l

2.09

512

2306

Other arthrosis

1254

5056

1.75

68.36

2.0

2.4

2.91

2.89

g/l

0.23

1133

4507

Other diseases of hard tissues of teeth

1491

4635

1.69

67.82

2.3

2.1

2.92

2.99

g/l

1.47

1312

4128

Chronic rhinitis, nasopharyngitis and pharyngitis

775

3979

1.99

67.80

2.1

2.2

2.91

2.94

g/l

0.32

693

3583

Coxarthrosis [arthrosis of hip](FG)

1303

5414

1.72

67.70

2.1

2.6

2.95

2.85

g/l

2.95

1156

4802

Benzodiazepine use

2313

10768

1.50

66.92

2.1

2.3

2.94

2.93

g/l

0.25

2009

9682

Unspecified privation

346

1279

2.84

66.64

1.9

2.3

3.25

2.97

g/l

4.73

316

1158

Asthma, hospital admissions , main diagnosis only

1853

10663

1.55

66.29

2.0

2.3

2.95

2.93

g/l

0.47

1678

9498

Other specified/unspecified systemic involvement of connective tissue

215

605

3.81

66.17

1.7

2.8

3.08

2.91

g/l

1.36

203

546

Vasculitis limited to skin, not elsewhere classified

140

288

5.49

65.97

2.3

2.6

3.08

3.05

g/l

0.12

134

259

Other diseases of intestine

439

1830

2.50

65.83

2.4

2.2

3.00

2.96

g/l

0.29

407

1634

Other symptoms and signs involving cognitive functions and awareness

1226

6623

1.72

65.82

2.0

2.4

2.90

2.97

g/l

1.43

1033

5860

Abdominal and pelvic pain

2258

7565

1.52

65.49

2.3

2.2

2.87

2.95

g/l

3.20

2039

6721

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

135

270

5.55

65.36

1.9

2.6

3.01

2.91

g/l

0.48

128

247

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2158

8676

1.52

65.04

1.9

2.4

2.97

2.91

g/l

2.06

1937

7743

Mixed connective tissue disease

235

711

3.54

64.72

1.7

2.6

3.10

2.95

g/l

1.32

218

644

Fibromyalgia

251

788

3.33

64.34

2.1

2.0

2.82

2.91

g/l

0.69

234

724

Dysphagia

690

3479

2.04

64.01

2.2

2.4

2.86

3.00

g/l

2.64

613

3065

SLE, ICD10

154

350

4.85

63.95

1.8

1.9

3.13

2.93

g/l

1.24

143

321

SLE, strict definition

154

350

4.85

63.95

1.8

1.9

3.13

2.93

g/l

1.24

143

321

Hernia

2148

9673

1.51

63.94

2.4

2.2

2.94

g/l

0.06

1904

8629

Other cataract

1174

5209

1.74

63.87

2.6

2.3

2.93

2.95

g/l

0.26

1035

4706

Hyperkalaemia

226

674

3.60

63.74

2.4

2.2

3.21

2.97

g/l

2.25

199

586

Diseases of oral cavity, salivary glands and jaws

1491

4686

1.66

63.54

2.3

2.1

2.95

2.99

g/l

0.66

1312

4168

Senile cataract

1588

6110

1.62

63.42

2.6

2.3

2.98

2.94

g/l

0.69

1400

5537

Episodal and paroxysmal disorders

2409

8351

1.48

63.20

1.9

2.4

2.84

2.97

g/l

8.22

2147

7476

Mood disorders, excluding more controls

2118

8454

1.51

63.07

2.0

2.3

2.90

2.93

g/l

0.96

1873

7642

Fracture of rib(s), sternum and thoracic spine

838

4538

1.90

62.82

2.5

2.3

2.97

2.96

g/l

0.11

724

4029

Other acute lower respiratory infections

1261

7279

1.68

62.64

3.3

2.1

3.04

2.93

g/l

3.65

1159

6434

Presence of cardiac and vascular implants and grafts

1276

5726

1.69

62.22

1.8

2.3

3.02

2.99

g/l

0.59

1100

5072

Pulmonary embolism

841

4574

1.89

62.21

2.5

2.3

3.08

2.96

g/l

3.05

759

4022

Vocal cord dysfunction

292

899

2.99

62.10

2.5

2.88

2.81

g/l

0.63

256

837

Arthrosis

1581

5429

1.62

62.09

2.1

2.4

2.92

2.90

g/l

0.30

1428

4840

Atherosclerosis, excluding cerebral and coronary sclerosis

1201

5674

1.72

62.07

2.0

2.4

3.23

2.94

g/l

16.78

1073

4947

Polyuria

654

3278

2.06

61.98

2.0

2.4

2.91

2.96

g/l

0.55

578

2906

Non-Hodgkin lymphoma, all

195

540

3.95

61.97

3.8

1.4

3.16

3.01

g/l

1.10

188

461

Temporal arteritis

178

465

4.26

61.86

1.5

2.8

3.78

2.97

g/l

11.04

157

408

Injuries to the thorax

1162

6934

1.71

61.79

2.3

2.98

2.95

g/l

0.43

1008

6180

Persons encountering health services for specific procedures, not carried out

248

794

3.27

61.68

2.2

2.0

3.06

2.90

g/l

2.02

231

726

Pulmonary heart disease

841

4588

1.88

61.62

2.5

2.3

3.08

2.96

g/l

2.96

759

4034

Bacterial intestinal infections, IBD co-morbidities

541

2532

2.21

61.58

4.0

2.1

3.02

2.98

g/l

0.39

484

2234

Diseases of the digestive system

1194

7154

1.69

61.44

2.3

3.03

2.95

g/l

2.10

1071

6311

Immunodeficiencies

183

486

4.06

61.41

4.4

2.4

2.79

2.91

g/l

0.78

172

446

Hernia of abdominal wall, postoperative

440

1888

2.40

61.28

2.2

2.0

2.92

2.85

g/l

0.69

402

1709

Diabetes, insulin treatment (Kela reimbursement)

2315

9605

1.47

60.55

1.9

2.4

2.98

2.92

g/l

1.76

2084

8553

Other nutritional deficiencies

1417

8388

1.61

60.32

1.9

2.3

3.02

2.90

g/l

4.54

1269

7581

Speech therapy

727

3812

1.96

60.31

2.4

2.3

3.07

2.95

g/l

2.51

685

3372

Exposure to other specified factors

1630

9714

1.56

60.03

2.0

2.3

3.02

2.91

g/l

4.19

1429

8772

Gingivitis and periodontal diseases

2351

8320

1.47

59.93

2.4

2.1

2.94

2.93

g/l

0.17

2092

7414

Depression or dysthymia

1596

5581

1.60

59.72

2.1

2.4

2.90

2.95

g/l

1.32

1393

5089

Shoulder lesions

1726

6779

1.56

59.63

2.2

2.3

2.91

2.95

g/l

1.06

1550

6023

Immunodeficiency with predominantly antibody defects

124

250

5.52

59.57

5.0

2.0

2.83

2.93

g/l

0.45

117

233

ILD, hospital admission 2, with pulmonary infections

327

1246

2.76

59.51

2.3

1.8

3.21

2.91

g/l

5.55

303

1082

Insulin, intermediate and long-acting

1361

8300

1.62

58.99

2.0

2.3

2.99

2.94

g/l

1.03

1220

7389

Concussion

953

4404

1.79

58.67

2.0

2.3

2.87

3.03

g/l

4.96

833

3979

Acute bronchitis

1007

5747

1.75

58.53

3.2

2.1

3.07

2.94

g/l

3.90

925

5045

Visual disturbances and blindness

1254

7738

1.65

58.44

2.2

2.86

2.96

g/l

2.67

1105

6859

Other and unspecified vasculitis limited to skin

125

260

5.42

58.18

2.4

2.5

3.10

3.02

g/l

0.34

120

232

Disorders of gallbladder, biliary tract and pancreas

2301

10051

1.46

58.09

2.3

2.95

2.93

g/l

0.29

2052

8972

Other retinal disorders

1633

8306

1.56

57.64

2.2

2.3

2.95

2.96

g/l

0.20

1414

7353

Secondary and unspecified malignant neoplasm of lymph nodes

281

1008

2.95

57.60

1.8

1.4

3.26

2.94

g/l

4.48

264

878

Other disorders of veins

996

5783

1.75

57.52

2.1

2.2

3.02

2.93

g/l

1.99

872

5142

IgA nephropathy (IgA glomerulonephritis)

115

224

5.74

57.51

1.7

2.6

3.05

2.92

g/l

0.67

108

203

Abnormalities of heart beat

818

4414

1.85

57.51

2.1

2.2

2.83

2.96

g/l

3.15

722

3881

Persons with potential health hazards related to communicable diseases

685

3528

1.96

57.46

2.2

2.0

2.85

2.88

g/l

0.41

655

3245

Nausea and vomiting

671

3399

1.98

57.42

2.8

2.3

3.00

2.99

g/l

0.04

604

2956

Non-allergic asthma (mode), excluding more controls

424

1822

2.36

57.34

1.9

1.7

3.08

2.83

g/l

5.61

383

1605

Other (seronegative) rheumatoid arthritis, wide

542

2613

2.15

57.20

2.0

2.3

3.21

2.95

g/l

5.59

493

2310

Systemic lupus erythematosus, unspecified

133

295

4.97

56.98

1.8

2.0

3.14

2.92

g/l

1.28

124

271

Insulin, combination of fast acting with intermediate-acting or long-acting

1499

8843

1.57

56.92

2.1

2.3

3.01

2.94

g/l

1.91

1346

7860

Abnormal findings on examination of urine, without diagnosis

176

481

3.96

56.82

3.4

2.7

2.90

2.99

g/l

0.48

164

436

Sleep disorders (combined)

2528

9326

1.44

56.79

1.9

2.3

2.87

2.96

g/l

3.98

2243

8343

Ischemic heart diseases

1939

7831

1.51

56.57

2.3

2.4

2.96

2.91

g/l

1.09

1771

6960

Polyarthrosis

551

2477

2.13

56.51

2.3

2.5

3.01

2.93

g/l

0.81

476

2164

Endocarditis

145

347

4.54

56.17

2.0

2.1

3.63

2.98

g/l

7.11

135

308

Visual disturbances

1158

7081

1.67

56.14

2.2

2.3

2.85

2.95

g/l

2.76

1035

6293

Other disorders of lacrimal gland

862

4869

1.81

56.11

2.7

2.3

2.83

2.95

g/l

2.98

758

4340

Other gastritis (incl. Duodenitis)

620

3161

2.02

55.87

2.3

2.4

3.06

2.98

g/l

1.11

544

2812

Cardiomyopathy, other and unspecified

259

903

3.03

55.87

2.3

2.2

3.08

2.89

g/l

2.18

237

794

Giant cell arteritis with polymyalgia rheumatica

178

500

3.95

55.82

1.5

2.7

3.78

3.01

g/l

10.22

157

441

Other diseases of pericardium

168

451

4.00

55.49

1.7

2.2

3.43

2.95

g/l

4.62

149

399

Irritable bowel syndrome

608

3081

2.02

55.30

2.3

2.2

2.73

2.93

g/l

6.04

536

2774

Cutaneous abscess, furuncle and carbuncle

614

3127

2.01

55.21

2.0

2.2

2.99

2.92

g/l

0.99

567

2829

Osteonecrosis

224

728

3.29

54.99

7.3

2.1

3.02

2.93

g/l

0.59

206

673

Asthma/COPD (KELA code 203)

2053

9667

1.47

54.94

2.0

2.3

2.95

2.91

g/l

1.23

1835

8630

Zoster [herpes zoster]

1244

7676

1.63

54.47

3.0

2.2

2.89

2.96

g/l

1.66

1099

6755

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1396

8980

1.58

54.37

2.1

2.3

3.02

2.93

g/l

2.46

1250

7976

Undetermined asthma, excluding more controls

308

1184

2.68

54.36

2.0

1.5

2.96

2.84

g/l

1.38

276

1048

Prurigo nodularis

122

264

5.17

54.13

1.6

3.1

2.88

3.05

g/l

1.02

111

235

Diabetes medication

2276

9435

1.45

54.03

1.9

2.4

2.97

2.91

g/l

2.05

2033

8412

Mycoses

1863

11054

1.48

53.69

2.2

2.91

2.93

g/l

0.49

1643

9928

Retention of urine

930

4433

1.76

53.34

1.9

2.4

3.01

2.96

g/l

0.79

821

3925

Biological medication for rheuma

382

1642

2.39

53.10

1.5

2.3

3.14

2.91

g/l

3.58

360

1515

Marginal zone B-cell lymphoma, including Hilmo

176

6.42

52.97

2.6

1.4

2.93

2.96

g/l

0.08

149

Fibrosis and cirrhosis of liver

266

975

2.89

52.54

1.6

2.6

3.00

2.95

g/l

0.37

240

887

Conduction disorders

759

3377

1.86

52.50

2.2

3.04

2.90

g/l

3.05

667

2955

Enterocolitis due to Clostridium difficile

346

1440

2.51

52.37

4.4

2.2

3.09

3.00

g/l

0.77

316

1272

Lumbar disc prolapse

1370

6735

1.58

52.08

2.3

2.2

2.81

2.97

g/l

6.64

1246

6015

Myelodysplastic syndrome

113

8.18

51.95

1.7

1.3

2.93

3.17

g/l

0.79

Fracture of femur

779

3956

1.83

51.68

2.2

2.3

3.13

3.00

g/l

2.30

589

3458

Any mental disorder

2447

8695

1.42

51.66

2.1

2.3

2.90

2.94

g/l

0.80

2162

7854

Viral infections characterized by skin and mucous membrane lesions

950

5635

1.72

51.59

3.4

2.1

2.89

2.93

g/l

0.66

866

5027

Obesity

1310

8107

1.58

51.46

1.8

2.3

3.02

2.90

g/l

4.14

1179

7324

Obesity and other hyperalimentation

1316

8141

1.58

51.45

1.8

2.3

3.02

2.90

g/l

4.13

1183

7354

Early onset COPD, excluding more controls

476

2268

2.15

51.34

2.0

1.8

3.17

2.84

g/l

9.60

430

2033

Anxiety disorders, excluding more controls

1737

7599

1.50

51.29

2.2

2.3

2.83

2.93

g/l

3.90

1561

6892

Coxarthrosis

1186

4845

1.64

51.11

2.1

2.5

2.94

2.91

g/l

0.50

1053

4292

Postmenopausal osteoporosis with pathological fracture

250

904

2.97

51.06

1.9

2.3

2.88

3.04

g/l

1.79

191

792

External causes of morbidity and mortality

1387

4400

1.60

50.83

2.2

2.3

2.95

2.90

g/l

0.81

1240

4025

Other anxiety disorders

838

4161

1.77

50.22

1.8

2.1

2.86

2.90

g/l

0.57

763

3802

Amputation

339

1427

2.49

50.15

2.0

2.3

3.28

2.96

g/l

6.79

307

1245

Soft tissue disorders related to use, overuse and pressure

655

3529

1.90

49.82

2.2

2.4

2.93

2.96

g/l

0.33

587

3141

Methotrexate

353

1510

2.41

49.80

1.8

2.6

3.10

2.85

g/l

4.23

328

1341

Other respiratory diseases principally affecting the interstitium

549

2803

2.03

49.70

2.4

2.3

3.15

2.96

g/l

4.35

508

2463

Other diseases of anus and rectum

734

4091

1.83

49.60

2.3

2.97

g/l

0.06

623

3623

Gonarthrosis

1425

5244

1.57

49.52

2.0

2.4

2.95

2.90

g/l

1.05

1288

4666

Sleep apnoea

2123

9676

1.44

49.50

2.0

2.4

2.86

2.94

g/l

3.19

1911

8701

Diabetic retinopathy, excluding more controls

625

1794

2.01

49.37

1.8

2.1

2.98

2.94

g/l

0.43

565

1577

Other CVD

595

3129

1.96

49.26

2.6

2.3

2.97

3.00

g/l

0.20

508

2713

Agranulocytosis

327

1364

2.50

49.23

3.4

2.3

3.03

2.96

g/l

0.61

313

1229

Other diseases of liver

463

2231

2.14

48.87

2.0

2.3

2.92

2.94

g/l

0.16

415

2024

Mood disorders

2196

10081

1.42

48.86

2.0

2.3

2.90

2.93

g/l

1.01

1950

9038

Seropositive rheumatoid arthritis, strict definition

423

1973

2.22

48.80

1.6

2.3

3.21

2.94

g/l

6.05

388

1769

Mood [affective] disorders

2189

10070

1.42

48.59

2.0

2.3

2.89

2.93

g/l

1.09

1943

9031

Cardiomyopathies, Primary/intrinsic

348

1501

2.41

48.45

1.9

2.3

3.13

2.89

g/l

3.94

316

1318

Cardiomyopathy in other diseases

12.16

48.43

8.3

2.2

2.80

3.08

g/l

1.05

ILD, hospital admissions 3, with pneumonia sepsis

285

1128

2.66

48.24

2.2

1.9

3.23

2.90

g/l

5.78

265

991

Acute myeloid leukaemia and myelodysplastic syndromes

105

221

5.33

48.22

1.6

1.4

3.01

3.09

g/l

0.23

192

Diffuse large B-cell lymphoma

180

558

3.49

48.08

1.9

1.4

3.49

3.02

g/l

4.84

167

489

Diffuse large B-cell lymphoma, helper endpoint

180

558

3.49

48.08

1.9

1.4

3.49

3.02

g/l

4.84

167

489

Diffuse large B-cell lymphoma, including Hilmo

180

558

3.49

48.08

1.9

1.4

3.49

3.02

g/l

4.84

167

489

Obesity, other/unspecified

707

3939

1.83

48.03

1.6

2.2

3.02

2.88

g/l

3.62

645

3581

Dental caries, including avohilmo

1781

6185

1.49

47.98

2.2

2.3

2.95

2.97

g/l

0.41

1574

5499

Emergency coronary revascularization (for ACS)

2014

8575

1.45

47.91

2.1

2.4

2.99

2.92

g/l

1.92

1830

7583

Secondary right heart disease

175

535

3.55

47.87

1.9

2.5

3.04

3.06

g/l

0.13

163

474

Chronic nephritic syndrome

151

420

3.88

47.58

2.5

2.7

3.17

2.93

g/l

1.87

143

382

Cardiomyopathy (excluding other)

356

1564

2.36

47.49

1.9

2.3

3.13

2.86

g/l

4.61

323

1371

Diseases of pulp and periapical tissues and dental caries

1615

5520

1.52

47.37

2.2

2.98

2.97

g/l

0.08

1420

4892

Symptoms and signs involving speech and voice

818

4787

1.75

47.17

2.4

2.3

2.90

2.95

g/l

0.80

722

4257

Percutaneous Coronary Intervention

1817

7679

1.47

47.08

2.1

2.4

2.97

2.91

g/l

1.64

1667

6820

Type 2 diabetes, definitions combined

2079

8610

1.43

47.03

2.0

2.4

2.98

2.91

g/l

2.37

1847

7672

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

429

2044

2.18

46.99

1.5

2.4

3.06

2.94

g/l

1.67

380

1850

Disorders of lacrimal system

1001

6159

1.65

46.98

2.7

2.3

2.82

2.96

g/l

4.28

878

5471

Hypotension

527

2707

2.02

46.90

2.7

2.2

2.95

3.02

g/l

0.71

443

2335

Benign neoplasm: Colon, unspecified

709

4011

1.82

46.44

2.3

2.99

2.95

g/l

0.43

599

3552

Anxiety (asthma-related co-morbidities)

1114

5405

1.61

46.43

1.9

2.3

2.84

2.90

g/l

1.11

1013

4940

Convulsions, not elsewhere classified

449

2142

2.11

46.42

1.7

2.1

3.09

2.84

g/l

4.82

404

1920

Type 2 diabetes, strict (exclude DM1)

2086

8668

1.43

46.35

2.0

2.4

2.98

2.91

g/l

2.24

1854

7725

Non-allergic asthma (mode)

424

1991

2.16

46.28

1.9

1.8

3.08

2.84

g/l

5.01

383

1764

Other dialysis

129

329

4.30

46.21

2.3

2.7

3.16

2.96

g/l

1.17

123

298

Undetermined asthma

308

1281

2.47

46.16

2.0

1.6

2.96

2.86

g/l

1.18

276

1140

Other neurological diseases

1741

9489

1.46

45.74

2.2

2.3

2.85

2.96

g/l

5.22

1521

8428

Urticaria and erythema

756

4365

1.76

45.45

2.3

2.2

2.90

2.91

g/l

0.16

684

3927

Coronary revascularization (ANGIO or CABG)

1808

7680

1.46

45.34

2.1

2.4

2.98

2.91

g/l

1.74

1661

6821

Other diseases of the digestive system

854

5118

1.71

45.15

2.2

2.3

3.11

2.97

g/l

3.54

761

4492

GI-bleeding

855

5129

1.70

45.01

2.3

3.11

2.97

g/l

3.45

764

4502

Non-invasive ventilation

464

2037

2.07

44.99

3.1

2.4

2.51

2.90

g/l

10.93

425

1836

All anxiety disorders

1129

5664

1.59

44.89

1.8

2.2

2.84

2.91

g/l

1.46

1028

5150

Other headache syndromes

873

5253

1.69

44.82

1.8

2.4

2.79

2.95

g/l

5.99

784

4722

Subjective visual disturbances

612

3342

1.88

44.76

2.1

2.3

2.85

2.95

g/l

1.79

546

2988

Other coagulation defects

218

782

2.92

44.61

2.4

2.5

3.21

2.98

g/l

2.31

197

710

Depression

1979

9509

1.42

44.60

2.0

2.3

2.88

2.93

g/l

1.59

1755

8554

Other abnormal findings of blood chemistry

159

477

3.56

44.51

3.1

2.4

2.91

2.93

g/l

0.10

152

432

Later onset COPD, excluding more controls

574

2346

1.94

44.49

1.6

1.9

3.26

2.89

g/l

14.99

499

2016

COPD

1162

6113

1.58

44.47

1.9

2.4

3.19

2.93

g/l

15.14

1028

5397

Chronic periodontitis, complicated

1291

8476

1.53

44.33

2.4

3.03

2.91

g/l

3.58

1149

7623

Arthropathies in other diseases classified elsewhere

129

338

4.09

44.16

2.2

2.5

2.99

2.82

g/l

1.08

116

305

Motor neuron disease

167

5.75

44.15

1.3

2.3

2.41

3.12

g/l

7.39

150

Other and unspecified immunodeficiencies with predominantly antibody defects

113

7.26

44.11

5.2

2.3

2.96

2.91

g/l

0.16

106

Type 1 diabetes

544

2867

1.93

44.01

1.8

2.3

2.98

2.91

g/l

0.79

504

2592

Injuries to the shoulder and upper arm

1875

10701

1.43

43.85

2.4

2.2

2.95

2.94

g/l

0.19

1637

9584

Noninfective enteritis and colitis

994

6218

1.62

43.67

2.4

2.2

3.00

2.92

g/l

1.69

890

5570

Motor neuron disease (with DMD)

169

5.66

43.52

1.3

2.3

2.41

3.12

g/l

7.44

151

Other and unspecified coagulation defects

159

483

3.49

43.50

2.5

3.16

2.95

g/l

1.71

144

439

Peripheral artery operations in Hilmo

393

1865

2.19

43.44

2.1

2.3

3.23

2.93

g/l

6.60

353

1631

Volume depletion

277

1134

2.54

43.40

1.8

2.2

3.13

2.99

g/l

1.28

233

973

Amputation of toe

248

973

2.70

42.96

2.1

2.5

3.28

3.01

g/l

3.55

225

868

Caries of dentine, including avohilmo

1850

6608

1.45

42.86

2.2

2.3

2.95

2.97

g/l

0.26

1641

5883

Iron deficiency anaemia secondary to blood loss (chronic)

441

2195

2.07

42.80

2.1

2.4

3.02

2.97

g/l

0.40

373

1936

Insulin, fast-acting

831

5010

1.69

42.66

1.9

2.3

2.97

2.94

g/l

0.35

758

4472

Fracture of shoulder and upper arm

852

5170

1.68

42.57

2.5

2.3

3.03

2.96

g/l

1.17

719

4584

Rotator cuff syndrome

1359

6512

1.52

42.52

2.2

2.4

2.92

2.95

g/l

0.54

1219

5788

Major coronary heart disease event

1926

8254

1.42

42.46

2.1

2.4

2.99

2.91

g/l

2.30

1756

7326

Disorder of lipoprotein metabolism, unspecified

374

1761

2.20

42.19

1.7

2.2

3.12

2.97

g/l

1.97

337

1539

Candidiasis

636

3575

1.82

42.18

2.5

2.2

2.89

2.94

g/l

0.69

555

3187

Neurotic, stress-related and somatoform disorders

1781

8768

1.43

42.16

2.2

2.3

2.83

2.93

g/l

4.11

1607

7891

Primary hyperparathyroidism

339

1540

2.30

42.14

2.7

2.4

2.87

3.00

g/l

1.52

296

1356

Conjunctivitis

1496

8557

1.48

42.13

2.2

2.87

2.93

g/l

1.77

1349

7659

Abnormal involuntary movements

358

1662

2.23

41.81

2.2

2.3

2.80

3.00

g/l

3.49

319

1490

Stroke, excluding SAH

1521

7629

1.48

41.73

2.4

3.04

2.97

g/l

2.18

1326

6762

Stroke, including SAH

1573

7888

1.47

41.72

2.4

3.04

2.96

g/l

2.32

1375

7005

Other symptoms and signs involving the nervous and musculoskeletal systems

908

5637

1.64

41.49

2.0

2.3

2.58

2.96

g/l

24.80

835

5027

Cirrhosis of liver, NAS

191

668

3.05

41.44

1.6

2.7

3.02

2.96

g/l

0.36

175

602

Type 2 diabetes, definitions combined, including avohilmo

2046

8570

1.40

41.41

2.0

2.4

2.97

2.91

g/l

2.15

1822

7643

Sleep apnoea, including avohilmo

2170

9785

1.39

41.34

1.9

2.4

2.85

2.94

g/l

4.00

1946

8792

AV-block

488

2213

1.99

41.32

2.3

2.2

3.02

2.91

g/l

1.59

426

1900

Pleural effusion

464

2386

2.01

41.27

2.6

2.2

3.29

2.93

g/l

9.93

427

2095

Other pulmonary heart/vessel disease

179

606

3.17

41.23

1.9

2.5

3.03

3.07

g/l

0.26

165

538

Ischaemic Stroke, excluding all haemorrhages

1449

7368

1.49

41.10

2.3

3.05

2.97

g/l

2.19

1262

6513

Zoster [herpes zoster]

503

2660

1.95

40.99

3.9

2.2

2.88

2.97

g/l

1.16

447

2332

Calcific aortic valvular stenosis, operated

836

4958

1.67

40.89

2.3

3.14

2.98

g/l

4.43

744

4277

Calcific aortic valvular stenosis

836

4958

1.67

40.89

2.3

3.14

2.98

g/l

4.43

744

4277

Calcific aortic valvular stenosis, diagnosis (helper)

835

4953

1.67

40.80

2.3

3.14

2.98

g/l

4.40

743

4272

Operations 2 for CAVS

835

4953

1.67

40.80

2.3

3.14

2.98

g/l

4.40

743

4272

Anxiety disorders

1797

8879

1.42

40.75

2.2

2.3

2.83

2.93

g/l

4.37

1620

7992

Calcific aortic valvular stenosis, including rheumatic fever

837

4965

1.67

40.74

2.3

3.14

2.98

g/l

4.40

745

4282

Pericarditis

125

340

3.92

40.56

1.9

2.1

3.51

2.95

g/l

5.32

111

303

Sequelae of external causes of morbidity and mortality

643

3676

1.79

40.48

2.3

3.09

2.95

g/l

2.51

602

3273

ILD, hospital admissions

455

2342

2.01

40.45

2.3

3.15

2.96

g/l

3.54

422

2066

Idiopathic thrombocytopenic purpura

118

311

4.11

40.28

2.4

2.5

2.74

3.01

g/l

2.12

108

275

Injury, poisoning and certain other consequences of external causes

1097

3485

1.59

40.19

2.2

2.4

2.96

2.91

g/l

0.71

984

3172

Coxibs

632

1822

1.86

39.97

2.1

2.3

2.99

g/l

0.01

569

1628

Chronic ulcer of skin, not elsewhere classified

225

871

2.72

39.96

2.2

2.4

3.05

2.96

g/l

0.57

203

777

Other interstitial pulmonary diseases

458

2376

2.00

39.78

2.3

3.15

2.96

g/l

3.74

425

2095

Fungal Sepsis

147

452

3.48

39.71

3.0

2.4

3.19

2.91

g/l

2.09

134

409

Diseases of pulp and periapical tissues, including avohilmo

2279

8679

1.37

39.43

2.2

2.93

2.94

g/l

0.23

2024

7736

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1046

6590

1.56

39.37

1.9

2.1

2.88

2.92

g/l

0.67

939

5910

Abnormal findings on diagnostic imaging of other body structures

378

1837

2.13

39.31

2.8

2.3

2.91

2.96

g/l

0.36

349

1648

Other diseases of upper respiratory tract

2423

9381

1.36

39.29

2.2

2.3

2.89

2.96

g/l

2.74

2176

8349

Interstitial lung disease

458

2388

1.99

39.20

2.3

3.15

2.96

g/l

3.71

425

2105

Interstitial lung disease endpoints

458

2388

1.99

39.20

2.3

3.15

2.96

g/l

3.71

425

2105

Disorders of conjunctiva

1676

9529

1.43

39.19

2.2

2.86

2.93

g/l

2.50

1509

8518

Other and unspecified types of non-Hodgkin lymphoma, hilmo

160

524

3.28

39.09

3.0

2.7

3.13

3.00

g/l

0.71

149

469

Secondary uncertain malignant neoplasm

359

1715

2.17

39.04

1.9

1.4

3.31

2.95

g/l

6.54

331

1479

Open wound of head

1212

7839

1.51

38.86

2.2

2.3

3.04

2.94

g/l

2.26

1054

7010

Chronic sinusitis

906

5706

1.61

38.85

2.3

2.85

2.93

g/l

1.71

825

5122

Other noninfective gastroenteritis and colitis

563

3128

1.84

38.80

2.7

2.2

3.03

2.96

g/l

1.04

504

2776

Cellulitis

521

2833

1.88

38.71

2.8

2.2

3.08

2.94

g/l

2.22

476

2549

Need for immunization against other single viral diseases

180

5.22

38.65

2.9

2.5

3.02

2.94

g/l

0.27

164

Anaemia in chronic diseases classified elsewhere

102

250

4.48

38.62

2.0

2.7

2.81

3.02

g/l

1.22

221

Acute upper respiratory infections of multiple and unspecified sites

1518

7830

1.45

38.61

3.3

2.0

2.91

2.94

g/l

0.49

1378

6998

Unspecified fall

1129

7375

1.53

38.57

2.2

2.3

3.05

2.95

g/l

2.47

954

6580

Other symptoms and signs involving the urinary system

300

1343

2.32

38.50

2.3

2.4

2.84

2.93

g/l

0.79

289

1195

Tumor necrosis factor alpha inhibitors

318

1455

2.24

38.25

1.4

2.3

3.14

2.91

g/l

3.13

299

1347

Allergic conjunctivitis

1082

6931

1.54

38.19

1.9

2.2

2.89

2.91

g/l

0.35

972

6230

Ischaemic heart disease, wide definition

1800

7983

1.41

38.18

2.4

2.98

2.92

g/l

1.63

1637

7078

Other (not insulin) diabetes medications

2113

9196

1.38

38.16

2.0

2.4

2.98

2.91

g/l

2.17

1878

8186

Hypokalaemia

314

1436

2.26

38.10

2.6

2.1

3.07

2.97

g/l

0.89

278

1255

Other abnormalities of plasma proteins

160

5.57

38.05

4.6

2.9

3.13

2.99

g/l

0.46

139

Drug-induced osteoporosis with pathological fracture

209

4.98

37.97

1.7

2.4

3.14

3.10

g/l

0.10

185

Isolated proteinuria with specified morphological lesion

111

6.76

37.74

4.4

2.6

2.91

2.93

g/l

0.06

100

Selective serotonin reuptake inhibitors

2107

8047

1.38

37.68

2.2

2.3

2.92

2.94

g/l

0.30

1886

7248

Acute sinusitis

988

5907

1.57

37.56

3.2

2.0

2.87

2.93

g/l

1.05

899

5326

Adverse effects, not elsewhere classified

419

2141

2.00

37.53

2.1

2.2

2.92

g/l

0.04

394

1951

Implicit fungal Sepsis

136

413

3.53

37.52

3.1

2.4

3.15

2.91

g/l

1.62

123

374

Lichen simplex chronicus and prurigo

197

737

2.81

37.44

1.9

2.7

2.85

2.99

g/l

0.96

178

661

Other chronic obstructive pulmonary disease

1095

5960

1.54

37.40

1.8

2.4

3.21

2.93

g/l

16.59

966

5258

Insulin, fast-acting or short human

834

5211

1.63

37.19

1.9

2.3

2.97

2.94

g/l

0.28

761

4644

Any death

1544

7793

1.44

36.98

3.1

2.2

3.27

2.88

g/l

34.28

1378

6916

Acetic acid derivatives and related substances

625

1813

1.82

36.96

2.1

2.3

2.98

g/l

0.04

563

1619

ILD, hospital admissions 1, main diag only

410

2104

2.02

36.88

2.4

2.3

3.14

2.95

g/l

3.16

379

1857

Diseases of the myoneural junction and muscle

339

1623

2.16

36.76

1.6

2.3

3.05

2.98

g/l

0.58

288

1447

Rash and other nonspecific skin eruption

263

1135

2.41

36.76

2.0

2.3

2.97

3.00

g/l

0.21

244

1019

Type 1 diabetes, wide definition, subgroup 1

422

2181

1.97

36.36

1.7

2.3

2.95

2.91

g/l

0.31

387

1991

Asthma and allergy, excluding more controls

207

786

2.65

36.34

1.9

1.4

2.77

2.80

g/l

0.16

185

720

Somatoform disorder

365

1798

2.08

36.32

2.3

2.81

2.96

g/l

2.04

325

1634

Voice disturbances

624

3649

1.75

36.26

2.6

2.3

2.91

2.94

g/l

0.26

558

3263

Overexertion and strenuous or repetitive movements

252

1073

2.43

36.24

2.3

2.4

3.11

2.94

g/l

1.94

223

986

Deforming dorsopathies

583

3341

1.78

36.19

2.3

2.2

2.83

2.98

g/l

3.57

523

2964

Dental operations

1497

5341

1.46

36.13

2.3

2.1

2.96

3.00

g/l

0.71

1318

4739

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1150

5207

1.52

36.06

2.7

1.4

2.93

2.94

g/l

0.08

1014

4561

Viral pneumonia (unknown virus, not influenza)

188

699

2.81

35.99

2.8

2.5

3.10

2.96

g/l

0.97

176

635

Obesity due to excess calories

915

5891

1.57

35.83

1.9

2.4

2.98

2.89

g/l

2.07

823

5341

Other reaction to severe stress, and adjustment disorders

630

3695

1.73

35.80

2.5

2.1

2.83

2.90

g/l

1.10

581

3374

Trochanteric bursitis

344

1678

2.11

35.30

2.3

2.93

3.00

g/l

0.75

303

1481

Psychiatric diseases

2121

7855

1.36

35.20

2.2

2.4

2.90

2.94

g/l

1.23

1875

7120

Allergic asthma (mode), excluding more controls

370

1804

2.03

35.18

1.9

1.6

2.80

2.81

g/l

0.04

343

1633

Special screening examination for infectious and parasitic diseases

363

1297

2.09

35.05

2.4

2.2

2.89

2.93

g/l

0.29

324

1222

Urticaria

570

3290

1.76

34.47

2.3

2.1

2.89

2.91

g/l

0.20

516

2975

Osteomyelitis

195

757

2.70

34.46

2.0

2.2

3.27

2.97

g/l

3.14

175

694

Biguanides

2076

9419

1.36

34.38

2.0

2.4

2.98

2.92

g/l

2.04

1856

8391

Acute upper respiratory infections

2225

10319

1.34

34.15

3.1

2.1

2.90

2.95

g/l

1.41

2011

9173

Malignant neoplasm of skin

1157

5364

1.50

34.06

2.6

1.4

2.93

2.94

g/l

0.03

1012

4702

Injuries to the knee and lower leg

2477

10488

1.32

33.95

2.0

2.3

2.94

2.93

g/l

0.20

2186

9409

Substance abuse, excluding more controls

1138

6598

1.49

33.55

1.6

2.4

3.03

2.92

g/l

2.94

987

6016

Other degenerative diseases of the nervous system

633

2797

1.72

33.46

2.0

2.4

2.89

3.08

g/l

4.21

522

2473

Superficial injury of head

543

3129

1.77

33.20

2.0

2.2

3.11

2.97

g/l

2.42

477

2765

Reactive arthropathies, FINNGEN

164

593

2.86

33.01

2.3

2.7

3.07

2.79

g/l

2.78

144

538

Other inflammation of eyelid

343

1716

2.06

32.96

2.7

2.3

2.80

2.97

g/l

2.55

287

1545

Complications of internal orthopaedic prosthetic devices, implants and grafts

590

3495

1.73

32.93

2.0

2.3

3.05

2.95

g/l

1.39

514

3045

Functional dyspepsia

574

3369

1.74

32.84

2.5

2.3

2.82

2.95

g/l

2.56

522

3031

Eosinophilic disease (BM)

111

6.01

32.76

2.3

1.4

3.13

2.88

g/l

0.89

101

Spondyloarthritis

393

2064

1.94

32.53

2.2

2.3

3.20

2.91

g/l

5.56

365

1843

Asthma and allergy

207

830

2.50

32.52

1.9

1.5

2.77

2.79

g/l

0.10

185

755

L01XX Other antineoplastic agents

200

812

2.61

32.50

3.5

2.5

2.96

3.00

g/l

0.30

183

729

Nonalcoholic fatty liver disease

245

1082

2.34

32.48

2.0

2.5

2.87

2.93

g/l

0.48

221

992

Other disorders of skin and subcutaneous tissue, not elsewhere classified

366

1883

2.00

32.47

2.2

2.1

2.96

2.97

g/l

0.12

315

1670

Diabetic neuropathy

326

1608

2.10

32.42

2.0

2.1

2.91

2.99

g/l

0.65

293

1429

Rheumatism, unspecified

319

1564

2.10

32.32

2.2

2.3

2.86

2.99

g/l

1.36

295

1381

Diseases of spleen

171

4.89

32.15

2.1

2.2

3.12

3.04

g/l

0.19

154

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

233

1013

2.38

32.05

3.6

2.4

2.96

2.93

g/l

0.13

216

919

L04AC Interleukin inhibitors

147

511

3.00

31.93

1.6

2.2

3.09

2.90

g/l

1.24

139

475

Disorders of continuity of bone

228

983

2.39

31.88

4.0

2.1

2.91

2.94

g/l

0.19

205

905

Migraine with aura

412

2213

1.89

31.62

1.5

2.3

2.82

2.94

g/l

2.01

377

2025

Other and unspecified effects of external causes

524

3029

1.76

31.60

2.0

2.2

2.91

g/l

0.03

486

2755

Spondylopathies (FG)

260

1187

2.24

31.50

1.7

2.6

3.01

2.81

g/l

2.39

245

1077

Type 1 diabetes, wide definition

436

2388

1.86

31.47

1.7

2.3

2.94

2.92

g/l

0.18

400

2170

Injuries to the elbow and forearm

1434

9058

1.41

31.46

2.0

2.3

2.97

2.93

g/l

0.78

1243

8106

Coronary atherosclerosis

1505

6847

1.41

31.44

2.2

2.4

3.01

2.93

g/l

2.47

1375

6048

Open wound of lower leg

360

1861

1.98

31.42

2.0

2.2

3.17

2.99

g/l

2.99

314

1667

Pain in thoracic spine

323

1607

2.06

31.32

2.9

2.2

2.76

2.99

g/l

4.11

300

1436

Personality disorders, excluding more controls

420

2278

1.87

31.23

1.7

2.2

2.87

2.88

g/l

0.06

381

2111

Other general symptoms and signs

116

351

3.39

31.21

1.4

2.6

2.83

2.99

g/l

0.95

104

317

Myeloproliferative diseases

247

1117

2.31

31.19

2.9

2.5

2.99

2.96

g/l

0.24

217

1003

Sequelae of cerebrovascular disease

914

5224

1.54

31.11

2.1

2.3

3.03

2.97

g/l

1.05

758

4610

Abnormal serum enzyme levels

736

4551

1.61

31.05

2.1

2.4

3.00

2.92

g/l

1.37

671

4079

Decubitus ulcer and pressure area

192

779

2.59

31.05

1.8

2.4

3.30

3.04

g/l

2.49

163

683

Migraine

836

4383

1.56

31.05

1.9

2.3

2.81

2.94

g/l

3.66

764

3991

Recurrent or chronic depression

732

3211

1.62

30.97

1.9

2.3

2.86

2.92

g/l

0.83

657

2978

Atopic dermatitis

983

5404

1.50

30.78

1.8

2.2

2.90

g/l

0.03

879

4896

Phlebitis and thrombophlebitis (not including DVT)

527

3082

1.75

30.73

2.7

2.3

2.95

2.94

g/l

0.03

475

2748

Mycoses

594

3585

1.69

30.73

2.7

2.3

2.94

g/l

0.01

535

3204

Solid cancers, helper endpoint

1642

7075

1.38

30.72

2.2

1.4

3.04

2.90

g/l

6.07

1491

6291

Hypoparathyroidism

131

440

3.19

30.72

1.7

2.4

2.91

3.07

g/l

1.02

111

395

Other chronic obstructive pulmonary disease, including avohilmo

1299

7620

1.43

30.64

1.8

2.4

3.15

2.93

g/l

12.86

1150

6763

Benign neoplasm of other and ill-defined parts of digestive system

462

2613

1.82

30.51

2.1

2.3

2.94

2.97

g/l

0.21

416

2324

Artrosis, including avohilmo

1745

7031

1.37

30.49

2.0

2.4

2.90

2.93

g/l

0.67

1557

6335

Allergic asthma (mode)

370

1905

1.93

30.15

1.9

1.6

2.80

2.84

g/l

0.27

343

1720

Progressive vascular leukoencephalopathy

144

517

2.99

30.05

2.1

2.4

3.06

3.12

g/l

0.36

120

449

Charcot foot

168

4.75

30.00

2.4

2.9

2.98

2.90

g/l

0.24

151

Cholelithiasis, broad definition with cholecystitis

1882

9515

1.34

29.95

2.3

2.93

g/l

0.06

1679

8462

DVT of lower extremities

473

2706

1.79

29.93

2.9

2.2

2.98

2.97

g/l

0.10

416

2405

Pacemaker

865

5504

1.54

29.74

2.1

2.3

3.04

2.98

g/l

0.90

747

4773

Psoriatic and enteropathic arthropathies

235

1060

2.27

29.44

1.7

2.6

3.05

2.79

g/l

2.66

215

964

Peripheral arterial reconstruction

476

2747

1.78

29.40

1.9

2.3

3.22

2.96

g/l

6.35

424

2399

Alcohol use disorder, Swedish definition

1149

7384

1.44

29.34

1.6

2.4

3.00

2.91

g/l

2.48

1007

6703

Papulosquamous disorders

848

5628

1.53

29.16

2.1

2.3

2.94

2.93

g/l

0.08

766

5055

Other diseases of arteries and capillaries

243

1121

2.25

29.11

2.0

2.4

3.13

2.93

g/l

1.91

213

1003

Disorders of skin appendages

895

5996

1.51

29.05

2.2

2.90

2.91

g/l

0.09

827

5405

Other peripheral vascular diseases

216

950

2.36

29.03

1.7

2.4

2.89

2.92

g/l

0.16

197

859

Hypothyroidism, strict autoimmune

1380

6524

1.40

28.87

2.0

2.4

2.87

2.90

g/l

0.64

1229

5755

Injuries to unspecified part of trunk, limb or body region

257

1215

2.18

28.85

1.7

2.4

3.26

2.96

g/l

4.43

227

1094

Other diseases of lip and oral mucosa

842

5599

1.53

28.68

2.4

2.3

2.86

2.93

g/l

1.24

742

5020

Pyogenic arthritis

177

716

2.57

28.64

2.7

2.4

3.20

2.89

g/l

2.84

161

637

In situ neoplasms

874

5863

1.51

28.62

2.4

2.3

3.03

2.96

g/l

1.23

778

5132

All influenza (not pneumonia)

314

1598

2.01

28.61

4.4

1.8

2.87

2.86

g/l

0.06

279

1436

Hypertrophic cardiomyopathy

137

491

2.96

28.52

2.6

2.8

3.14

2.99

g/l

0.95

128

442

Missing teeth due to accident, extraction or parodontitis

1351

9237

1.40

28.47

2.2

2.4

2.91

2.95

g/l

0.54

1118

8302

1197

7679

1.42

28.41

1.6

2.4

3.02

2.91

g/l

3.32

1052

6972

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1056

4993

1.47

28.35

2.7

1.4

2.93

2.94

g/l

0.16

922

4361

Superficial injury of lower leg

508

3010

1.72

28.14

1.9

2.3

2.96

2.94

g/l

0.15

441

2699

Reactive arthropathies

197

842

2.41

28.12

2.1

2.5

3.02

2.88

g/l

1.07

173

763

Adalimumab

195

831

2.41

27.98

1.3

2.4

3.04

2.91

g/l

0.97

184

771

Other and unspecified aplastic anaemias

110

5.71

27.95

1.5

2.7

2.98

2.90

g/l

0.18

Cerebral palsy and other paralytic syndromes

270

1316

2.11

27.93

2.0

2.3

2.95

2.96

g/l

0.08

242

1193

Gastroduodenal ulcer

634

3980

1.62

27.75

2.0

2.3

3.09

2.99

g/l

1.59

560

3513

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

693

4452

1.58

27.69

2.3

2.2

2.90

2.94

g/l

0.38

621

3991

1240

7844

1.41

27.40

1.6

2.4

3.01

2.91

g/l

3.02

1089

7125

Basal cell carcinoma, including avohilmo

1048

5012

1.46

27.23

2.5

1.4

2.96

2.94

g/l

0.26

916

4377

Myeloproliferative diseases (CML excluded)

222

1018

2.27

27.19

3.0

2.5

3.01

2.95

g/l

0.40

195

916

Major coronary heart disease event excluding revascularizations

1414

6886

1.38

27.13

2.2

2.5

3.06

2.93

g/l

4.62

1254

6068

Migraine without aura

300

1528

1.99

27.09

2.0

2.2

2.83

2.91

g/l

0.75

278

1412

Nonorganic sleeping disorders, excluding more controls

348

1866

1.90

27.04

1.6

2.3

2.85

2.93

g/l

0.80

317

1712

Hypocalcemia

242

3.85

26.90

4.0

2.6

3.11

2.99

g/l

0.48

224

Haemorrhage, not elsewhere classified

117

396

3.11

26.90

2.8

2.7

3.24

3.04

g/l

1.24

109

348

Stomatitis and related lesions

414

2350

1.80

26.86

2.7

2.3

2.92

2.96

g/l

0.32

376

2111

Diseases of external ear

727

4758

1.55

26.77

2.1

2.3

2.93

2.94

g/l

0.12

595

4262

Phobic anxiety disorders

200

875

2.32

26.72

2.1

2.90

g/l

0.04

188

813

Paralytic ileus and intestinal obstruction

576

3573

1.64

26.71

2.8

2.3

3.03

2.97

g/l

0.62

514

3162

Other metabolic disorders

268

1324

2.07

26.61

3.2

2.1

2.88

2.94

g/l

0.44

256

1192

Other disorders of bone

387

2160

1.83

26.52

3.8

2.0

2.91

2.90

g/l

0.04

349

1991

Disorders of muscles

227

1061

2.20

26.18

1.6

2.2

2.88

2.97

g/l

0.70

208

960

Cholelithiasis

1792

9405

1.32

26.17

2.3

2.92

2.93

g/l

0.10

1596

8360

Gastric ulcer

442

2580

1.75

26.11

2.0

2.4

3.05

2.99

g/l

0.63

385

2267

Other pleural conditions

291

1498

2.01

26.07

3.1

2.4

3.25

2.96

g/l

5.53

261

1313

Cervical disc disorders

752

4987

1.53

25.99

2.3

2.2

2.78

2.98

g/l

6.41

671

4438

Injuries to the ankle and foot

1262

8156

1.39

25.87

2.1

2.2

2.93

2.91

g/l

0.23

1137

7397

Other enthesopathies

574

3590

1.62

25.71

1.9

2.3

2.81

2.95

g/l

2.76

517

3216

Essential (haemorrhagic) thrombocythaemia

122

435

2.97

25.68

2.6

1.4

3.00

2.96

g/l

0.20

105

382

Etanercept

150

591

2.63

25.66

1.5

2.3

3.17

2.90

g/l

2.20

144

548

Disease of hard tissues of teeth, NOS

1187

4413

1.42

25.59

2.2

2.1

2.86

2.98

g/l

3.25

1067

3943

Other disorders of eye and adnexa

303

1586

1.96

25.57

1.9

2.3

2.95

g/l

0.01

280

1434

Basal cell carcinoma

1006

4857

1.45

25.51

2.6

1.4

2.95

g/l

0.04

876

4236

Heart failure and hypertrophic cardiomyopathy

219

3.97

25.45

3.1

2.7

3.25

3.00

g/l

1.32

193

Sequelae with surgical and medical care as external cause

490

2963

1.69

25.43

2.1

2.3

3.04

2.96

g/l

0.93

455

2625

Other and unspecified acquired haemolytic anaemias

109

5.57

25.30

2.9

1.6

3.07

2.96

g/l

0.28

100

Other viral diseases

614

3882

1.59

25.27

3.3

2.0

2.96

2.89

g/l

0.84

582

3542

Discitis, unspecified

170

4.37

25.19

3.5

2.1

3.60

3.04

g/l

2.99

152

Superficial injury of hip and thigh

350

1932

1.85

25.03

1.8

2.3

3.04

2.98

g/l

0.49

296

1718

COPD, early/later onset

1107

6685

1.42

24.99

1.8

2.4

3.21

2.93

g/l

16.43

975

5913

Psoriasis

596

3791

1.60

24.98

1.8

2.4

3.01

2.92

g/l

1.30

540

3422

Meniscus derangement

1083

5170

1.42

24.88

2.2

2.4

2.88

2.90

g/l

0.26

967

4617

Postprocedural endocrine and metabolic disorders, not elsewhere classified

250

1237

2.07

24.77

3.2

2.1

2.91

2.94

g/l

0.22

238

1119

Sequelae of other external causes

153

621

2.57

24.74

2.7

2.5

3.13

2.97

g/l

0.98

148

560

Other viral diseases

499

3033

1.66

24.73

3.5

2.1

2.98

2.90

g/l

1.00

475

2767

Other and unspecified drugs and medicaments

213

998

2.21

24.60

3.4

2.4

2.93

2.96

g/l

0.18

196

900

Cardiodefibrillation

887

6156

1.46

24.35

2.2

2.4

3.16

2.95

g/l

7.12

804

5425

Valvular operations

333

1827

1.87

24.34

1.6

2.2

3.19

2.89

g/l

5.35

300

1587

Gonarthrosis,primary

2007

9636

1.29

24.25

2.0

2.4

2.96

2.93

g/l

0.60

1777

8580

Nonischemic cardiomyopathy

256

1292

2.04

24.17

2.3

3.07

2.94

g/l

1.26

231

1142

Other infectious diseases

233

1138

2.11

24.15

2.6

2.3

3.27

2.97

g/l

3.70

215

1023

Other enthesopathy of foot (+metatarsalgia)

220

1049

2.15

24.14

2.2

2.3

2.80

2.96

g/l

1.65

200

950

Metatarsalgia

211

992

2.19

24.04

2.2

2.3

2.81

2.96

g/l

1.46

192

899

Disorders of sclera, cornea, iris and ciliary body

1097

7926

1.40

23.96

2.2

2.94

2.93

g/l

0.10

991

7091

Other symptoms and signs involving the circulatory and respiratory systems

157

653

2.48

23.94

2.1

2.3

2.73

2.96

g/l

1.84

137

582

Myocardial infarction

1138

5776

1.40

23.93

2.2

2.4

3.11

2.94

g/l

6.56

1001

5074

Radiculopathy

374

2140

1.79

23.74

2.5

2.3

2.78

3.03

g/l

5.71

338

1887

COPD related to multimorbidity

980

5868

1.43

23.61

1.7

2.4

3.20

2.94

g/l

12.95

856

5176

Noninfectious colitis NAS

301

1615

1.91

23.61

2.7

2.3

3.04

2.97

g/l

0.55

273

1445

Bipolar affective disorders

315

1710

1.87

23.61

1.8

2.3

2.92

2.88

g/l

0.30

287

1579

Other extrapyramidal and movement disorders in other diseases

541

3417

1.61

23.53

2.2

2.3

2.83

2.96

g/l

2.59

481

3046

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

352

1988

1.81

23.45

2.0

1.4

3.15

2.93

g/l

3.06

329

1746

Infection of intervertebral disc (pyogenic)

149

4.54

23.45

2.2

2.3

3.70

3.01

g/l

3.32

132

COPD, hospital admissions

1088

6645

1.40

23.44

1.8

2.4

3.20

2.93

g/l

15.09

958

5873

Intracranial injury

1171

8112

1.38

23.29

2.1

2.2

2.92

2.94

g/l

0.14

1007

7232

Systemic atrophies primarily affecting the central nervous system

132

516

2.70

23.29

1.4

2.7

2.44

2.96

g/l

8.93

123

463

Disorders of the thyroid gland

1920

9747

1.29

23.27

2.1

2.3

2.87

2.94

g/l

2.25

1718

8697

Budesonide

262

1349

1.98

23.18

1.9

2.5

2.97

2.82

g/l

1.39

235

1211

Cramp and spasm

124

470

2.76

23.11

2.5

2.4

2.79

2.90

g/l

0.69

112

432

Oxicams

506

1748

1.67

22.99

2.3

2.87

2.98

g/l

1.67

445

1556

Paracetamol or NSAID medication

282

713

2.01

22.87

2.5

1.8

2.98

2.94

g/l

0.19

254

650

Oter anti-inflammatory and antirheumatic agents, non-steroids

505

1696

1.67

22.80

2.4

2.98

2.99

g/l

0.03

446

1505

Sub-endpoint used in defining T1D endpoints

578

3665

1.57

22.75

1.7

2.1

2.97

2.94

g/l

0.30

531

3268

Fracture of foot, except ankle

454

2771

1.66

22.55

2.4

2.2

2.89

2.92

g/l

0.25

408

2532

Pneumonia derived septicemia

104

365

3.00

22.52

5.8

2.4

2.80

2.99

g/l

0.99

324

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

311

3.16

22.48

1.5

2.1

3.02

2.95

g/l

0.27

289

Viral pneumonia (known virus, not influenza)

287

3.31

22.45

6.6

2.6

2.82

3.06

g/l

1.31

252

Idiopathic urticaria

170

4.06

22.44

1.2

1.9

2.77

2.92

g/l

0.63

160

Other encephalitis

261

3.41

22.42

2.0

2.6

2.95

2.93

g/l

0.07

239

Raynaud syndrome

193

903

2.20

22.35

1.5

2.5

2.73

2.95

g/l

2.23

176

824

Protozoal diseases

341

3.09

22.31

6.4

2.7

3.19

2.99

g/l

0.98

307

Substance abuse

1138

7852

1.37

22.30

1.6

2.4

3.03

2.90

g/l

4.01

987

7127

Fissure and fistula of anal and rectal regions

477

2958

1.64

22.26

2.2

2.3

2.86

2.94

g/l

0.87

421

2668

Herpesviral [herpes simplex] infections

444

2704

1.67

22.25

2.8

2.2

2.90

2.92

g/l

0.14

405

2440

Disorders of synovium and tendon

972

6083

1.41

22.23

1.9

2.3

2.81

2.95

g/l

4.09

875

5421

Diabetic retinopathy

787

3350

1.49

22.19

1.8

2.0

2.97

3.00

g/l

0.23

709

2983

Diseases of salivary glands

640

4248

1.53

22.15

2.2

2.3

2.85

2.93

g/l

1.26

559

3819

Benign neoplasm: Sigmoid colon

473

2943

1.64

22.06

2.3

2.4

3.01

2.96

g/l

0.50

423

2617

Encephalitis

279

3.29

22.04

2.0

2.5

2.91

2.92

g/l

0.04

256

Myeloid leukaemia

312

3.18

21.97

1.8

2.7

3.04

2.97

g/l

0.22

279

Recurrent aphthous stomatitis , including avohilmo

305

1685

1.85

21.85

2.7

2.3

2.88

2.99

g/l

1.08

278

1515

5-aminosalicylic acid

352

2024

1.76

21.80

1.9

2.3

3.00

2.83

g/l

2.58

320

1824

Cervicalgia

415

2501

1.69

21.74

2.1

2.3

2.87

2.99

g/l

1.78

363

2226

Elevated blood glucose level

193

914

2.18

21.71

2.0

2.2

3.01

2.95

g/l

0.39

164

829

Panic disorder

226

1131

2.03

21.62

1.5

2.3

2.78

2.94

g/l

1.93

207

1042

Mixed and other personality disorders

150

641

2.40

21.50

1.6

2.0

2.89

2.87

g/l

0.06

140

600

Faecal incontinence

233

1188

2.02

21.49

1.5

2.4

2.85

3.07

g/l

2.31

211

1040

Generalized anxiety disorder

234

1188

2.00

21.48

1.7

2.3

2.79

2.92

g/l

1.49

211

1094

Non-selective monoamine reuptake inhibitors

787

5271

1.46

21.47

2.2

2.4

2.95

2.94

g/l

0.07

700

4694

Transient ischemic attack

1220

7360

1.36

21.46

2.2

2.3

2.89

2.97

g/l

1.83

1063

6503

Mental and behavioural disorders due to psychoactive substance use

1167

8018

1.36

21.45

1.6

2.4

3.04

2.90

g/l

4.54

1014

7267

Benign neoplasm: Transverse colon

286

1569

1.88

21.23

2.7

2.4

3.01

2.94

g/l

0.57

247

1404

Other complications of surgical and medical care, not elsewhere classified

223

1124

2.04

21.18

2.6

2.3

2.98

2.95

g/l

0.16

199

1016

Disorders of adult personality and behaviour

447

2759

1.64

21.18

1.7

2.1

2.87

g/l

0.01

406

2553

Other embolism and thrombosis

301

1674

1.84

21.17

2.8

2.3

3.15

2.97

g/l

2.00

276

1484

Persons encountering health services in other circumstances

717

4885

1.48

21.13

2.3

2.79

2.94

g/l

4.20

666

4317

Pneumococcal septicemia

351

2.97

21.08

5.7

2.5

2.80

2.97

g/l

0.90

313

Degeneration of macula and posterior pole

1154

6808

1.37

21.05

2.2

2.4

2.98

g/l

0.01

975

5955

Persistent mood disorders

384

2289

1.71

20.99

2.0

2.2

2.87

2.96

g/l

1.02

350

2064

Other specified and unspecified disorders of eye and adnexa

110

414

2.79

20.90

2.3

2.5

3.03

2.95

g/l

0.41

101

373

Benign neoplasm of other and unspecified endocrine glands

306

1721

1.82

20.78

2.3

2.90

2.96

g/l

0.40

268

1563

Other/unspecified reactive arthropathies

154

679

2.34

20.71

2.4

2.5

3.06

2.90

g/l

1.12

136

625

Other overlap syndromes

167

3.99

20.67

1.8

2.5

3.04

2.96

g/l

0.21

152

Injury of unspecified body region

189

906

2.15

20.67

1.6

2.5

3.28

2.98

g/l

3.30

164

819

Amputation of foot

324

3.08

20.65

1.4

2.7

3.21

3.01

g/l

1.07

285

Memory loss

250

1327

1.95

20.62

2.1

2.4

3.02

3.01

g/l

0.03

211

1190

Special screening examination for other diseases and disorders

207

1023

2.06

20.58

2.6

2.3

2.62

3.02

g/l

7.00

198

924

Other infectious diseases

199

975

2.11

20.57

2.6

2.3

3.31

2.98

g/l

3.67

184

875

Other or unspecified ileus, impaction or obstruction

408

2488

1.67

20.48

2.6

2.2

3.01

2.96

g/l

0.46

363

2204

Neuromuscular dysfunction of bladder

216

1091

2.04

20.46

2.0

2.6

2.96

2.92

g/l

0.16

197

979

Extrapyramidal and movement disorders

845

6016

1.42

20.39

2.0

2.3

2.85

2.97

g/l

3.13

738

5318

Other hammer toe(s) (acquired)

378

2083

1.71

20.36

1.9

2.5

3.08

2.95

g/l

1.55

323

1803

Spondylolisthesis/Spondylolysis

372

2221

1.71

20.28

2.6

2.3

2.82

3.00

g/l

3.23

335

1976

Fracture of forearm

1084

7346

1.36

20.25

1.9

2.3

2.98

2.94

g/l

0.66

930

6533

Psoriatic arthropathies

201

993

2.07

20.13

1.7

2.4

3.10

2.87

g/l

1.94

181

900

Diabetic maculopathy, excluding more controls

246

1306

1.93

20.08

1.4

2.4

2.89

2.94

g/l

0.32

224

1176

Fitting and adjustment of other devices

799

5088

1.44

20.00

2.4

2.1

2.62

2.96

g/l

16.30

670

4414

Amiodarone users

269

1477

1.88

19.96

2.0

2.3

3.12

2.96

g/l

1.61

247

1317

Open wound of ankle and foot

219

1120

2.00

19.94

2.2

2.3

3.12

2.95

g/l

1.60

195

1026

Bronchiectasis

220

1132

2.01

19.93

2.7

2.5

3.03

2.96

g/l

0.59

203

994

Chronic pancreatitis

291

1634

1.83

19.90

1.9

2.3

3.06

2.94

g/l

1.10

262

1475

Other diseases of the respiratory system

488

3138

1.58

19.77

2.1

2.3

3.10

2.95

g/l

2.25

424

2754

Other respiratory disorders and diseases

488

3138

1.58

19.77

2.1

2.3

3.10

2.95

g/l

2.25

424

2754

Eosinophilia

169

3.91

19.63

2.3

3.13

3.05

g/l

0.23

155

Respiratory insufficiency

189

921

2.10

19.58

1.8

1.6

3.04

2.87

g/l

1.32

161

797

Dilated cardiomyopathy

299

1703

1.81

19.57

1.8

2.4

3.14

2.94

g/l

2.44

271

1531

Collagenous colitis

218

1124

2.00

19.52

3.0

2.5

3.06

2.96

g/l

0.68

195

1013

Enthesopathies of lower limb, excluding foot

410

2533

1.64

19.50

2.3

2.2

2.89

2.96

g/l

0.77

368

2275

Carcinoma in situ of skin of scalp and neck

359

2.91

19.38

1.8

2.6

3.05

3.07

g/l

0.05

317

Retinal detachments and breaks

805

5739

1.42

19.33

2.5

2.4

2.95

2.96

g/l

0.13

715

5092

Localized swelling, mass and lump of skin and subcutaneous tissue

627

4265

1.49

19.33

2.2

2.3

2.88

2.95

g/l

1.03

562

3804

Myocardial infarction, strict

1051

5527

1.37

19.32

2.0

2.4

3.11

2.94

g/l

5.67

931

4851

Other and unspecified myopathies

220

1145

1.98

19.21

1.6

2.3

3.10

2.99

g/l

0.80

180

1016

Vascular disorders of the intestines

181

879

2.13

19.19

2.5

2.1

3.14

3.03

g/l

0.71

165

764

Heartburn

233

1233

1.93

19.18

2.0

2.3

2.76

2.99

g/l

3.18

201

1095

Benign neoplasm: Ascending colon

352

2110

1.71

19.18

2.2

2.4

3.02

2.97

g/l

0.36

306

1870

Use of pramipexole

509

3331

1.56

19.09

1.9

2.3

2.87

2.97

g/l

1.43

437

2950

Migraine with aura and triptan purchases

228

1198

1.93

19.01

1.4

1.9

2.78

2.90

g/l

1.12

214

1089

Carpal tunnel syndrome

1227

8224

1.33

18.97

2.3

2.83

2.96

g/l

5.17

1125

7317

Invasive ventilation

184

904

2.10

18.94

2.4

3.56

2.95

g/l

10.98

165

812

Scoliosis

162

755

2.19

18.93

2.2

2.3

2.92

3.03

g/l

0.72

143

673

Nonorganic sleeping disorders

348

2080

1.70

18.85

1.6

2.2

2.85

2.91

g/l

0.65

317

1909

Vasomotor and allergic rhinitis

613

4090

1.48

18.77

2.1

2.2

2.79

2.91

g/l

2.49

548

3706

Dermatophytosis

1186

9000

1.33

18.76

2.1

2.3

2.89

2.93

g/l

0.78

1042

8083

COPD, hospital admissions 3, with asthma pneumonia sepsis

671

3966

1.47

18.70

1.9

2.4

3.29

2.95

g/l

14.22

589

3465

Fracture of lower leg, including ankle

1085

8060

1.34

18.67

2.0

2.3

2.94

2.93

g/l

0.05

946

7209

Congenital malformations, deformations and chromosomal abnormalities

1086

7505

1.34

18.50

1.9

2.2

2.91

g/l

0.02

980

6792

Guillain-Barre syndrome

157

3.91

18.47

2.6

2.2

2.93

3.05

g/l

0.34

142

Hallux valgus (acquired)

627

3065

1.49

18.42

2.1

2.5

3.03

2.90

g/l

2.35

545

2704

Other disorders of glucose regulation and pancreatic internal secretion

184

913

2.07

18.32

2.0

2.3

2.97

3.00

g/l

0.16

165

821

Abnormal findings in nipple discharge synovial fluid wound secretions

135

4.14

18.29

3.4

2.1

3.23

2.94

g/l

1.32

123

Personality disorders

420

2650

1.60

18.27

1.7

2.1

2.87

g/l

0.00

381

2450

Ascites

188

944

2.05

18.23

1.5

2.4

3.01

g/l

0.00

173

838

Myocardial infarction, without ST-elevation

966

6518

1.37

18.21

2.1

2.3

3.09

2.96

g/l

3.00

839

5717

Restless leg syndrome

297

1723

1.76

18.17

2.0

2.3

2.79

2.98

g/l

2.47

263

1555

Substance use, excluding alcohol

349

2109

1.68

18.16

1.5

2.3

3.04

2.91

g/l

1.51

291

1954

Other/unspecified rheumatoid arthritis

300

1750

1.76

18.05

1.8

2.3

3.11

3.00

g/l

0.93

269

1535

KRA_PSY_EATING, excluding more controls

330

2.78

18.04

1.4

1.7

2.81

2.88

g/l

0.27

306

COPD, hospital admission 2, with asthma infections

764

4671

1.42

18.00

1.9

2.4

3.26

2.94

g/l

14.08

670

4109

Agoraphobia

158

3.72

17.97

1.7

2.92

2.91

g/l

0.02

150

Acute pancreatitis

426

2715

1.60

17.95

1.9

2.3

3.05

2.95

g/l

1.08

384

2424

Sequelae of injuries of lower limb

197

1009

2.00

17.94

2.2

2.5

2.95

2.92

g/l

0.23

182

924

Alcoholic liver disease

238

1300

1.88

17.92

1.3

2.4

3.08

2.93

g/l

1.39

199

1184

Other disorders of eyelid

999

7100

1.36

17.89

2.1

2.3

2.92

2.98

g/l

1.05

878

6255

Ankylosing spondylitis

175

861

2.08

17.80

1.5

2.1

3.07

3.00

g/l

0.39

165

785

Suppurative and necrotic conditions of lower respiratory tract

149

693

2.23

17.78

2.7

2.5

3.31

2.95

g/l

3.16

139

619

Fenamates

306

1199

1.76

17.64

2.0

2.3

3.04

2.98

g/l

0.35

274

1066

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

246

1365

1.85

17.61

1.9

1.4

3.24

2.92

g/l

4.34

223

1186

Diagnoses used for exclusion with ILD

564

3840

1.49

17.45

2.1

2.2

2.96

2.95

g/l

0.10

497

3411

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

402

2527

1.60

17.43

1.9

2.2

2.91

2.90

g/l

0.05

355

2333

Other viral hepatitis

116

487

2.44

17.42

2.1

1.9

3.05

2.85

g/l

1.38

107

455

111

455

2.48

17.42

1.4

1.7

2.88

2.78

g/l

0.47

106

427

Atopic dermatitis, strict definition with reimbursement

409

2500

1.59

17.41

1.8

2.1

2.88

2.90

g/l

0.22

366

2298

Unspecified acute lower respiratory infection

303

1790

1.72

17.29

3.2

2.2

3.02

2.95

g/l

0.61

282

1610

Covid-19 suspected case

360

2220

1.64

17.29

2.5

2.1

3.00

2.90

g/l

1.32

326

2023

Alcohol induced polyneuropathy

106

4.59

17.27

1.3

2.0

2.83

3.07

g/l

0.63

Vitamin B12 deficiency anaemia

253

1424

1.82

17.24

2.0

2.4

3.06

2.96

g/l

0.80

225

1257

Benign neoplasm: Stomach

245

1371

1.84

17.13

2.4

2.98

2.97

g/l

0.05

217

1227

Migraine without aura and triptan purchases

223

1207

1.87

17.01

1.6

1.9

2.83

2.87

g/l

0.26

208

1110

Sarcoidosis

288

1688

1.74

17.01

1.9

2.3

2.85

2.95

g/l

0.99

266

1533

Thyrotoxicosis

494

3292

1.52

16.96

1.8

2.2

3.02

2.94

g/l

1.08

437

2932

Folate deficiency anaemia

108

4.52

16.90

2.1

1.8

3.10

3.08

g/l

0.04

Inflammatory bowel disease

567

3888

1.47

16.81

2.1

2.3

2.98

2.91

g/l

0.94

511

3530

Bullous disorders

156

757

2.14

16.73

2.0

2.5

2.86

3.01

g/l

1.21

145

679

Exclusions for E4_PCOS_BROAD

313

1883

1.69

16.61

3.0

2.2

2.84

2.93

g/l

0.84

290

1718

Crystal arthropathies, rheuma endpoint

204

3.35

16.58

1.7

3.3

3.42

2.84

g/l

2.79

176

978

6752

1.34

16.56

2.7

2.3

2.94

2.99

g/l

0.92

848

5878

Herpesviral [herpes simplex] infections

234

1301

1.84

16.56

3.3

2.3

2.97

g/l

0.01

216

1177

Diplopia

286

1686

1.73

16.55

2.0

2.2

2.84

2.97

g/l

1.27

259

1517

Thyroiditis, ILD-related definition

211

1137

1.89

16.47

2.4

2.90

g/l

0.03

190

1023

Pyothorax

117

509

2.40

16.46

3.0

2.6

3.24

2.97

g/l

1.63

109

456

Drug-induced polyneuropathy

4.86

16.41

13.6

1.3

2.73

3.12

g/l

1.66

Conjunctivitis (acute, non atopic)

485

3229

1.51

16.37

2.8

2.1

2.83

2.93

g/l

1.29

444

2920

Psoriasis vulgaris

376

2380

1.61

16.36

1.8

2.2

3.02

2.92

g/l

1.02

338

2169

Hyperplasia of prostate

795

3255

1.40

16.36

2.5

2.85

2.97

g/l

2.31

719

2949

Vitreous haemorrhage

235

1316

1.83

16.35

2.1

2.4

2.95

2.96

g/l

0.05

218

1186

Lesion of lateral popliteal nerve

119

522

2.36

16.35

2.3

2.4

2.73

2.95

g/l

1.47

106

473

Candidiasis

278

1631

1.74

16.34

3.2

2.3

2.97

2.96

g/l

0.09

245

1462

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

972

7116

1.34

16.30

2.3

2.83

2.94

g/l

3.11

871

6407

Aortic aneurysm

537

3602

1.49

16.29

2.1

2.4

3.14

2.91

g/l

6.14

466

3189

Cutaneous lupus erythematosus

259

3.02

16.28

2.1

2.2

2.72

2.99

g/l

1.65

234

Juvenile arthritis (FINNGEN)

235

3.05

16.26

1.8

2.0

2.98

2.78

g/l

0.88

219

Thoracic aortic aneurysm

333

2059

1.65

16.12

2.2

2.4

3.07

2.89

g/l

2.94

290

1854

Congenital malformations, deformations and chromosomal abnormalities

952

6824

1.34

15.98

1.9

2.2

2.90

g/l

0.06

861

6182

Thyrotoxicosis, other and/or unspecified

381

2433

1.59

15.93

1.9

2.3

2.98

2.94

g/l

0.39

341

2181

Abnormal results of function studies

185

970

1.95

15.81

2.4

2.6

2.75

2.94

g/l

2.04

167

893

Hypermobility syndrome

328

2.69

15.81

2.1

1.8

2.79

2.90

g/l

0.52

317

Fall on and from stairs and steps

517

3530

1.48

15.79

2.2

2.3

2.98

2.96

g/l

0.17

447

3154

Actinic keratosis

914

6361

1.35

15.75

2.8

2.3

2.93

2.99

g/l

0.94

792

5526

Special screening examination for neoplasms

126

574

2.26

15.75

3.1

2.2

3.11

3.05

g/l

0.23

111

523

Primary biliary cholangitis (PBC)

210

3.22

15.74

1.5

1.9

3.06

3.00

g/l

0.21

191

Viral hepatitis

135

632

2.19

15.72

2.1

3.03

2.88

g/l

1.06

122

584

Intestinal stricture

673

4831

1.41

15.64

2.7

2.3

3.00

2.96

g/l

0.44

595

4261

COPD-related respiratory insufficiency

298

1808

1.69

15.61

1.9

2.4

3.27

2.94

g/l

5.87

253

1574

Chronic tubulo-interstitial nephritis

391

2.55

15.58

2.2

3.06

2.95

g/l

0.40

352

Disorders of vitreous body and globe

1094

8110

1.31

15.54

2.3

2.4

2.87

2.95

g/l

2.07

977

7198

Acute posthaemorrhagic anaemia

369

2.60

15.46

3.3

2.7

3.19

3.06

g/l

0.49

322

Mucosal proctocolitis

227

1277

1.81

15.43

2.2

2.4

3.10

2.92

g/l

1.87

215

1176

Fibroblastic disorders

471

3172

1.51

15.42

2.4

2.86

2.97

g/l

1.61

415

2805

Early onset COPD

476

3217

1.50

15.39

2.0

2.4

3.17

2.90

g/l

6.91

430

2889

Demyelinating diseases of the central nervous system

154

765

2.06

15.32

1.5

2.1

2.74

2.92

g/l

1.45

142

704

Carcinoma in situ of skin of other and unspecified parts of face

232

1326

1.81

15.24

2.2

2.4

3.06

g/l

0.03

213

1151

Other skin changes

400

2616

1.56

15.16

3.3

2.3

2.84

2.99

g/l

1.96

348

2324

Hydronephrosis

235

1346

1.78

15.10

1.8

2.1

3.16

2.92

g/l

2.70

217

1201

Skin changes due to chronic exposure to nonionizing radiation

928

6488

1.34

15.09

2.8

2.3

2.93

2.99

g/l

1.00

805

5639

Other and unspecified visual disturbances

217

1216

1.83

15.07

2.5

2.3

2.91

2.98

g/l

0.43

199

1098

Other and unspecified injuries of head

155

780

2.04

14.98

1.6

2.3

2.94

2.99

g/l

0.31

131

699

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

222

1257

1.81

14.93

2.8

2.5

3.02

2.97

g/l

0.29

200

1142

Coxarthrosis, primary

1339

9003

1.27

14.92

2.1

2.4

2.96

g/l

0.06

1176

7937

Allergic urticaria

154

773

2.04

14.91

2.0

2.4

2.91

2.94

g/l

0.13

140

708

Pain and other conditions associated with female genital organs and menstrual cycle

289

1605

1.67

14.89

2.0

2.79

2.96

g/l

2.32

256

1454

Fracture of skull and facial bones

400

2626

1.54

14.80

2.6

2.2

2.96

2.93

g/l

0.24

352

2395

Disorders of vitreous body

1060

7924

1.31

14.80

2.3

2.4

2.86

2.95

g/l

2.32

949

7038

Sequelae of injuries, of poisoning and of other consequences of external causes

443

2972

1.51

14.80

2.5

2.3

2.94

2.92

g/l

0.14

392

2709

Internal derangement of knee

635

4529

1.41

14.76

1.9

2.4

2.96

2.89

g/l

0.85

557

4064

Nummular dermatitis

183

982

1.91

14.66

2.2

2.6

2.82

2.98

g/l

1.27

166

882

Benign neoplasm: Caecum

264

1581

1.71

14.61

2.6

2.3

2.95

2.97

g/l

0.12

235

1418

Caries of enamel

1582

9223

1.24

14.60

2.5

2.2

2.88

2.91

g/l

0.77

1415

8352

Inflammatory diseases of the central nervous system

173

912

1.94

14.59

2.7

2.4

2.87

2.95

g/l

0.50

148

826

Mental and behavioural disorders due to alcohol

967

7116

1.32

14.55

1.6

2.4

3.02

2.91

g/l

2.79

850

6468

Other inflammatory liver diseases

150

755

2.04

14.53

1.7

2.7

3.09

2.94

g/l

0.83

130

687

Alcohol-induced chronic pancreatitis

147

735

2.06

14.53

1.8

2.5

3.08

2.90

g/l

0.95

128

678

Allergic rhinitis

438

2904

1.50

14.51

2.2

2.1

2.76

2.89

g/l

2.26

394

2665

Acute pancreatitis (for exclusion)

426

2852

1.52

14.46

1.9

2.3

3.05

2.94

g/l

1.23

384

2555

Traumatic subdural haemorrhage

289

1700

1.66

14.36

2.3

2.4

3.00

3.12

g/l

1.19

241

1498

Other shoulder lesions

175

931

1.92

14.30

1.6

2.1

2.88

2.93

g/l

0.28

160

849

Open wound of forearm

188

1025

1.87

14.26

2.0

2.3

3.06

2.97

g/l

0.56

167

930

Speech disturbances, not elsewhere classified

209

1180

1.82

14.23

1.9

2.4

2.84

3.01

g/l

1.63

176

1060

Viral haemorrhagic fevers, not elsewhere classified/unspecified

314

1972

1.62

14.18

2.6

2.3

3.11

2.94

g/l

2.34

290

1784

Ulcerative colitis

439

2966

1.50

14.16

2.3

2.2

2.98

2.91

g/l

0.72

393

2692

Other lack of coordination

166

3.39

14.16

1.6

2.9

2.67

3.01

g/l

1.91

149

Other specified/unspecified bacterial intestinal infections

155

798

2.00

14.12

3.3

2.4

2.95

2.96

g/l

0.03

133

725

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

294

1763

1.64

14.09

1.7

2.3

3.00

2.95

g/l

0.42

265

1603

Other and unspecified local infections of skin and subcutaneous tissue

198

1102

1.84

14.08

3.0

2.4

3.07

2.96

g/l

0.65

178

1003

Biomechanical lesions, not elsewhere classified

124

590

2.18

14.07

2.3

2.6

2.86

2.97

g/l

0.75

116

534

Familial hypercholesterolemia

331

2112

1.60

14.05

2.5

2.2

2.87

2.99

g/l

1.16

287

1828

Mental and behavioural disorders due to alcohol, excluding acute intoxication

848

6387

1.33

13.98

1.6

2.3

3.01

2.91

g/l

2.13

741

5807

Other crystal arthropathies

226

3.01

13.97

1.7

2.4

3.42

2.92

g/l

2.17

196

Delirium, not induced by alcohol and other psychoactive substances

288

1779

1.65

13.95

2.0

2.3

3.21

3.00

g/l

2.50

241

1573

Chronic viral hepatitis

380

2.45

13.92

1.8

3.01

2.80

g/l

1.23

362

Iridocyclitis

439

2979

1.49

13.91

2.4

2.2

2.99

2.94

g/l

0.58

398

2673

Congenital malformations of the urinary system

121

571

2.18

13.91

2.0

2.6

3.11

2.94

g/l

1.08

115

523

Hypothyroidism, other/unspecified

1706

9177

1.23

13.90

2.1

2.3

2.85

2.94

g/l

2.81

1526

8179

Intestinal malabsorption

107

482

2.29

13.87

1.9

2.6

3.01

2.92

g/l

0.42

101

436

Other viral diseases, not elsewhere classified

408

2711

1.51

13.84

3.1

2.1

2.95

2.91

g/l

0.32

385

2469

Other diseases of pancreas

194

1082

1.84

13.81

2.2

2.4

3.03

2.98

g/l

0.28

172

970

Oesophageal varices

106

479

2.30

13.71

1.5

2.5

3.18

2.93

g/l

2.07

433

Ptosis of eyelid

260

1577

1.69

13.69

2.6

2.4

2.89

2.98

g/l

0.81

240

1410

Other disorders of the musculoskeletal system and connective tissue

319

2032

1.60

13.68

2.2

2.3

2.94

2.96

g/l

0.13

296

1828

Hypoglycaemia, other or unspecified

142

717

2.03

13.62

1.7

2.3

2.96

2.98

g/l

0.06

130

648

Diseases of male genital organs

966

3714

1.32

13.60

2.1

2.4

2.86

2.96

g/l

1.97

888

3386

Cyst of kidney

178

973

1.89

13.58

2.6

2.88

2.98

g/l

0.67

170

876

Other and unspecified urticaria

335

2157

1.57

13.58

2.4

2.2

2.90

2.93

g/l

0.21

300

1955

Other local infections of skin and subcutaneous tissue

208

1188

1.79

13.57

2.9

2.4

3.06

2.97

g/l

0.57

184

1082

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

272

1613

1.66

13.56

1.8

2.3

3.00

2.95

g/l

0.31

246

1474

Other viral diseases, not elsewhere classified

306

1927

1.60

13.47

3.4

2.2

3.00

2.94

g/l

0.47

291

1755

Malignant melanoma, including Hilmo

363

2388

1.55

13.45

2.3

1.4

2.97

2.93

g/l

0.26

314

2092

Benign neoplasm: Rectum, anus and anal canal

457

3152

1.47

13.45

2.2

2.3

3.02

2.95

g/l

0.71

412

2798

Disorders of vestibular function (Vertigo)

970

7396

1.30

13.45

2.0

2.3

2.84

2.97

g/l

3.45

842

6522

Tubulo-interstitial nephritis, not specified as acute or chronic

146

748

2.00

13.44

2.6

2.0

2.95

g/l

0.00

130

671

Neuralgia and neuritis, unspecified

109

501

2.24

13.43

2.7

2.3

2.83

2.95

g/l

0.59

456

Other bursopathies

268

1645

1.66

13.37

2.3

2.2

3.01

2.98

g/l

0.18

245

1468

Congenital malformations of the urinary system

113

529

2.19

13.28

2.0

2.5

3.13

2.94

g/l

1.15

108

485

Artificial opening status

136

687

2.05

13.16

3.1

2.2

3.24

3.04

g/l

1.42

123

621

Fentanyl

216

1256

1.75

13.15

5.8

1.7

3.05

2.97

g/l

0.46

180

1087

Postviral fatigue syndrome

6.48

13.10

1.1

2.1

2.65

2.61

g/l

0.08

Other localized connective tissue disorders

201

3.05

13.06

2.7

2.1

3.08

3.00

g/l

0.27

182

Benign neoplasm: Adrenal gland

183

1022

1.84

13.02

2.0

2.6

3.06

2.95

g/l

0.67

160

926

Epilepsy

564

4045

1.40

12.95

2.0

2.4

2.98

2.99

g/l

0.07

485

3623

Spirochaetal infections, other/unspecified

193

1097

1.80

12.91

2.3

2.5

2.95

2.96

g/l

0.03

154

988

Presence of other functional implants

1255

6961

1.26

12.86

2.3

2.95

2.97

g/l

0.26

1076

6186

Lesion of ulnar nerve

276

1724

1.63

12.85

2.0

2.2

2.90

2.95

g/l

0.32

254

1574

Atopic dermatitis, strict definition

383

2512

1.51

12.82

1.8

2.0

2.89

2.88

g/l

0.03

348

2322

Arthropod-borne viral fevers and viral haemorrhagic fevers

349

2300

1.54

12.79

2.6

2.2

3.11

2.94

g/l

2.66

325

2074

Colonic or urogenital fistula

516

3671

1.42

12.73

2.3

2.92

2.93

g/l

0.14

455

3309

Pemphigoid

350

2.50

12.73

1.6

2.5

2.93

3.09

g/l

0.92

307

Cervicobrachial syndrome

376

2518

1.51

12.72

2.2

2.78

2.96

g/l

3.75

352

2243

Diseases of inner ear

1113

8546

1.27

12.70

1.9

2.3

2.84

2.96

g/l

3.41

969

7571

Insulin, fast-acting (human)

237

1427

1.68

12.69

1.7

2.1

2.88

2.95

g/l

0.53

217

1309

Keratitis

646

4769

1.37

12.68

2.1

2.2

2.91

2.92

g/l

0.09

578

4279

Barrett oesophagus

122

602

2.10

12.63

2.3

2.8

2.89

2.96

g/l

0.26

108

546

Poisoning by drugs, medicaments and biological substances

363

2416

1.52

12.63

2.0

2.2

3.01

2.89

g/l

1.50

322

2233

Traumatic subarachnoid haemorrhage

343

2.47

12.62

2.5

2.2

3.11

g/l

0.01

309

Angina pectoris

1207

6421

1.26

12.53

2.3

2.5

2.93

g/l

0.03

1090

5657

Personal history of malignant neoplasm

149

790

1.94

12.47

2.8

1.8

3.37

2.99

g/l

3.29

135

714

Hypothyreosis and Thyroxine purchase for inclusion criteria

1766

9621

1.21

12.40

2.1

2.3

2.86

2.94

g/l

2.98

1580

8565

Transport accidents

727

4700

1.34

12.33

1.8

2.3

2.87

2.89

g/l

0.22

651

4332

Abnormal spermatozoa

1894

0.46

12.31

2.0

2.5

2.63

2.92

g/l

2.21

1696

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

453

2.22

12.26

1.5

1.9

2.96

2.87

g/l

0.41

430

Ocular pain

157

852

1.88

12.18

1.6

2.4

2.89

2.95

g/l

0.36

145

774

Other specified/unspecified soft tissue disorders

109

522

2.15

12.16

2.4

2.1

2.94

3.01

g/l

0.26

103

460

Haemorrhoids and perianal venous thrombosis

612

4507

1.37

12.06

2.3

2.84

2.96

g/l

2.44

543

3988

Otitis externa

403

2769

1.47

12.05

2.1

2.2

2.85

2.94

g/l

1.03

342

2515

Diseases of the ear and mastoid process

2187

9280

1.19

12.05

2.2

2.81

2.96

g/l

9.70

1947

8384

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

281

1788

1.60

12.05

2.5

1.4

3.04

2.97

g/l

0.58

243

1516

Mental and behavioural disorders due to sedatives or hypnotics

121

604

2.05

12.01

1.4

2.1

2.89

g/l

0.01

105

557

Poisoning by medicine

326

2146

1.54

11.98

2.0

2.2

3.00

2.90

g/l

1.09

290

1986

Superficial injury of abdomen, lower back and pelvis

269

1699

1.61

11.95

2.1

2.2

2.94

2.98

g/l

0.26

242

1535

Intestinal adhesions without obstruction

182

1041

1.79

11.91

3.3

2.1

3.08

2.99

g/l

0.66

159

926

Dermatitis due to substances taken internally

112

546

2.10

11.91

3.4

2.6

3.00

3.04

g/l

0.14

104

494

Ankylosing spondylitis, ICD10

165

916

1.84

11.90

1.6

2.4

3.09

2.91

g/l

1.56

155

845

Fall involving bed

411

2.31

11.90

2.6

3.15

3.08

g/l

0.26

359

Synovial cyst of popliteal space [Baker]

158

867

1.87

11.88

2.7

2.2

3.01

g/l

0.00

145

773

Inflammatory diseases of female pelvic organs

974

5615

1.28

11.83

1.7

2.3

2.89

2.94

g/l

0.64

855

4998

Total colectomy

417

2.28

11.82

2.6

2.98

2.92

g/l

0.21

382

Total colectomy operation

417

2.28

11.82

2.6

2.98

2.92

g/l

0.21

382

Social phobias

100

466

2.17

11.80

1.8

2.84

2.94

g/l

0.44

439

Malignant melanoma

299

1945

1.56

11.76

2.4

1.5

2.98

2.93

g/l

0.34

255

1696

Problems related to lifestyle

168

940

1.81

11.75

1.5

2.3

2.95

2.93

g/l

0.11

152

852

Carbimazole or st.post thyroidectomy, condition for graves disease

372

2531

1.49

11.72

2.3

2.2

2.94

2.93

g/l

0.10

334

2278

Microscopic polyangiitis

4.49

11.68

1.5

1.9

3.82

3.18

g/l

1.60

Impacted cerumen

224

1365

1.68

11.66

2.3

2.5

2.91

3.00

g/l

0.47

151

1222

Vitamin deficiency, wide

107

518

2.13

11.64

2.4

2.95

2.93

g/l

0.09

467

Vitamin deficiency

107

518

2.13

11.64

2.4

2.95

2.93

g/l

0.09

467

Emotionally unstable personality disorder

157

862

1.84

11.64

1.6

1.8

2.77

2.87

g/l

0.69

142

809

Asthma and opportunity respiratory infection

123

629

2.03

11.61

2.5

2.8

3.15

3.01

g/l

0.88

115

553

Olecranon bursitis

132

689

1.97

11.61

2.3

2.1

2.99

2.96

g/l

0.14

120

625

Diabetic retinopathy, strict definition

355

2114

1.51

11.61

1.7

2.0

2.89

2.99

g/l

1.12

315

1877

Infections with a predominantly sexual mode of transmission

408

2822

1.46

11.61

2.1

2.0

2.84

2.86

g/l

0.14

367

2604

Gingival hyperplasia

345

2.40

11.58

3.1

2.8

3.25

2.98

g/l

1.33

311

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

290

2.52

11.51

1.5

1.7

2.80

2.78

g/l

0.04

278

Mixed hyperlipidaemia

456

2.20

11.43

1.6

2.2

3.18

2.97

g/l

1.04

414

Personal history of other diseases and conditions

154

842

1.85

11.42

4.2

2.0

2.84

2.96

g/l

0.93

135

771

Alcohol-induced acute pancreatitis

373

2.33

11.38

2.1

2.6

3.00

2.90

g/l

0.30

343

Other diseases of stomach and duodenum

147

801

1.88

11.37

2.1

2.7

3.04

3.01

g/l

0.14

135

720

Hernia of abdominal wall

899

7062

1.28

11.35

2.3

2.92

2.93

g/l

0.16

823

6305

Other congenital malformations

194

1142

1.72

11.35

1.7

2.4

3.05

2.95

g/l

0.74

180

1049

Alcohol use disorder, ICD-based

768

5914

1.31

11.31

1.6

2.3

3.01

2.90

g/l

2.12

677

5373

Retinal vascular occlusion

282

1830

1.57

11.30

2.5

2.4

3.03

2.97

g/l

0.36

252

1599

Temporomandibular joint disorders, including avohilmo

643

4757

1.34

11.29

2.1

2.2

2.76

2.89

g/l

3.16

580

4317

Injuries to the neck

379

2609

1.47

11.23

2.6

2.2

2.82

2.91

g/l

1.15

335

2376

Colectomy operation

368

2525

1.48

11.23

2.6

2.3

3.07

2.96

g/l

1.11

326

2232

Lung cancer and mesothelioma

377

2214

1.48

11.21

2.1

2.0

3.36

2.85

g/l

15.82

338

1932

Other and unspecified mood [affective] disorders

470

2.14

11.20

1.6

2.1

2.95

2.91

g/l

0.12

435

Macular pucker

361

2474

1.49

11.16

1.9

2.5

3.04

2.96

g/l

0.76

302

2186

Background retinopathy and retinal vascular changes

231

2.73

11.14

1.8

2.9

2.86

2.98

g/l

0.37

209

Benign neoplasm: Rectum

402

2810

1.45

11.14

2.2

2.4

3.05

2.94

g/l

1.22

362

2497

Unspecified nephritic syndrome

243

2.67

11.10

2.1

2.6

3.11

2.97

g/l

0.51

219

Drug-induced cataract

243

2.67

11.09

2.5

2.99

2.92

g/l

0.20

222

Cervicocranial syndrome

193

1144

1.72

11.09

2.0

2.2

2.87

3.02

g/l

1.27

178

1017

Artificial joint operation, meniscal resection

1867

10228

1.19

11.08

2.2

2.3

2.98

2.93

g/l

1.06

1658

9126

Speech and linguistic disorders, excluding more controls

405

2.19

11.07

2.3

2.86

3.08

g/l

1.06

362

Paraplegia, diplegia of upper limbs

226

2.73

11.05

1.8

2.5

3.17

2.94

g/l

0.98

205

Specific personality disorders

333

2241

1.50

11.04

1.7

2.1

2.86

2.87

g/l

0.03

300

2072

Retinal vascular disorders

284

1856

1.56

11.03

2.5

2.4

3.03

2.98

g/l

0.35

254

1623

Viral and other specified intestinal infections

364

2403

1.47

10.99

2.1

2.0

2.92

2.91

g/l

0.04

341

2181

Adhesive capsulitis of shoulder

314

2094

1.52

10.98

1.9

2.3

2.93

2.96

g/l

0.21

282

1873

Other/unspecified enthesopathies of lower limb, excluding foot

127

666

1.94

10.98

1.9

2.2

2.92

2.99

g/l

0.31

116

607

Infections with a predominantly sexual mode of transmission

496

3340

1.39

10.97

2.0

2.84

2.87

g/l

0.20

449

3081

Primary gonarthrosis, bilateral

1103

7615

1.25

10.97

1.9

2.4

3.00

2.94

g/l

1.00

968

6722

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

519

3772

1.38

10.92

2.1

2.2

2.89

2.88

g/l

0.07

468

3471

Pollen allergy

222

1349

1.64

10.90

2.4

2.0

2.85

2.91

g/l

0.42

195

1263

Cardiomyopathy, Hypertrophic obstructive

177

2.96

10.87

1.6

2.4

3.12

2.99

g/l

0.38

159

Propionic acid derivatives

510

1834

1.41

10.86

2.5

2.3

2.97

2.99

g/l

0.09

456

1640

Ventral hernia

482

3489

1.40

10.86

2.5

2.3

2.89

2.95

g/l

0.66

435

3096

Anti-inflammatory and antirheumatic products, non-steroids

510

1834

1.41

10.85

2.7

2.3

3.00

2.99

g/l

0.14

459

1640

Other disorders of ear

1822

10064

1.19

10.85

2.2

2.3

2.81

2.97

g/l

8.93

1582

9046

Anogenital herpesviral [herpes simplex] infection

138

745

1.88

10.84

2.1

2.0

2.76

2.90

g/l

0.95

126

696

Left bundle-branch block

155

872

1.82

10.79

1.7

2.2

2.94

2.92

g/l

0.09

129

763

Adrenocortical insufficiency

363

2.31

10.75

2.7

2.77

2.98

g/l

1.02

337

Hallux rigidus

263

1697

1.57

10.74

2.1

2.5

2.97

2.93

g/l

0.22

222

1501

Artificial joint re-operation

172

1004

1.76

10.65

2.1

2.6

3.16

2.99

g/l

1.14

157

890

Benign neoplasm: Rectosigmoid junction

107

538

2.06

10.64

2.0

2.7

2.82

2.99

g/l

1.08

482

Exclusions for E4_PCOS_CONSORTIUM

1178

5974

1.24

10.64

2.2

2.92

2.93

g/l

0.12

1038

5339

Malignant neoplasm of kidney, except renal pelvis

194

1168

1.70

10.63

1.8

1.4

3.20

2.93

g/l

2.64

175

1014

Symptoms and signs involving emotional state

230

2.64

10.58

1.7

2.0

2.99

g/l

0.01

208

Exfoliative dermatitis

102

3.66

10.55

1.5

2.6

3.13

3.10

g/l

0.05

Squamous cell neoplasms and carcinomas of the skin

192

1155

1.70

10.53

2.4

1.4

3.02

2.97

g/l

0.33

165

973

Exposure to other and unspecified inanimate mechanical forces

132

713

1.89

10.46

2.2

2.4

3.04

2.91

g/l

0.82

126

646

Other specified/unspecified hearing loss

192

1159

1.69

10.42

2.5

2.3

2.81

3.01

g/l

2.12

179

1036

Other sleep disorders

210

1295

1.65

10.40

1.7

2.5

2.86

3.00

g/l

1.15

176

1179

Mantle cell lymphoma, including Hilmo

144

3.17

10.38

2.6

1.4

2.88

2.97

g/l

0.22

125

Behavioural syndromes associated with physiological disturbances and physical factors

1644

9795

1.20

10.37

2.0

2.3

2.86

2.93

g/l

2.31

1462

8782

Other and unspecified erythematous conditions

344

2.32

10.34

2.5

2.4

2.85

2.97

g/l

0.50

310

Cardiac arrest

120

534

1.96

10.34

2.1

2.3

3.18

2.81

g/l

2.88

107

468

Emphysema

170

997

1.75

10.30

2.7

2.5

3.13

2.93

g/l

2.08

156

883

Striking against or struck by other objects

529

3917

1.36

10.21

1.9

2.2

2.98

2.91

g/l

0.82

456

3575

Mental disorders, not otherwise specified

130

705

1.87

10.15

1.7

2.2

2.78

2.90

g/l

0.80

124

654

Idiopathic pulmonary fibrosis

187

1132

1.69

10.11

2.1

2.4

3.09

2.99

g/l

0.83

170

996

Other and unspecified glaucoma

173

1026

1.73

10.10

2.0

2.6

3.07

3.02

g/l

0.22

148

892

Carcinoma in situ of other and unspecified digestive organs

420

2.18

10.10

2.1

2.9

3.13

2.97

g/l

0.63

374

Other demyelinating diseases of the central nervous system

290

2.41

10.08

1.7

1.8

2.74

2.85

g/l

0.39

273

Malignant neoplasm of urinary organs

208

1294

1.64

10.03

1.8

1.4

3.20

2.93

g/l

2.79

188

1124

Other diseases of oesophagus

202

1247

1.65

10.02

2.0

2.5

2.78

2.99

g/l

2.09

185

1115

Anterior Iridocyclitis

373

2624

1.44

9.95

2.5

2.2

2.96

2.94

g/l

0.12

340

2365

Other disorders of adrenal gland

436

2.12

9.83

2.6

2.5

2.78

2.97

g/l

0.97

403

Superficial injury of thorax

277

1846

1.52

9.79

1.5

2.3

2.94

2.98

g/l

0.28

236

1663

Dissociative [conversion] disorders

263

2.45

9.78

1.2

2.0

2.86

2.94

g/l

0.36

241

Anogenital herpesviral [herpes simplex] infection

423

2.12

9.72

2.2

1.8

2.76

2.92

g/l

0.80

393

Chronic laryngitis and laryngotracheitis

271

1803

1.53

9.68

1.8

2.2

2.76

2.98

g/l

2.95

231

1613

Acute pharyngitis

200

1228

1.63

9.68

2.6

2.0

2.90

2.91

g/l

0.06

189

1135

Cholecystectomy

1389

10010

1.20

9.68

2.4

2.3

2.92

2.94

g/l

0.32

1240

8870

Deviated nasal septum

604

4600

1.32

9.67

2.6

2.4

2.79

2.95

g/l

4.25

551

4176

Acute peritonitis

137

770

1.82

9.65

2.2

2.5

3.12

2.97

g/l

0.89

132

694

Eating disorder

443

2.07

9.63

1.4

1.6

2.81

2.91

g/l

0.45

418

Attention to artificial openings

461

2.08

9.60

2.6

2.0

3.25

2.93

g/l

2.41

418

Other infective otitis externa

121

656

1.89

9.57

2.2

2.4

2.79

2.92

g/l

0.84

108

597

Diseases of peritoneum

211

1333

1.61

9.56

2.0

2.4

3.02

2.98

g/l

0.18

192

1192

Other spirochaetal diseases

563

4260

1.33

9.55

2.6

2.4

2.91

2.92

g/l

0.13

488

3837

Other and unspecified injuries of lower leg

131

727

1.83

9.55

2.3

2.4

2.92

2.98

g/l

0.22

118

664

Other erythematous conditions

382

2.19

9.55

2.5

2.4

2.84

2.99

g/l

0.72

345

Glucagon-like peptide-1 (GLP-1) analogues

513

3832

1.35

9.50

1.6

2.5

2.99

2.87

g/l

1.86

469

3495

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

513

3832

1.35

9.50

1.6

2.5

2.99

2.87

g/l

1.86

469

3495

Fall on same level involving ice and snow

1056

8625

1.23

9.50

2.0

2.3

2.90

2.95

g/l

0.75

917

7701

Acute gastritis

158

931

1.73

9.42

1.9

2.6

2.93

3.01

g/l

0.41

137

837

Bacterial, viral and other infectious agents

150

870

1.75

9.40

2.9

2.3

2.98

2.94

g/l

0.15

139

805

Pain associated with micturition

220

1409

1.59

9.37

2.3

2.4

2.62

2.98

g/l

7.76

189

1259

Acute and subacute iridocyclitis

346

2430

1.44

9.35

2.6

2.2

2.97

2.94

g/l

0.25

315

2197

Cerebral cysts

104

540

1.97

9.35

1.5

2.3

2.73

2.96

g/l

1.27

493

Ulcerative colitis, NAS

234

1520

1.56

9.32

2.1

2.3

2.95

2.93

g/l

0.07

215

1388

Trigger finger

247

1628

1.54

9.21

1.6

2.3

2.85

2.95

g/l

0.95

227

1477

Ovarian cyst

558

2415

1.34

9.18

1.9

2.1

2.86

3.02

g/l

3.46

504

2150

Other spirochaetal diseases

555

4218

1.33

9.15

2.6

2.4

2.90

2.92

g/l

0.20

481

3798

Parkinson's disease, excluding more controls

272

1724

1.51

9.15

1.9

2.4

3.01

3.12

g/l

1.04

228

1526

Sleep disorders

1558

9529

1.19

9.13

1.9

2.3

2.86

2.93

g/l

2.40

1386

8552

Hepatic failure, not elsewhere classified

416

2.11

9.12

1.9

2.8

2.86

2.98

g/l

0.51

372

Calculus of kidney and ureter

597

4591

1.31

9.06

2.0

2.4

2.98

2.94

g/l

0.55

540

4110

Abnormality of white blood cells, not elsewhere classified

3.85

9.06

2.1

1.7

2.88

2.99

g/l

0.16

Xerosis cutis

185

2.74

9.01

1.6

2.4

2.84

2.97

g/l

0.39

167

Algoneurodystrophy

268

2.38

8.98

1.2

2.0

2.83

2.81

g/l

0.06

253

Spirochaetal infections, other/unspecified

553

4214

1.32

8.96

2.6

2.4

2.91

2.93

g/l

0.09

479

3795

Arthropathic psoriasis

210

1347

1.58

8.92

1.7

2.4

3.13

2.94

g/l

1.49

188

1237

Dermatographic urticaria

113

613

1.88

8.90

1.8

2.3

2.83

2.95

g/l

0.98

107

568

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.64

8.90

1.7

2.2

2.90

3.06

g/l

0.31

Lyme disease

549

4185

1.32

8.88

2.6

2.4

2.91

2.92

g/l

0.16

475

3768

Disorders of optic nerve and visual pathways

164

992

1.68

8.85

2.2

2.5

3.07

2.94

g/l

0.84

148

908

Polycystic ovarian syndrome, consortium definition

1125

5477

1.22

8.84

2.0

2.2

2.85

2.95

g/l

2.30

959

4894

Other specified and unspecified personality disorders

135

774

1.77

8.83

1.9

2.2

3.00

2.89

g/l

0.73

122

716

Alzheimer disease, excluding more controls

371

1739

1.42

8.83

2.1

2.5

2.98

3.12

g/l

1.47

293

1529

Benign neoplasm of mouth and pharynx

219

1423

1.57

8.82

3.0

2.4

2.93

2.96

g/l

0.15

190

1287

Disorders of orbit

490

1.99

8.80

3.5

2.5

3.02

2.96

g/l

0.24

448

Coeliac disease

211

1359

1.57

8.78

2.4

2.2

2.71

2.95

g/l

3.41

191

1225

Other disorders of bladder

246

1641

1.52

8.77

2.1

2.5

3.00

2.91

g/l

0.69

214

1459

Cluster headache, strict

277

2.33

8.76

1.7

2.8

2.74

2.97

g/l

1.38

255

Other follicular disorders

121

674

1.83

8.76

2.3

2.4

2.86

2.91

g/l

0.23

113

620

Other orthopaedic follow-up care

111

603

1.88

8.75

1.7

2.0

2.95

2.92

g/l

0.14

101

543

D07AA Corticosteroids, weak (group I)

226

1475

1.55

8.75

1.8

2.3

2.96

2.94

g/l

0.09

197

1350

Parkinson's disease, strict definition, excluding more controls

256

1637

1.51

8.74

1.9

2.4

2.98

3.12

g/l

1.38

216

1453

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

186

1167

1.63

8.74

2.2

2.4

2.98

2.94

g/l

0.17

157

1047

Insomnia

1498

9245

1.19

8.73

1.9

2.3

2.86

2.93

g/l

2.24

1331

8302

Fracture of neck

135

780

1.77

8.72

3.2

2.3

2.80

2.99

g/l

1.57

117

698

MS-disease / Multiple Sclerosis

112

610

1.87

8.71

1.6

2.1

2.63

2.94

g/l

2.66

107

562

Mental and behavioural disorders due to opioids

222

2.48

8.69

1.6

1.8

3.09

2.93

g/l

0.56

211

Pulmonary oedema

218

2.54

8.67

2.9

2.5

3.14

3.08

g/l

0.15

186

Anosmia

116

3.09

8.67

3.5

1.5

2.92

2.78

g/l

0.32

102

Secondary thrombocytopenia

132

3.05

8.66

4.5

1.6

3.29

3.00

g/l

0.74

120

Disorders of oesophagus in diseases classified elsewhere

243

2.45

8.64

3.5

3.0

3.19

3.06

g/l

0.33

213

Abscess of anal and rectal regions

141

825

1.74

8.61

1.3

2.1

3.09

2.90

g/l

1.37

128

764

Psoriatic arthropathies, ICD10

196

1249

1.60

8.59

1.7

2.4

3.11

2.94

g/l

1.11

176

1141

Bullous pemphigoid

282

2.34

8.58

1.4

2.7

2.95

3.09

g/l

0.74

245

Erosion of teeth , including avohilmo

362

2602

1.40

8.56

2.4

2.1

2.87

2.89

g/l

0.19

327

2389

COPD, hospital admissions 1, only main diagnosis

750

5108

1.27

8.55

1.9

2.3

3.20

2.95

g/l

9.31

651

4500

Alcohol abuse, main dg, excluding more controls

241

1607

1.52

8.53

1.2

2.5

2.96

2.91

g/l

0.37

211

1482

Eating disorders

121

677

1.80

8.52

2.0

1.8

2.87

2.90

g/l

0.15

112

628

Portal vein thrombosis

161

2.80

8.51

2.1

2.6

3.02

2.98

g/l

0.07

150

Dementia in Alzheimer disease

207

2657

0.65

8.50

1.5

2.3

2.82

3.06

g/l

2.27

141

2300

Dislocation, sprain and strain of joint and ligaments of hip

449

2.02

8.46

1.5

2.6

3.08

3.03

g/l

0.17

407

Mouth breathing

705

5577

1.27

8.46

2.5

2.3

2.79

2.91

g/l

2.36

647

5076

Exophthalmic conditions

107

3.27

8.46

5.4

1.8

3.04

2.85

g/l

0.40

Acute generalized exanthematous pustulosis

483

1.98

8.45

3.5

2.6

2.97

2.99

g/l

0.09

435

Other disorders of nervous system

140

825

1.74

8.43

2.6

2.4

2.67

2.97

g/l

3.66

122

751

Crushed, pushed or stepped on by crowd or human stampede

104

559

1.89

8.42

2.6

2.2

2.99

2.97

g/l

0.10

514

Follicular cysts of skin and subcutaneous tissue

330

2345

1.42

8.42

2.4

2.2

2.95

2.93

g/l

0.16

307

2118

Cholecystitis

292

2034

1.46

8.35

2.3

2.98

2.97

g/l

0.06

256

1781

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

402

2951

1.37

8.35

1.9

2.1

2.91

2.89

g/l

0.12

355

2726

Superficial injury of ankle and foot

168

1037

1.64

8.35

1.8

2.3

2.91

2.95

g/l

0.19

147

957

Cryoglobulinemia

13.75

8.34

4.5

1.3

3.01

3.15

g/l

0.11

Other/unspecified enthesopathies, not elsewhere classified

162

994

1.66

8.31

1.7

2.1

2.88

2.97

g/l

0.52

147

893

Hypothyroidism, strict autoimmune, 3 medication purchases required

1545

8896

1.18

8.29

2.0

2.3

2.87

2.94

g/l

2.12

1377

7906

Benign paroxysmal vertigo

569

4405

1.30

8.27

2.0

2.4

2.78

2.97

g/l

4.67

494

3906

Visual impairment including blindness (binocular or monocular)

143

852

1.71

8.26

2.1

2.2

2.92

3.04

g/l

0.59

113

753

Misadventures to patients during surgical and medical care

269

1851

1.47

8.21

1.8

2.2

3.00

2.95

g/l

0.39

238

1655

Bacterial, viral and other infectious agents

137

807

1.72

8.19

3.0

2.2

2.98

2.90

g/l

0.44

126

749

Other specified and unspecified retinal disorders

413

2.05

8.19

2.5

2.7

2.83

2.98

g/l

0.62

372

Thyrotoxicosis with toxic multinodular goitre

137

811

1.73

8.16

1.7

2.4

3.22

2.98

g/l

1.92

116

718

therapeutic use

387

2.09

8.15

1.6

2.4

2.95

2.96

g/l

0.03

347

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

428

2.02

8.12

2.7

2.6

3.03

3.01

g/l

0.06

388

Carcinoma in situ of skin

199

1295

1.57

8.08

2.1

2.5

3.13

3.00

g/l

0.87

181

1143

Follicular lymphoma, hilmo

104

571

1.88

8.06

1.4

2.9

3.15

3.00

g/l

0.74

513

Hemiplegia

104

569

1.87

8.06

1.8

2.4

2.89

2.98

g/l

0.51

510

Superficial injury of wrist and hand

303

2137

1.43

8.04

1.9

2.2

2.88

2.92

g/l

0.29

272

1956

Other congenital malformations

120

684

1.78

8.03

1.7

2.3

3.04

2.94

g/l

0.45

114

631

Other/unspecified disorders of vestibular function

501

1.93

7.97

1.7

2.7

2.99

3.00

g/l

0.04

453

Rosacea

204

1335

1.55

7.97

1.9

2.3

2.86

2.94

g/l

0.53

190

1212

Gonarthrosis, primary, with knee surgery

1216

8143

1.20

7.96

2.2

2.4

3.06

2.94

g/l

3.12

1074

7199

Dermatophytosis

255

1749

1.48

7.95

2.3

2.92

2.94

g/l

0.11

231

1567

Speech and linguistic disorders

477

1.91

7.94

2.3

2.0

2.86

3.03

g/l

0.82

429

Carcinoma in situ of skin of trunk

461

1.98

7.94

3.1

2.5

3.17

3.06

g/l

0.38

404

Otalgia

140

838

1.70

7.93

2.0

2.3

2.70

3.01

g/l

3.55

116

762

Monoamine oxidase A inhibitors

212

1402

1.53

7.89

1.9

2.5

2.83

2.93

g/l

0.92

190

1264

Organic, including symptomatic, mental disorders

1127

6703

1.21

7.83

2.2

2.4

2.96

2.98

g/l

0.28

924

5918

Other psoriatic arthropathies

187

1206

1.58

7.83

1.8

2.4

3.10

2.94

g/l

1.04

168

1101

Impingement syndrome of shoulder

419

3133

1.35

7.82

2.5

2.4

2.79

2.94

g/l

2.12

360

2818

Malignant melanoma of skin, including Hilmo

279

1953

1.45

7.81

2.2

1.4

2.93

g/l

0.00

242

1710

Other disorders of patella

232

1565

1.50

7.78

2.0

2.4

2.88

2.85

g/l

0.15

210

1442

Viral and other specified intestinal infections

253

1693

1.47

7.77

2.1

1.9

2.95

2.94

g/l

0.10

233

1535

Arterial embolism and thrombosis

125

731

1.75

7.75

1.4

2.5

3.26

2.97

g/l

2.13

110

647

Coronary artery bypass grafting

575

3336

1.30

7.73

1.6

2.4

3.20

2.95

g/l

6.81

517

2895

Vascular diseases of the intestine

492

1.92

7.72

3.1

2.3

3.33

3.00

g/l

2.36

435

Umbilical hernia

487

3729

1.32

7.70

2.1

2.3

2.98

2.93

g/l

0.49

451

3386

Suggestive for eosinophilic asthma

181

1165

1.58

7.67

2.2

2.4

2.92

2.95

g/l

0.14

170

1054

Diabetic maculopathy

245

1582

1.48

7.64

1.4

2.0

2.89

3.00

g/l

1.04

223

1399

Cluster headache, wide

314

2.15

7.63

1.8

2.7

2.73

2.99

g/l

1.71

287

Carcinoma in situ of colon

246

2.34

7.55

2.5

3.0

3.41

3.04

g/l

1.29

218

Congenital malformations and deformations of the musculoskeletal system

141

850

1.67

7.55

1.5

2.1

2.95

2.94

g/l

0.02

132

785

Other symptoms and signs involving the digestive system and abdomen

287

2030

1.43

7.55

1.9

2.3

2.76

3.00

g/l

3.32

241

1795

Melanocytic naevi

481

3687

1.31

7.53

2.4

2.3

2.86

2.91

g/l

0.58

454

3320

Excessive, frequent and irregular menstruation

577

2452

1.30

7.51

1.8

2.1

2.84

3.02

g/l

3.92

502

2177

Superficial injury of forearm

151

935

1.64

7.49

2.2

2.3

2.87

2.97

g/l

0.71

132

860

Somnolence, stupor and coma

454

1.94

7.48

1.5

2.9

3.01

3.02

g/l

0.04

405

Superficial injury of shoulder and upper arm

195

1283

1.54

7.45

2.2

2.3

2.86

2.97

g/l

0.76

168

1171

Chondrocostal junction syndrome [Tietze]

393

2.01

7.42

2.0

2.1

2.95

2.98

g/l

0.13

354

Other and unspecified psoriasis

134

809

1.69

7.42

2.0

2.5

2.98

2.93

g/l

0.20

122

735

Melanoma in situ

105

594

1.82

7.42

2.4

2.8

3.00

g/l

0.00

530

Crohn disease

199

1317

1.53

7.38

1.6

2.3

3.02

2.93

g/l

0.61

185

1204

Sulfonylureas

779

5039

1.24

7.36

1.9

2.4

3.06

2.97

g/l

1.36

679

4379

Menorrhagia

552

2371

1.30

7.35

1.8

2.1

2.81

3.03

g/l

5.14

466

2099

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

225

1528

1.49

7.34

1.9

2.3

3.01

2.89

g/l

1.11

197

1424

Panniculitis affecting regions of neck and back

353

2.06

7.34

1.8

2.1

2.90

2.99

g/l

0.35

321

Other and/or unspecified nontoxic goitre

165

1052

1.60

7.32

2.3

2.4

2.93

2.99

g/l

0.30

151

939

Blepharochalasis

587

4639

1.28

7.32

1.9

2.4

2.92

2.97

g/l

0.61

513

4097

Follow-up examination after treatment for malignant neoplasms

182

1185

1.56

7.31

2.3

2.2

3.03

3.07

g/l

0.22

161

1048

Respiratory disorders in diseases classified elsewhere

151

2.72

7.30

1.5

2.1

2.82

3.01

g/l

0.63

137

Urolithiasis

632

5038

1.27

7.30

2.0

2.3

2.99

2.94

g/l

0.78

568

4503

Pneumothorax

139

851

1.66

7.29

2.4

2.3

2.98

2.94

g/l

0.23

126

770

Unstable angina pectoris

788

5063

1.24

7.26

2.3

2.4

2.97

2.94

g/l

0.31

705

4411

Other disorders of optic [2nd] nerve and visual pathways

117

685

1.74

7.25

2.2

2.7

3.11

2.95

g/l

0.89

103

624

Polycythaemia vera

390

2.01

7.25

2.7

1.5

3.10

3.02

g/l

0.27

333

Carrier of infectious disease

224

2.35

7.23

1.2

2.2

2.68

2.97

g/l

1.46

207

Disorders of ocular muscles, binocular movement, accommodation and refraction

728

5847

1.24

7.18

2.1

2.2

2.82

2.91

g/l

1.65

665

5260

Other superficial mycoses

148

922

1.62

7.17

1.6

2.3

2.88

2.95

g/l

0.39

131

846

Crohn's disease NAS

105

598

1.79

7.15

1.9

2.4

2.98

2.91

g/l

0.34

549

Golimumab

263

2.22

7.14

1.3

1.9

3.37

2.88

g/l

2.69

254

Arthropathy in hypersensitivity reactions classified elsewhere

20.39

7.08

1.7

1.3

2.92

2.68

g/l

—

Other noninfective disorders of lymphatic vessels and lymph nodes

379

2.00

7.08

1.5

2.5

3.14

2.94

g/l

0.78

345

679

4767

1.25

7.04

2.2

2.3

3.00

3.01

g/l

0.10

563

4120

Other symptoms and signs involving general sensations and perceptions

408

1.96

7.01

2.3

2.5

2.81

3.06

g/l

1.65

369

Bronchitis, not specified as acute or chronic

156

993

1.59

6.96

1.9

2.4

2.86

2.92

g/l

0.25

136

880

Other and unspecified rosacea

157

1002

1.59

6.94

1.9

2.5

2.85

2.94

g/l

0.49

147

914

Other abnormal uterine and vaginal bleeding

396

2129

1.34

6.92

2.1

2.2

2.85

3.06

g/l

2.87

309

1868

Chronic hepatitis, not elsewhere classified

348

2.04

6.91

1.4

2.7

2.99

2.93

g/l

0.21

322

Diseases of tongue

115

680

1.72

6.89

2.6

2.1

2.70

3.04

g/l

3.16

102

594

Acute bronchiolitis

232

2.20

6.88

6.0

1.9

2.94

2.99

g/l

0.14

211

Other/unspecified synovitis and tenosynovitis

189

1260

1.52

6.82

1.9

2.2

2.93

2.95

g/l

0.09

173

1133

Scabies

179

1179

1.53

6.80

1.6

2.3

2.78

2.93

g/l

1.31

169

1093

Hypopituitarism

106

615

1.75

6.77

2.6

2.4

2.80

2.96

g/l

0.78

573

Postmenopausal bleeding

515

2133

1.30

6.76

2.0

2.2

2.99

3.06

g/l

0.69

445

1874

Suicide or other Intentional self-harm

356

2658

1.35

6.75

2.0

2.2

2.94

2.91

g/l

0.30

315

2448

Procreative management

439

2806

1.31

6.73

1.8

2.1

2.91

2.90

g/l

0.05

415

2579

Thiazolidinediones

243

1711

1.44

6.71

1.7

2.4

3.05

2.95

g/l

0.79

215

1519

Disorders of psychological development

114

624

1.71

6.71

2.0

1.9

2.85

2.97

g/l

0.64

105

572

Childhood asthma (age<16), excluding more controls

387

1.84

6.69

1.4

2.84

2.80

g/l

0.17

368

Pustular psoriasis

531

1.81

6.66

1.9

2.3

3.07

2.94

g/l

0.57

485

Generalized skin eruption due to drugs and medicaments

423

1.91

6.65

3.6

2.7

2.96

3.01

g/l

0.14

382

Inguinal hernia

1088

6146

1.19

6.63

2.7

2.2

2.90

2.95

g/l

0.79

980

5496

Bell's palsy

205

1399

1.48

6.63

2.3

2.2

2.75

2.97

g/l

2.74

179

1255

Disorders of synovium and tendon in diseases classified elsewhere

189

2.40

6.59

1.6

2.2

3.04

2.94

g/l

0.29

174

Supplementary factors related to causes of morbidity and mortality classified elsewhere

524

4137

1.28

6.59

1.9

2.3

2.80

2.94

g/l

2.36

440

3714

Retinal detachment with retinal break

261

1867

1.42

6.57

2.7

2.4

2.97

2.93

g/l

0.26

228

1671

Hyperkinetic disorders, excluding more controls

396

1.90

6.56

1.4

1.6

2.62

2.87

g/l

1.62

374

Mantle cell lymphoma

3.15

6.56

1.9

1.4

2.94

2.98

g/l

0.08

Other hearing loss

605

4758

1.26

6.55

2.3

2.2

2.88

3.03

g/l

3.19

516

4179

Injury of eye and orbit

218

1508

1.46

6.54

1.8

2.2

2.87

2.92

g/l

0.32

191

1394

Unspecified urinary incontinence

174

1153

1.53

6.54

1.3

2.3

2.97

3.02

g/l

0.22

126

1013

Benign neoplasm: Pancreas

357

2.00

6.52

2.4

2.8

2.75

3.02

g/l

1.36

319

Acidosis

229

2.26

6.49

1.9

2.5

3.30

3.00

g/l

1.02

208

Unspecified lump in breast

269

1937

1.40

6.49

1.9

2.3

2.94

2.98

g/l

0.21

243

1722

Seborrhoeic keratosis

438

3393

1.30

6.48

2.5

2.3

2.90

2.94

g/l

0.35

390

2986

IBD patients in KELA-register

341

2548

1.35

6.46

2.3

2.2

3.02

2.90

g/l

1.42

314

2341

Plantar fascial fibromatosis

161

1051

1.55

6.45

2.4

2.2

2.77

2.95

g/l

1.63

147

957

Drug-induced neutropenia

142

903

1.60

6.45

2.9

2.6

3.23

2.94

g/l

2.00

136

819

Disorders of breast

764

5713

1.22

6.42

2.0

2.2

2.88

2.94

g/l

0.95

671

5067

Varicose veins

1194

7713

1.17

6.42

2.4

2.3

2.91

2.93

g/l

0.28

1052

6822

Other chondrocalcinosis

168

2.52

6.41

1.6

2.2

3.50

3.06

g/l

1.40

149

Right bundle-branch block

386

1.94

6.39

3.0

2.2

3.17

2.95

g/l

1.20

341

Malignant neoplasm of other connective and soft tissue, including Hilmo

480

1.84

6.37

4.1

1.4

3.23

2.98

g/l

1.16

422

Clear cell adenocarcinoma of kidney

539

1.79

6.37

1.6

1.4

3.22

2.96

g/l

1.30

477

Cardiac murmurs and other cardiac sounds

132

815

1.62

6.36

2.7

2.2

3.03

2.99

g/l

0.17

122

728

Other and unspecified vascular occlusions

201

1381

1.48

6.35

2.5

3.09

2.99

g/l

0.59

181

1211

Other or ill-defined heart diseases

501

1.81

6.34

2.2

2.1

3.22

2.92

g/l

1.51

449

Melanocytic naevi of trunk

197

1347

1.48

6.33

2.2

2.4

2.79

2.95

g/l

1.86

184

1233

Childhood asthma (age<16)

395

1.80

6.30

1.4

2.84

2.79

g/l

0.17

375

Congenital malformations and deformations of the musculoskeletal system

106

624

1.71

6.30

1.5

2.0

2.92

2.93

g/l

0.03

101

579

Testicular dysfunction

305

2.04

6.26

1.4

2.6

2.85

2.91

g/l

0.19

278

Other and unspecified parapsoriasis

3.79

6.24

1.5

2.0

2.92

3.14

g/l

0.44

Other congenital malformations of skin

121

745

1.65

6.23

1.8

2.3

3.02

2.94

g/l

0.39

111

680

Entropion and trichiasis of eyelid

189

1289

1.49

6.22

2.3

2.5

2.94

2.99

g/l

0.30

165

1131

Enteropathic arthropathies

175

2.40

6.22

1.5

2.4

2.81

2.80

g/l

0.03

161

Necrosis of pulp, including avohilmo

902

7557

1.20

6.22

2.2

2.3

2.88

2.91

g/l

0.32

829

6862

Postprocedural disorders of nervous system

541

1.76

6.20

2.2

2.0

2.57

2.97

g/l

3.69

506

Other and unspecified disorders of vitreous body

809

6647

1.21

6.18

2.3

2.4

2.84

2.95

g/l

2.68

718

5918

Bursitis of shoulder

240

2.19

6.17

2.4

1.9

2.83

2.99

g/l

0.47

218

Benign neoplasm: Other and unspecified parts of mouth

399

1.91

6.16

3.0

2.7

3.07

2.95

g/l

0.41

361

Psychotic depression

565

1.74

6.16

1.8

2.7

2.74

2.95

g/l

1.03

514

Palmar fascial fibromatosis [Dupuytren]

297

2198

1.37

6.09

2.4

2.3

2.88

2.97

g/l

0.87

257

1936

Primary coxarthrosis, bilateral

597

4839

1.24

6.07

2.1

2.4

2.89

2.98

g/l

1.37

526

4225

Pneumonia due to Streptococcus pneumoniae

400

1.89

6.06

5.1

1.8

2.97

2.90

g/l

0.18

351

Open wound of abdomen, lower back and pelvis

255

2.13

6.04

1.7

2.1

2.98

2.95

g/l

0.05

237

Viral warts

309

2301

1.35

6.03

2.1

2.2

2.87

2.92

g/l

0.35

278

2098

Seborrhoeic dermatitis

168

1125

1.51

6.03

2.3

2.4

2.75

2.98

g/l

2.58

146

1019

Thrombotic microangiopathy

3.75

6.02

4.4

1.5

3.32

2.96

g/l

0.72

Other disorders of penis

165

1101

1.52

6.01

1.6

2.4

2.88

2.95

g/l

0.39

147

989

Other and unspecified tonsillitis

391

2524

1.31

5.97

1.8

1.9

2.91

2.90

g/l

0.08

370

2351

Atypical facial pain

564

1.74

5.97

1.9

2.5

3.01

2.99

g/l

0.07

506

Autoimmune hyperthyroidism

548

1.74

5.97

1.9

2.6

2.96

2.91

g/l

0.16

499

Other obstetric conditions, not elsewhere classified

271

1244

1.39

5.97

1.5

1.7

2.76

2.77

g/l

0.07

251

1179

Extreme obesity with alveolar hypoventilation

461

1.82

5.96

1.8

2.7

3.18

2.88

g/l

2.12

418

Other aneurysm

114

702

1.66

5.95

2.0

2.6

3.20

2.95

g/l

1.50

107

629

Assault

161

1071

1.52

5.91

1.6

2.1

3.08

2.90

g/l

1.14

143

1008

Nontoxic goitre/thyroid nodule

545

4388

1.25

5.88

2.2

2.3

2.93

2.97

g/l

0.37

480

3860

Tinnitus

426

3332

1.29

5.88

2.2

2.3

2.81

2.97

g/l

2.85

383

3012

Inflammatory disease of uterus

186

1276

1.47

5.87

1.7

2.1

2.95

2.92

g/l

0.15

164

1163

Unspecified/other endometriosis

113

694

1.64

5.87

1.9

2.79

2.97

g/l

1.20

100

628

Chondropathies

238

1709

1.41

5.87

1.9

2.2

2.98

2.94

g/l

0.23

208

1567

Lactose intolerance

272

2.07

5.85

1.4

1.7

2.72

3.00

g/l

1.53

250

Type of accident

486

3864

1.27

5.83

1.9

2.2

2.81

2.95

g/l

2.14

404

3475

Congenital malformations of the circulatory system

206

1399

1.44

5.83

1.7

2.3

2.92

2.95

g/l

0.14

182

1279

Fracture at wrist and hand level

543

4362

1.25

5.82

2.2

2.3

2.93

g/l

0.07

474

3945

Other keratitis

177

1206

1.48

5.82

2.1

2.3

2.87

2.94

g/l

0.44

160

1099

Astigmatism

544

1.73

5.81

2.3

2.4

2.67

2.98

g/l

2.93

489

Pediculosis, acariasis and other infestations

219

1553

1.42

5.78

1.6

2.3

2.85

2.92

g/l

0.48

205

1435

Complications of cardiac and vascular prosthetic devices, implants and grafts

261

2.11

5.78

2.0

2.8

3.50

2.97

g/l

2.48

230

Benign neoplasm: Parathyroid gland

127

2.65

5.78

2.7

2.0

2.54

3.04

g/l

1.35

117

Other specified/unspecified spondylopathies

281

2.05

5.77

3.0

2.1

2.98

3.08

g/l

0.26

247

Alzheimer’s disease (Late onset), excluding more controls

308

1502

1.36

5.76

2.3

2.4

3.02

3.13

g/l

0.83

243

1314

Amenorrhoea

435

1.81

5.74

1.9

2.90

2.95

g/l

0.17

404

Periapical abscess

752

6268

1.21

5.73

2.0

2.4

2.94

2.90

g/l

0.48

686

5682

Alcohol dependence

475

3776

1.27

5.73

1.5

2.4

3.06

2.90

g/l

2.60

412

3444

Iridocyclitis in diseases classified elsewhere

189

2.30

5.72

1.8

2.3

3.04

3.00

g/l

0.09

175

Injuries to the wrist and hand

1778

10915

1.13

5.71

2.0

2.3

2.91

2.93

g/l

0.25

1593

9795

Ganglion

302

2261

1.35

5.71

2.1

2.2

2.69

2.93

g/l

4.45

270

2034

Malignant neoplasm of bladder, including Hilmo

232

1660

1.41

5.67

2.5

1.4

3.06

2.94

g/l

1.00

198

1445

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

110

2.71

5.64

4.9

1.7

2.73

2.90

g/l

0.62

101

Deficiency of other B group vitamins

237

2.14

5.59

3.6

2.0

3.09

2.94

g/l

0.52

213

Other benign neoplasms of skin

686

5688

1.21

5.57

3.1

2.3

2.83

2.96

g/l

2.57

592

5045

Use of donepezil

270

3458

0.74

5.56

1.8

2.3

2.85

3.04

g/l

1.89

204

2955

Endometriosis

512

2394

1.26

5.55

1.8

2.1

2.82

3.03

g/l

5.03

453

2126

Benign neoplasm: Duodenum

328

1.95

5.54

2.7

2.8

3.04

3.05

g/l

0.01

294

Adenomyosis (Endometriosis of uterus)

229

1652

1.40

5.53

2.2

2.85

3.07

g/l

2.98

208

1463

Wet age-related macular degeneration

390

2952

1.30

5.53

2.5

2.2

3.08

3.02

g/l

0.54

327

2512

Other and unspecified nerve root and plexus disorders, also in other diseases

326

2483

1.32

5.51

2.6

2.2

2.68

2.94

g/l

5.02

281

2257

Duodenal ulcer

215

1537

1.42

5.51

1.8

2.5

3.13

2.99

g/l

1.21

197

1361

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

258

1190

1.38

5.50

1.4

1.7

2.77

2.76

g/l

0.03

240

1129

Benign neoplasm of major salivary glands

186

1298

1.45

5.47

1.9

2.4

3.02

2.97

g/l

0.25

168

1165

Coxarthrosis, primary, with hip surgery

976

7823

1.17

5.43

2.2

2.4

2.95

2.97

g/l

0.13

857

6876

Other epidermal thickening

482

1.76

5.43

2.0

2.7

2.85

2.95

g/l

0.37

436

Disorders of optic nerve, not elsewhere classified

247

2.10

5.43

2.4

2.9

3.02

3.01

g/l

0.03

222

Visual field defects

161

1097

1.49

5.37

2.3

2.92

2.99

g/l

0.37

142

986

Use of antiglaucoma preparations and miotics

172

1188

1.47

5.37

2.2

2.5

3.02

3.03

g/l

0.01

145

1021

Open wound of hip and thigh

288

1.99

5.37

1.3

2.6

3.17

2.90

g/l

1.13

268

Inflammatory bowel disease, strict (require KELA)

341

2623

1.31

5.36

2.3

2.2

3.02

2.91

g/l

1.12

314

2411

Disorders of purine and pyrimidine metabolism

3.35

5.35

1.5

3.56

3.11

g/l

0.96

Benign neoplasm: Descending colon

146

978

1.52

5.34

2.0

2.5

3.08

2.97

g/l

0.54

123

888

Later onset COPD

635

4175

1.22

5.33

1.6

2.4

3.24

2.96

g/l

10.37

547

3620

Thyrotoxicosis with diffuse goitre

216

1555

1.40

5.29

2.0

2.3

2.97

2.93

g/l

0.26

200

1415

Postzoster neuralgia

170

2.32

5.29

4.1

2.1

2.87

3.05

g/l

0.55

147

Nail disorders

133

874

1.54

5.27

1.8

2.4

2.92

g/l

0.01

120

799

Obsessive-compulsive disorder

353

1.86

5.24

2.0

2.1

2.82

2.97

g/l

0.61

334

Orchitis and epididymitis

161

1103

1.48

5.21

1.9

2.3

2.90

2.96

g/l

0.24

144

985

Other noninflammatory disorders of vulva and perineum

139

924

1.52

5.20

1.5

2.2

2.88

3.02

g/l

0.91

124

829

Congenital malformations of cardiac septa

544

1.68

5.20

1.7

2.3

3.02

2.93

g/l

0.36

498

Vulvovaginal ulceration/inflammation in other diseases

450

1.76

5.18

1.8

2.1

2.79

2.96

g/l

0.97

421

Specific development disorders of speech and language

355

1.84

5.17

1.8

2.3

2.97

3.10

g/l

0.42

315

Irregular menses

611

3974

1.22

5.14

2.1

2.82

2.90

g/l

1.19

557

3623

Other retinal artery occlusion

287

1.98

5.13

2.0

2.8

2.86

3.05

g/l

0.56

258

Lichen ruber planus, wide definition including periferal and oral lichen planus

391

3083

1.28

5.13

2.3

2.87

2.96

g/l

1.16

351

2755

Benign neoplasm: salivary glands, exclude unknown (D119)

166

1150

1.47

5.11

1.9

2.5

3.00

2.95

g/l

0.29

150

1044

Other and specified injuries of hip and thigh

246

2.05

5.09

1.4

2.2

2.89

3.12

g/l

0.68

221

Benign neoplasm: Parotid gland

149

1012

1.50

5.09

1.9

2.4

2.99

2.96

g/l

0.16

136

919

Alcohol abuse, main dg

241

1779

1.37

5.08

1.2

2.3

2.96

2.92

g/l

0.24

211

1640

Thyroiditis

119

770

1.57

5.08

2.3

2.4

2.88

2.96

g/l

0.38

103

700

Sequelae of injuries of neck and trunk

295

1.94

5.05

3.1

2.7

3.01

2.92

g/l

0.24

272

Other disorders of iris and ciliary body

303

1.93

5.02

2.2

2.7

3.03

2.97

g/l

0.17

270

Cluster headache, strict, including avohilmo

418

1.77

5.01

1.6

2.3

2.72

2.86

g/l

0.83

388

Type1 diabetes, definitions combined, early onset

293

1.92

5.01

1.4

1.5

2.77

2.87

g/l

0.31

280

Spontaneous abortion

431

3632

0.80

5.00

1.9

2.3

2.78

2.91

g/l

2.21

392

3271

severe traumatic brain injury, does not include concussion

428

3424

1.26

4.97

2.3

3.01

2.97

g/l

0.36

360

3010

Disorders of speech understanding and production

290

1.92

4.96

1.9

2.4

3.04

3.11

g/l

0.18

256

Diffuse brain injury

275

1.96

4.96

2.5

2.0

3.08

g/l

0.00

251

Type 1 diabetes, definitions combined

102

637

1.61

4.96

2.0

2.78

2.91

g/l

0.62

601

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

593

1.64

4.95

1.9

2.3

2.90

2.86

g/l

0.14

549

Monocytic leukaemia

3.94

4.94

3.2

1.4

3.35

3.11

g/l

0.23

Benign neoplasm: Spinal meninges

125

2.52

4.94

1.3

1.9

2.90

3.02

g/l

0.17

110

Event of undetermined intent

587

1.64

4.92

1.9

2.3

3.06

2.92

g/l

0.59

539

Lactose intolerance, other/unspecified

242

2.03

4.90

1.4

1.7

2.72

2.98

g/l

1.16

223

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.52

4.89

1.4

1.3

3.55

3.21

g/l

0.68

Pure hyperglyceridaemia

229

2.06

4.89

1.8

2.3

2.89

3.07

g/l

0.63

208

Recurrent dislocation and subluxation of joint

496

1.69

4.87

2.0

2.3

2.92

2.86

g/l

0.19

464

Other and unspecified follicular disorders

378

1.81

4.87

3.0

2.5

2.78

2.94

g/l

0.59

352

Benign neoplasm: Small intestine

545

1.67

4.87

2.5

2.7

3.05

3.00

g/l

0.19

488

Status epilepticus

364

1.82

4.84

1.7

2.9

2.83

3.11

g/l

1.31

328

Lichen planus, including avohilmo

333

2595

1.30

4.83

2.4

2.3

2.84

2.96

g/l

1.64

300

2314

Other and unspecified trigeminal disorders

132

2.42

4.82

1.4

2.0

2.61

2.85

g/l

0.72

117

Other Crohn's disease

598

1.63

4.82

1.4

2.2

3.27

2.90

g/l

2.99

549

Abnormal blood-pressure reading, without diagnosis

446

1.73

4.81

2.2

2.4

3.04

2.97

g/l

0.23

403

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

230

1701

1.36

4.81

2.5

2.3

2.99

2.93

g/l

0.40

212

1562

Other obstructive and reflux uropathy

365

1.81

4.78

1.9

2.1

3.05

2.91

g/l

0.54

334

Alzheimer’s disease (undefined)

122

0.00

4.78

0.0

2.0

—

3.09

—

101

Excessive earwax

1038

8810

1.16

4.77

2.5

2.3

2.82

2.96

g/l

4.09

888

7839

Urethral stricture

114

743

1.56

4.77

2.1

2.5

2.97

2.92

g/l

0.23

100

660

Type 1 diabetes, strict (exclude DM2)

101

636

1.60

4.76

2.0

2.78

2.90

g/l

0.58

600

Scleritis and episcleritis

624

1.61

4.76

1.7

2.2

2.86

2.89

g/l

0.09

582

Other deformities of toe(s)

374

1.80

4.75

1.8

2.2

2.96

2.90

g/l

0.14

329

Other disorders of pigmentation

502

1.69

4.73

2.7

2.4

2.81

2.99

g/l

0.97

455

Otitis externa, unspecified

166

1167

1.44

4.72

1.9

2.4

2.82

2.94

g/l

0.77

147

1064

Drug-induced hypoglycaemia without coma

159

2.27

4.71

1.3

2.5

3.05

3.01

g/l

0.06

143

Disorders of refraction and accommodation

367

2890

1.27

4.70

2.0

2.1

2.82

2.92

g/l

1.02

337

2622

Focal brain injury

102

649

1.59

4.70

2.0

2.4

3.03

3.06

g/l

0.11

588

Cluster headache, wide,, including avohilmo

449

1.72

4.70

1.7

2.3

2.71

2.87

g/l

1.01

414

Ulcerative colitis (strict definition, all Crohn cases excluded)

206

1505

1.38

4.67

2.7

2.3

3.01

2.93

g/l

0.48

188

1386

Ulcerative colitis (strict definition, require KELA)

236

1762

1.35

4.65

2.5

2.3

2.98

2.93

g/l

0.37

217

1621

Other salmonella infections

384

1.78

4.64

2.9

2.1

2.96

2.91

g/l

0.14

343

Triptan medication for migraine, min. 3 purchases

719

4634

1.19

4.64

2.2

2.1

2.77

2.89

g/l

2.63

661

4245

Postprocedural disorders of digestive system, not elsewhere classified

370

1.80

4.62

1.8

2.8

3.08

2.98

g/l

0.41

334

Other and unspecified nonorganic psychotic disorders

246

1850

1.34

4.61

1.5

2.3

2.94

2.91

g/l

0.17

218

1711

Benign neoplasm: Pituitary gland, craniopharyngeal duct

545

1.64

4.57

2.8

2.5

2.70

2.94

g/l

1.42

496

Other condition

221

1640

1.36

4.56

2.2

2.81

2.97

g/l

1.49

204

1493

Viral infections of the central nervous system

120

799

1.52

4.53

2.2

2.3

3.04

2.97

g/l

0.25

105

726

Viral infections of the central nervous system

113

743

1.54

4.53

2.2

2.3

3.04

2.97

g/l

0.25

676

Acute laryngitis and tracheitis

120

785

1.51

4.50

1.6

1.9

2.85

2.96

g/l

0.77

111

724

Disorders of tooth development and eruption

206

1220

1.37

4.49

1.8

2.0

2.95

2.96

g/l

0.06

187

1100

Viral warts

142

980

1.46

4.48

2.0

2.4

2.89

2.94

g/l

0.24

130

894

Ectropion of eyelid

573

1.62

4.47

1.5

2.4

3.16

3.06

g/l

0.38

491

Achilles tendinitis

160

1130

1.43

4.46

2.5

2.2

2.83

2.97

g/l

1.09

143

1039

Senility

2.75

4.45

2.0

1.7

2.78

3.41

g/l

1.21

Malignant neoplasm, without specification of site, including Hilmo

573

1.61

4.43

3.0

1.4

3.38

3.02

g/l

1.71

487

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

466

3813

1.23

4.43

2.6

2.2

2.96

2.93

g/l

0.31

423

3452

Corneal scars and opacities

288

1.89

4.41

1.7

2.8

3.11

3.03

g/l

0.20

256

Psoriasis (vulgaris), strict definition

325

1.82

4.36

1.4

2.7

2.83

2.90

g/l

0.20

300

Meralgia paraesthetica

340

1.80

4.35

1.5

2.3

3.04

2.94

g/l

0.37

306

Malignant melanoma of skin

195

1433

1.38

4.33

2.3

1.4

2.93

g/l

0.02

168

1250

N06DA Anticholinesterases

553

5213

0.83

4.32

1.9

2.3

2.94

3.01

g/l

0.75

433

4501

Use of anticholinesterases

553

5213

0.83

4.32

1.9

2.3

2.94

3.01

g/l

0.75

433

4501

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.67

4.31

1.5

2.90

3.08

g/l

0.37

Presence of other devices

475

3894

1.22

4.30

2.6

2.3

2.54

3.01

g/l

20.64

425

3412

Ulcerative enterocolitis

276

1.88

4.28

1.8

2.3

3.14

2.89

g/l

0.76

250

All dysplastic lesions of the cervix uteri, vagina or vulva

323

2509

1.27

4.25

2.2

2.0

2.87

2.85

g/l

0.12

296

2303

Allergic contact dermatitis

189

1385

1.38

4.25

1.4

2.3

2.93

g/l

0.01

169

1255

Post-traumatic wound infection, not elsewhere classified

256

1.92

4.23

1.7

2.7

2.99

2.90

g/l

0.26

233

Additional codes for the location of defect, injury or illness

636

1.56

4.21

1.4

2.6

2.67

2.97

g/l

2.17

579

Other and unspecified iridocyclitis

480

1.65

4.20

3.1

2.4

3.17

2.90

g/l

1.59

437

Congenital iodine-deficiency syndrome/hypothyroidism

352

1.77

4.19

3.1

2.2

2.81

3.04

g/l

0.97

313

Injury of muscle and tendon at lower leg level

249

1907

1.32

4.18

2.5

2.4

2.85

2.93

g/l

0.72

229

1751

Aortic valve malfunction, age under 60 years

143

1004

1.44

4.16

1.8

2.3

3.19

2.88

g/l

2.54

133

931

Maternal care for other conditions predominantly related to pregnancy

206

1503

1.35

4.16

1.9

2.80

g/l

0.03

191

1414

Arthropathy in ulcerative colitis

116

2.40

4.16

1.6

1.8

2.85

2.92

g/l

0.11

109

Lichen planus

231

1754

1.33

4.15

2.7

2.3

2.79

2.97

g/l

2.22

207

1569

Other otitis externa (chronic)

111

743

1.52

4.14

2.5

3.13

2.92

g/l

1.05

675

Salpingitis and oophoritis

269

2084

1.30

4.14

1.8

2.4

2.98

2.93

g/l

0.35

243

1882

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

401

3255

1.24

4.13

1.6

2.2

2.91

g/l

0.01

362

2984

Ulcer of oesophagus

131

908

1.46

4.12

2.1

2.7

2.92

2.99

g/l

0.35

114

816

Postprocedural musculoskeletal disorders, not elsewhere classified

137

959

1.45

4.10

2.3

2.5

2.89

2.96

g/l

0.28

127

868

Malignant neoplasm, without specification of site

362

1.75

4.08

2.9

1.4

3.25

3.09

g/l

0.44

302

Bicipital tendinitis

523

1.61

4.07

2.1

2.4

2.88

2.91

g/l

0.09

482

Other secondary coxarthrosis

393

1.72

4.06

1.7

2.4

2.88

2.96

g/l

0.29

357

Left ventricular outflow tract obstruction (LVOTO), broad definition

149

1059

1.42

4.06

1.8

2.4

3.21

2.89

g/l

2.67

139

980

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

196

2611

0.74

4.04

1.9

1.4

3.00

2.93

g/l

0.38

174

2286

Dislocation, sprain and strain of joints and ligaments at neck level

195

1448

1.36

4.04

2.3

2.85

2.91

g/l

0.44

178

1337

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

254

1960

1.30

4.03

2.5

2.2

2.98

2.93

g/l

0.39

235

1799

Ulcerative proctitis

587

1.57

4.02

1.4

2.3

2.87

2.89

g/l

0.08

534

Hepatocellular carcinoma, including Hilmo

342

1.77

4.01

2.8

1.4

2.97

3.01

g/l

0.13

295

Atrophic disorders of skin

233

1780

1.32

4.00

2.0

2.2

2.96

2.98

g/l

0.12

214

1580

Hordeolum and other deep inflammation of eyelid

596

1.56

4.00

2.5

2.6

2.97

2.93

g/l

0.14

557

Acute suppurative otitis media

265

1918

1.29

3.97

2.8

2.0

2.88

2.90

g/l

0.13

246

1775

Other and unspecified mononeuropathies of upper limb

276

1.85

3.97

1.3

2.2

2.94

2.90

g/l

0.13

255

Benign neoplasm: Skin of ear and external auricular canal

496

1.62

3.97

2.2

2.5

2.89

3.00

g/l

0.52

449

Other salmonella infections

441

1.66

3.96

2.7

2.2

2.98

2.91

g/l

0.22

398

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

310

2427

1.27

3.96

2.1

2.0

2.82

2.89

g/l

0.69

281

2227

Disorder of external ear, unspecified

358

1.74

3.96

2.9

2.7

2.87

2.93

g/l

0.20

328

Malignant neoplasm of mesothelium and soft tissue

465

1.64

3.96

3.1

1.4

3.43

2.99

g/l

2.03

408

Crohn's disease of small intestine

630

1.54

3.93

1.7

2.3

3.01

2.94

g/l

0.28

577

Other and unspecified mononeuropathies, also in other diseases

314

1.79

3.93

1.8

2.4

2.77

3.02

g/l

0.88

277

Premature rupture of membranes

109

1146

0.68

3.93

1.9

1.8

2.60

2.84

g/l

2.29

101

1076

Other and unspecified bullous disorders

120

2.34

3.90

3.2

2.1

3.00

2.96

g/l

0.06

109

Nontoxic multinodular goitre

352

2841

1.25

3.90

1.9

2.4

2.98

2.99

g/l

0.07

300

2502

Corns and callosities

115

787

1.48

3.88

1.9

2.4

2.89

2.94

g/l

0.26

100

715

Subacute thyroiditis

383

1.70

3.87

2.8

2.3

2.77

2.96

g/l

0.98

349

Nasal polyp

328

2629

1.26

3.86

3.0

2.3

2.84

2.96

g/l

1.57

302

2366

Degenerative macular diseases

237

1829

1.31

3.83

2.2

2.4

2.94

3.00

g/l

0.31

205

1595

Other disorders of cornea

163

1190

1.39

3.83

1.9

2.2

2.92

2.95

g/l

0.15

145

1075

Other disorders of central nervous system

108

2.39

3.83

1.2

1.9

2.64

2.95

g/l

0.75

100

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

202

1522

1.34

3.82

1.9

2.1

2.80

2.93

g/l

1.16

187

1378

Asthma mixed form (mode), excluding more controls

422

1.65

3.80

2.0

1.5

2.72

2.96

g/l

1.20

371

Carcinoma in situ of skin of ear and external auricular canal

210

1.98

3.79

1.6

2.6

2.99

2.93

g/l

0.15

179

Benign neoplasm: Skin of eyelid, including canthus

283

2238

1.28

3.77

3.1

2.3

2.82

2.98

g/l

2.03

248

1996

Central retinal artery occlusion

283

1.82

3.72

3.5

2.3

3.08

3.05

g/l

0.06

250

Other renal tubulo-interstitial diseases

196

1.98

3.72

1.8

2.0

3.39

2.85

g/l

1.64

181

Peroneal tendinitis

122

2.27

3.72

2.1

1.9

2.94

2.86

g/l

0.23

116

Alzheimer’s disease (undefined), excluding more controls

0.00

3.72

0.0

1.8

—

3.42

—

Injury of muscle and tendon at hip and thigh level

153

1111

1.39

3.72

2.1

2.3

2.84

2.92

g/l

0.48

142

1029

Complications of genitourinary prosthetic devices, implants and grafts

268

1.83

3.71

1.9

3.21

2.98

g/l

0.82

237

Glucosamine medication

985

6936

1.14

3.71

2.4

2.3

3.00

2.97

g/l

0.47

874

6049

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

146

932

1.40

3.69

1.4

1.6

2.66

2.86

g/l

2.02

136

876

Other neurotic disorders

537

1.57

3.67

1.5

2.6

2.98

2.99

g/l

0.01

480

Single delivery by forceps and vacuum extractor

656

0.62

3.67

1.3

1.6

2.80

2.89

g/l

0.32

613

Malignant neoplasm of small intestine, including Hilmo

344

1.72

3.66

2.3

1.4

3.07

2.99

g/l

0.22

302

Alzheimer’s disease (Early onset)

606

0.50

3.65

1.3

2.1

3.02

3.05

g/l

0.06

524

Excessive attrition of teeth

842

7371

1.15

3.64

2.3

2.2

2.75

2.91

g/l

5.69

755

6695

Hyperaldosteronism

315

1.75

3.62

2.4

2.6

3.09

3.03

g/l

0.16

287

Oesophageal obstruction

423

1.64

3.58

2.8

2.9

3.01

3.04

g/l

0.07

379

Atlantoaxial subluxation

2.82

3.57

1.3

1.7

3.08

2.90

g/l

0.29

Autonomic disorders

228

1.88

3.56

2.1

2.3

2.74

3.00

g/l

1.19

205

Brachial plexus disorders

118

825

1.44

3.56

2.4

2.3

2.63

2.90

g/l

2.93

113

769

Focal epilepsy, strict definition

322

2601

1.25

3.55

2.1

2.3

3.03

2.96

g/l

0.45

274

2335

Epiphora

258

1.83

3.54

2.6

2.4

2.97

3.01

g/l

0.13

232

Hereditary angioödema type 1

8.31

3.54

8.3

1.0

2.11

3.03

g/l

—

Focal epilepsy

342

2782

1.24

3.53

2.1

2.3

3.00

2.96

g/l

0.32

292

2503

Atopic conjunctivitis

362

1.68

3.52

1.5

1.9

2.94

2.91

g/l

0.11

331

!Aliquae complicationes praecoces traumatis

456

1.60

3.51

2.5

3.13

2.93

g/l

0.85

417

Early complications of trauma

456

1.60

3.51

2.5

3.13

2.93

g/l

0.85

417

Spontaneous rupture of synovium and tendon

135

971

1.41

3.50

1.9

2.2

2.83

2.96

g/l

0.84

114

873

Dissection of aorta

395

1.65

3.49

1.7

2.7

3.18

2.97

g/l

0.93

355

Vascular dementia (subcortical)

474

1.60

3.48

2.9

2.2

3.06

3.14

g/l

0.30

409

Injury of other and unspecified intrathoracic organs

109

756

1.46

3.47

1.7

2.3

3.08

2.98

g/l

0.44

683

Gluteal tendinitis

388

1.65

3.44

2.0

2.3

2.94

2.98

g/l

0.11

355

Tongue abnormality

111

775

1.45

3.43

2.6

2.5

2.68

2.99

g/l

2.52

695

Unspecified misadventure during surgical and medical care

668

1.49

3.43

1.8

2.5

3.00

2.95

g/l

0.20

605

Assault by bodily force

561

1.53

3.43

1.6

2.2

2.95

2.89

g/l

0.18

529

Flat foot [pes planus] (acquired)

136

983

1.40

3.42

1.8

2.7

2.83

2.90

g/l

0.30

119

882

Contusion of toe(s) without damage to nail

181

1.97

3.42

1.2

2.4

2.64

2.84

g/l

0.59

173

Medical abortion

973

4661

1.14

3.41

1.8

2.3

2.95

g/l

0.01

854

4115

Hydrocele

205

1578

1.31

3.41

2.5

2.6

2.86

2.97

g/l

0.83

187

1404

Disorders of parathyroid gland, other and/or unspecified

2.53

3.40

1.4

1.8

3.07

3.04

g/l

0.04

Benign neoplasm of meninges

187

1424

1.33

3.39

1.9

2.4

2.90

2.99

g/l

0.51

160

1259

Atrial septal defect

296

1.74

3.38

2.0

3.11

2.99

g/l

0.37

273

Lichen simplex chronicus

352

1.68

3.37

2.9

2.7

2.95

2.97

g/l

0.04

319

Benign neoplasm: Kidney

407

1.63

3.36

2.2

2.8

3.08

2.94

g/l

0.51

365

Other specified/unspecified disorders of bone/cartilage

277

1.77

3.35

2.4

2.0

2.59

2.86

g/l

1.69

257

Blindness, monocular

2.38

3.34

4.6

1.9

2.91

3.00

g/l

0.10

Arterial embolism and thrombosis of lower extremity artery

455

1.59

3.32

1.5

2.7

3.22

3.03

g/l

0.77

407

Redundant prepuce, phimosis and paraphimosis

296

2365

1.25

3.32

2.0

2.4

2.95

2.94

g/l

0.09

275

2149

Vascular dementia

188

1385

1.32

3.31

2.4

2.2

2.99

3.09

g/l

0.60

149

1195

Contact with and exposure to communicable diseases

314

2538

1.24

3.30

2.2

2.0

2.61

2.87

g/l

6.15

304

2359

Septal defects

515

1.54

3.30

1.7

2.3

2.90

2.91

g/l

0.04

473

Abdominal aortic aneurysm (AAA)

196

1497

1.31

3.27

1.9

2.3

3.26

2.92

g/l

4.42

168

1298

malignant neoplasm of male genital organs

515

2660

1.19

3.26

2.1

1.4

3.02

2.91

g/l

1.51

456

2377

UC patients in KELA-register (code 208), prior to 1994

505

1.55

3.26

2.6

2.91

2.92

g/l

0.03

461

Complications of labour and delivery

695

4443

0.87

3.25

2.4

2.2

2.81

2.93

g/l

2.75

641

3977

Melanoma in situ of trunk

193

1.93

3.24

2.4

3.0

2.80

3.03

g/l

0.64

172

Complications of other internal prosthetic devices, implants and grafts

490

1.56

3.24

2.1

2.4

2.97

3.01

g/l

0.10

440

Benign neoplasm of urinary organs

595

1.50

3.23

2.1

2.7

2.96

2.99

g/l

0.08

537

Migraine, single triptan purchase ok & required. ICD-code if available is included

1116

6768

1.12

3.22

2.1

2.2

2.79

2.91

g/l

4.20

1029

6141

Triptan medication for migraine, single purchase ok

1116

6768

1.12

3.22

2.1

2.2

2.79

2.91

g/l

4.20

1029

6141

Malignant neoplasm of colon, including Hilmo

330

2704

1.23

3.22

2.4

1.4

3.13

2.95

g/l

1.98

285

2344

Familial hypercholesterolemia, with ischemic heart disease

189

1454

1.32

3.21

1.9

2.4

2.94

2.96

g/l

0.06

163

1259

Melanoma in situ of other and unspecified parts of face

180

1.97

3.21

2.3

2.9

2.98

3.07

g/l

0.16

158

Secondary parkinsonism, excluding more controls

222

1.83

3.19

2.8

2.2

2.79

3.11

g/l

1.15

196

Colitis, primary sclerosing, strict definition

2.47

3.18

2.2

3.26

2.91

g/l

1.18

Prepatellar bursitis

453

1.57

3.14

2.4

2.3

2.91

2.94

g/l

0.09

408

Contusion of other and unspecified parts of foot

374

1.62

3.14

2.2

2.93

g/l

0.02

347

Other diseases of spinal cord

306

1.70

3.12

2.5

2.8

2.89

2.94

g/l

0.14

281

Other and unspecified primary disorders of muscles

2.60

3.10

1.4

2.6

3.17

2.93

g/l

0.64

Malnutrition

225

1.82

3.08

1.8

2.2

3.12

3.00

g/l

0.24

197

448

3569

1.19

3.08

2.1

2.2

2.95

3.02

g/l

0.61

368

3044

Campylobacter enteritis

262

1.75

3.07

2.2

2.4

2.81

3.00

g/l

0.72

236

Pneumonitis due to solids and liquids

148

1107

1.35

3.07

1.4

2.2

3.12

2.99

g/l

0.80

115

975

Burns and corrosions

189

1462

1.30

3.06

1.9

2.2

3.07

2.94

g/l

0.92

171

1346

Retinal breaks without detachment

280

2272

1.24

3.06

2.4

2.87

2.93

g/l

0.41

246

2046

Mental and behavioural disorders due to tobacco

134

988

1.37

3.04

1.7

2.5

3.22

2.91

g/l

2.54

109

909

Ventricular septal defect, a heart condition

126

2.09

3.03

1.5

1.6

3.30

2.99

g/l

0.89

118

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

603

1.47

3.02

1.8

2.3

2.77

2.96

g/l

1.20

554

Corneal ulcer

272

2202

1.24

3.02

2.2

2.97

2.92

g/l

0.33

244

1997

Malignant neoplasm of prostate, including Hilmo

523

2658

1.18

3.01

2.1

1.4

3.00

2.92

g/l

1.03

468

2374

Postpartum haemorrhage

151

1682

0.75

3.01

1.9

2.0

2.70

2.84

g/l

1.44

136

1565

Noninflammatory disorders of female genital tract

571

2462

1.17

2.98

2.2

2.1

2.95

3.02

g/l

0.86

509

2187

Hyperfunction of pituitary gland

395

1.59

2.98

2.9

2.0

2.88

2.94

g/l

0.23

371

Type 1 diabetes, strict definition

401

1.58

2.98

1.3

1.5

2.77

2.84

g/l

0.23

383

Other congenital malformations of upper alimentary tract

0.00

2.98

0.0

2.6

—

3.00

—

Graves ophthalmopathy, strict

228

1.79

2.96

1.2

1.8

3.04

2.95

g/l

0.22

210

Melanocytic naevi of upper limb, including shoulder

228

1.79

2.95

1.9

2.5

2.75

2.95

g/l

0.75

211

Strabismus

378

3160

1.20

2.95

2.2

2.83

2.93

g/l

1.29

341

2854

Lung diseases due to external agents

256

2066

1.25

2.95

2.4

2.3

3.09

2.95

g/l

1.28

211

1824

Tracheo-bronchomalasia

4.86

2.95

1.6

3.8

2.60

2.74

g/l

—

Other arterial embolism and thrombosis

343

1.63

2.93

1.4

2.6

3.31

3.00

g/l

1.21

304

Other, unspecified and serous retinal detachments

367

1.61

2.92

2.0

2.7

2.96

2.99

g/l

0.07

328

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

124

909

1.38

2.91

2.4

2.5

2.90

3.00

g/l

0.63

113

811

Congenital malformations of heart and great arteries

163

1207

1.32

2.90

2.0

2.3

2.90

2.95

g/l

0.29

140

1113

Single spontaneous delivery

507

3128

0.85

2.89

2.6

2.1

2.96

3.01

g/l

0.51

463

2729

Malignant neoplasm of bladder

123

903

1.38

2.88

2.1

1.4

3.10

2.92

g/l

1.05

105

776

Other predominantly sexually transmitted diseases, not elsewhere classified

202

1589

1.28

2.87

2.0

2.79

2.89

g/l

0.73

182

1478

Open wound of shoulder and upper arm

179

1.88

2.86

1.5

2.1

3.12

3.04

g/l

0.16

162

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

3.01

3.29

g/l

—

Disturbance of activity and attention

493

1.50

2.84

1.4

1.5

2.60

2.87

g/l

1.80

467

All dysplastic lesions of the cervix uteri

258

2075

1.24

2.81

2.2

2.0

2.84

g/l

0.04

239

1917

Delivery

511

3131

0.86

2.80

2.5

2.1

2.97

3.01

g/l

0.39

467

2732

Tobacco use

523

1.49

2.80

1.7

2.5

3.04

2.92

g/l

0.63

483

Smoking dependency

134

1003

1.35

2.79

1.7

2.5

3.22

2.91

g/l

2.57

109

923

Benign neoplasm of breast

191

1501

1.28

2.79

2.2

2.87

2.99

g/l

0.80

165

1327

Malignant neoplasm of small intestine

248

1.73

2.78

2.7

1.4

3.06

2.97

g/l

0.21

217

Trigeminal neuralgia

665

1.43

2.77

2.7

2.4

2.88

2.97

g/l

0.34

600

Burns and corrosions of multiple and unspecified body regions

196

1.82

2.75

1.9

2.6

3.39

2.92

g/l

1.29

182

Impotence

650

1.43

2.74

1.9

2.3

2.83

2.93

g/l

0.45

579

Other predominantly sexually transmitted diseases, not elsewhere classified

178

1388

1.29

2.74

2.1

2.0

2.76

2.90

g/l

1.00

160

1289

Focal epilepsy, mode (most common among epilepsy diagnosis)

293

2418

1.22

2.73

2.2

2.3

2.95

2.96

g/l

0.08

248

2169

Delivery, wide proxy

421

2628

0.85

2.72

2.4

2.0

2.98

3.06

g/l

0.79

381

2256

Other diseases of gallbladder

560

1.47

2.72

2.4

2.5

2.83

3.01

g/l

0.68

497

Appendectomy

993

8560

1.11

2.72

2.2

2.93

2.90

g/l

0.35

895

7749

Other disorders of the genitourinary system

225

1810

1.25

2.71

2.1

2.4

3.06

2.99

g/l

0.54

202

1595

Convergent concomitant strabismus

453

1.52

2.71

2.2

2.0

2.85

2.95

g/l

0.31

414

Endocrine disorders, other/unspecified

185

0.32

2.70

1.7

2.2

2.72

3.00

g/l

—

172

Other changes in lacrimal passages

5.21

2.70

3.1

1.9

2.64

3.31

g/l

—

Combinations of oral blood glucose lowering drugs

509

4412

1.16

2.69

1.8

2.5

2.93

2.92

g/l

0.09

467

3959

Any dementia, excluding more controls

744

4539

1.13

2.68

2.1

2.4

2.98

3.01

g/l

0.26

600

3971

Other and unspecified disorders of adult personality and behaviour

3.25

2.68

1.4

1.3

2.88

2.78

g/l

0.14

Other puerperal infections

422

1.53

2.67

1.2

1.6

2.48

2.88

g/l

3.07

403

Viral encephalitis, not elsewhere classified/unspecified

207

1.78

2.62

3.7

2.5

3.20

2.97

g/l

0.49

186

Alport

6.00

2.62

1.3

3.5

3.42

2.95

g/l

—

Asthma mixed form (mode)

465

1.50

2.61

2.0

1.6

2.72

2.95

g/l

1.12

409

Chronic iridocyclitis

532

1.47

2.60

2.1

2.4

2.92

2.93

g/l

0.00

483

Diseases of appendix

1198

9849

1.10

2.60

2.5

2.2

2.89

2.92

g/l

0.40

1081

8894

Contact with sharp object, undetermined intent

185

1.81

2.60

1.7

2.0

3.20

2.89

g/l

0.79

172

Schizophrenia or delusion, excluding more controls

389

3277

1.18

2.59

1.9

2.3

2.96

2.93

g/l

0.30

336

2985

Malignant neoplasm of prostate

504

2607

1.16

2.59

2.1

1.4

3.03

2.92

g/l

1.41

445

2326

Mental and behavioural disorders due to cannabinoids

128

1.97

2.56

1.8

1.5

2.98

2.93

g/l

0.10

121

Pre-eclampsia or eclampsia

254

2082

1.23

2.56

2.4

2.1

2.84

2.87

g/l

0.16

235

1902

Malignant neoplasm of pancreas

869

0.66

2.55

2.0

1.4

3.06

2.98

g/l

0.24

748

Hereditary sideroblastic anaemia

3.14

2.55

2.8

1.6

2.91

2.66

g/l

0.53

Use of disulfiram, acamprosate or naltrexone

120

897

1.35

2.55

1.5

2.3

2.94

2.89

g/l

0.25

103

834

Cholangitis (primary sclerosing, PSC)

100

727

1.39

2.55

2.0

2.4

3.18

2.97

g/l

1.21

652

Benign neoplasm: Liver/bile ducts

247

1.69

2.53

2.3

1.9

2.85

2.90

g/l

0.15

230

Hyperkinetic disorders

530

1.45

2.53

1.4

1.5

2.62

2.86

g/l

1.61

502

Disorders of lacrimal system and orbit in diseases classified elsewhere

255

1.68

2.52

1.2

1.9

3.02

2.94

g/l

0.23

236

Other specified disorders of kidney and ureter

365

1.56

2.52

2.4

2.8

2.64

2.96

g/l

1.98

331

HSIL lesion of the cervix uteri, vagina or vulva

203

1627

1.25

2.52

2.1

2.0

2.88

2.86

g/l

0.10

183

1498

Maternal care for known or suspected fetal abnormality and damage

135

881

1.32

2.52

1.7

2.77

2.78

g/l

0.06

130

834

Sudden idiopathic hearing loss

175

1382

1.28

2.51

2.1

2.3

2.84

2.98

g/l

1.01

145

1250

Acute appendicitis

1097

9334

1.10

2.50

2.5

2.2

2.89

2.91

g/l

0.47

994

8434

Other strabismus

280

2315

1.21

2.50

2.2

2.81

2.94

g/l

1.53

255

2108

Infective dermatitis

173

1364

1.28

2.50

1.9

2.4

2.89

3.00

g/l

0.73

155

1231

Graves ophthalmopathy

256

1.67

2.49

1.2

1.9

3.02

2.93

g/l

0.26

237

Crohn disease (strict definition, require KELA)

547

1.44

2.44

1.7

2.1

3.04

2.90

g/l

0.56

505

Crohn's disease of large intestine

473

1.47

2.44

1.6

2.3

3.06

2.90

g/l

0.73

434

Malignant neoplasm of breast, ER-positive, including Hilmo

493

3306

1.15

2.44

2.0

1.4

3.06

2.93

g/l

1.95

421

2884

Other and unspecified mononeuropathies of lower limb

289

1.62

2.43

1.7

2.2

2.99

2.97

g/l

0.04

256

Burns and corrosions of external body surface, specified by site

145

1122

1.30

2.43

2.0

2.3

3.11

2.94

g/l

1.18

129

1035

Myocardial infarction, with ST-elevation

328

2773

1.19

2.42

1.9

2.3

3.19

2.95

g/l

3.97

290

2435

Injury of nerves and spinal cord at neck level

243

1.68

2.42

2.8

2.9

2.58

3.02

g/l

1.85

218

Embedded teeth, including avohilmo

581

1.42

2.41

2.7

1.8

2.71

2.92

g/l

1.06

543

Ingrowing nail

491

1.46

2.40

1.9

2.5

3.00

2.92

g/l

0.32

450

Procedures for purposes other than remedying health state

228

1.69

2.40

2.3

1.5

2.92

2.90

g/l

0.04

214

Other noninflammatory disorders of uterus, except cervix

365

2091

1.18

2.39

2.5

2.3

2.96

3.06

g/l

1.06

319

1834

Other specified disorders of external ear

452

1.48

2.38

1.9

2.7

2.98

2.94

g/l

0.10

413

Status post-ami

513

3419

1.15

2.37

1.6

2.4

3.05

2.95

g/l

1.20

451

2961

Paralytic strabismus

118

892

1.34

2.37

2.0

2.4

2.87

2.98

g/l

0.47

104

807

Myopia

140

1082

1.30

2.36

1.9

2.3

2.74

2.94

g/l

1.65

133

998

Laparoscopic right hemicolectomy

109

816

1.35

2.36

2.2

2.6

2.96

3.00

g/l

0.16

733

Schizophrenia

137

1763

0.77

2.35

2.4

2.3

3.01

2.92

g/l

0.52

116

1626

Rare circulating lymphoid malignancy

2.47

2.35

4.4

1.4

3.39

2.95

g/l

1.06

Pre-eclampsia or poor fetal growth

316

2660

1.19

2.33

2.3

2.0

2.82

2.84

g/l

0.16

293

2442

Other and unspecified acute skin changes due to ultraviolet radiation

301

1.59

2.32

1.9

2.5

2.99

3.04

g/l

0.13

266

Other and unspecified injuries of wrist and hand

332

1.55

2.32

1.1

1.9

2.80

2.96

g/l

0.55

304

Graves disease, strict definition

133

1025

1.31

2.31

2.2

2.87

2.95

g/l

0.47

121

939

Acute alcohol intoxication, ICD10

290

2437

1.20

2.30

1.3

2.3

2.94

2.92

g/l

0.14

257

2240

Benign neoplasm: Cerebral meninges

164

1301

1.27

2.30

2.0

2.4

2.91

2.99

g/l

0.47

143

1156

Contact with heat and hot substances

496

1.45

2.29

1.7

2.4

3.25

2.94

g/l

1.54

453

Secondary polycythaemia

239

1.66

2.29

2.8

2.7

3.10

2.99

g/l

0.33

215

Retinal haemorrhage

318

1.57

2.29

4.8

2.8

2.98

3.04

g/l

0.15

283

Suppurative and unspecified otitis media

414

3169

1.16

2.29

2.5

2.1

2.88

2.91

g/l

0.25

385

2893

Benign neoplasm: Liver

216

1.69

2.28

2.5

2.0

2.85

2.87

g/l

0.05

200

Crohn disease (strict definition, require KELA, min 2 HDR)

538

1.42

2.28

1.8

2.1

3.08

2.91

g/l

0.77

497

Malignant neoplasm of breast, including Hilmo

625

3588

1.13

2.27

2.0

1.4

3.03

2.91

g/l

1.97

545

3149

Other acquired deformities of musculoskeletal system and connective tissue

498

1.44

2.26

2.2

2.4

3.20

2.92

g/l

1.19

452

Acute appendicitis, no complications

810

7282

1.11

2.24

2.5

2.2

2.86

2.90

g/l

0.74

735

6638

Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

4.78

2.23

2.8

1.0

2.28

3.26

g/l

—

Other blood glucose lowering drugs, excl. Insulins

296

2503

1.19

2.22

1.9

2.4

3.04

2.97

g/l

0.55

266

2192

Polyp of the female genital tract

461

2303

1.15

2.22

1.9

2.2

2.94

3.04

g/l

1.17

410

2035

Malignant neoplasm of breast, HER2-negative, including Hilmo

624

3588

1.13

2.22

2.0

1.4

3.03

2.91

g/l

2.01

544

3149

Malignant neoplasm of digestive organs

657

4632

1.12

2.19

2.1

1.4

3.07

2.94

g/l

2.43

578

4039

Appendicitis, broad definition

1175

9774

1.09

2.19

2.5

2.2

2.88

2.92

g/l

0.56

1062

8826

HSIL lesion of the cervix uteri

174

1397

1.25

2.18

1.9

2.0

2.87

2.84

g/l

0.16

159

1295

Other acute skin changes due to ultraviolet radiation

403

1.49

2.18

1.7

2.3

2.98

3.01

g/l

0.07

361

Benign neoplasm: Prostate

2.13

2.17

1.2

3.5

2.61

2.94

g/l

0.91

Granuloma annulare

137

1.86

2.17

2.0

1.8

2.72

2.97

g/l

0.87

127

Glaucoma-related operations

107

811

1.34

2.16

2.6

3.03

3.05

g/l

0.06

717

Amyloidosis of skin

5.72

2.15

3.2

1.0

2.16

3.16

g/l

—

Leisure time condition

275

2317

1.19

2.15

1.7

2.2

2.80

2.97

g/l

1.70

213

2082

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

108

820

1.33

2.14

2.1

1.4

3.03

3.00

g/l

0.11

707

Respiratory tuberculosis, confirmed

213

1.68

2.14

1.7

2.6

3.09

3.06

g/l

0.05

185

Hepatocellular carcinoma

252

1.62

2.13

2.5

1.4

3.06

3.05

g/l

0.03

214

Colitis, primary sclerosing

102

2.00

2.13

2.1

2.0

3.18

2.91

g/l

0.79

Sequelae of injuries of head

521

1.42

2.13

2.8

2.5

3.21

2.87

g/l

2.08

475

Reduction defects of unspecified limb

5.44

2.12

1.0

1.2

2.84

2.75

g/l

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

597

1.38

2.12

1.7

2.2

3.08

2.90

g/l

0.82

546

Cerebral aneurysm, nonruptured

137

1076

1.28

2.11

1.8

2.4

2.92

2.94

g/l

0.06

122

974

Benign neoplasm of middle ear and respiratory system

130

1015

1.29

2.10

2.5

2.4

2.90

2.96

g/l

0.35

120

916

Abnormal findings in secretions and smears from cervix uteri vagina vulva

599

4030

1.13

2.10

2.2

2.1

2.88

2.89

g/l

0.05

546

3635

Benign neoplasm of eye and adnexa

169

1363

1.25

2.08

1.7

2.4

2.90

2.95

g/l

0.24

148

1230

Conductive and sensorineural hearing loss

1493

9363

1.08

2.08

2.3

2.81

2.98

g/l

8.34

1274

8387

Retrobulbar neuritis in diseases classified elsewhere

3.63

2.08

5.4

1.1

3.11

2.91

g/l

—

Other sexually transmitted chlamydial diseases

292

1.55

2.08

1.4

2.98

2.85

g/l

0.34

278

Malignant neoplasm of thymus, including Hilmo

2.52

2.08

3.7

1.2

3.29

2.85

g/l

0.49

Moderate visual impairment, binocular

358

1.50

2.08

1.7

2.2

2.98

3.14

g/l

0.35

315

Other mental disorders due to brain damage and dysfunction and to physical disease

212

1752

1.22

2.08

2.7

2.4

2.81

2.98

g/l

1.78

171

1563

Malignant neoplasm of breast, HER-positive

479

3284

1.14

2.07

1.9

1.4

3.07

2.93

g/l

2.09

407

2864

Malignant neoplasm of colon

249

2089

1.20

2.06

2.4

1.4

3.09

2.95

g/l

1.21

218

1798

Other and unspecified degenerative diseases of nervous system

343

1.51

2.06

1.6

2.7

2.85

3.05

g/l

0.69

305

Other disorders of breast

176

1427

1.24

2.06

2.2

2.83

2.96

g/l

1.05

150

1280

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

132

1.84

2.05

3.0

2.1

3.05

2.96

g/l

0.21

123

Type 1 diabetes, strict definition, subgroup 1

365

1.48

2.05

1.3

1.5

2.80

2.85

g/l

0.12

348

Tonsillectomy and adenotomy

517

4064

0.88

2.05

1.8

2.0

2.76

2.86

g/l

1.45

474

3773

Systemic sclerosis,strict definition

2.02

2.04

1.2

1.7

2.91

2.94

g/l

0.05

Pyoderma

185

1.71

2.04

2.1

2.4

2.92

2.95

g/l

0.06

170

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

577

1.38

2.03

1.9

1.4

3.09

3.04

g/l

0.21

498

Sixth [abducent] nerve palsy

393

1.47

2.03

2.5

2.7

2.98

3.00

g/l

0.05

347

Vascular dementia (mixed)

256

1.60

2.02

2.1

2.78

3.07

g/l

0.85

223

Other disorders of bone density and structure

216

1.64

2.02

1.5

2.2

2.74

2.92

g/l

0.59

201

Lateral epicondylitis

172

1394

1.24

2.02

1.8

2.2

2.75

2.93

g/l

1.37

156

1277

Brain meningioma

578

1.38

2.02

2.2

1.4

3.03

2.93

g/l

0.36

498

Tooth eruption problems

106

788

1.32

2.01

2.3

1.8

2.79

2.91

g/l

0.54

736

Other lesions of median nerve

312

1.53

2.01

1.2

2.2

3.01

3.13

g/l

0.27

269

Transient acantholytic dermatosis [Grover]

3.22

2.01

1.3

2.8

2.90

2.92

g/l

—

Haemangioma and lymphangioma, any site

133

1048

1.28

2.01

3.1

2.4

2.92

2.95

g/l

0.10

121

953

Varicose veins of other sites

707

1.34

2.00

2.5

2.72

2.90

g/l

0.93

646

Meningitis

503

1.41

1.98

2.7

2.4

2.82

2.90

g/l

0.33

462

Disorders of endocrine glands in diseases classified elsewhere

4.82

1.98

1.0

2.86

3.01

g/l

—

Open wound of wrist and hand

655

5763

1.11

1.97

2.3

2.2

2.91

g/l

0.00

593

5246

Other facial nerve disorders

265

1.57

1.97

2.1

2.2

2.99

2.95

g/l

0.06

234

Endometriosis of pelvic peritoneum

187

1460

1.23

1.97

1.4

2.2

2.71

2.98

g/l

3.28

164

1319

Haemangioma, any site

126

989

1.28

1.97

2.8

2.4

2.95

g/l

0.00

114

900

Malignant neoplasm of breast

610

3560

1.12

1.96

2.0

1.4

3.05

2.92

g/l

2.29

529

3121

Orthopaedic devices associated with adverse incidents

243

1.60

1.94

1.2

2.4

2.53

3.02

g/l

1.01

215

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

400

3459

1.15

1.94

3.0

1.5

3.38

2.94

g/l

10.11

357

3045

Ménière disease

157

1268

1.25

1.94

1.7

2.5

2.84

2.98

g/l

1.05

140

1137

Macular cyst

381

1.47

1.94

2.5

2.9

2.99

3.04

g/l

0.12

344

Other sexually transmitted chlamydial diseases

454

1.42

1.93

1.3

1.5

2.95

2.83

g/l

0.39

431

Hypertrophic disorders of skin

497

1.40

1.93

2.5

2.3

2.97

2.96

g/l

0.01

461

Malignant neoplasm of thyroid gland, including Hilmo

106

816

1.31

1.93

2.8

1.4

2.82

2.93

g/l

0.54

715

Viral haemorrhagic fevers, not elsewhere classified/unspecified

922

0.72

1.92

3.2

2.3

2.77

2.94

g/l

0.96

845

Undefined dementia

147

1681

0.80

1.92

1.9

2.3

2.91

3.09

g/l

1.24

121

1408

Corneal degeneration

181

1.69

1.92

1.2

2.0

3.25

2.98

g/l

0.58

161

Alkalosis

3.36

1.92

1.9

2.5

3.04

3.00

g/l

—

Disorders of eyelid in diseases classified elsewhere

340

1.49

1.92

1.1

2.5

2.88

3.01

g/l

0.42

307

1172

0.75

1.91

1.3

2.3

3.14

2.94

g/l

1.04

1051

Congenital malformations of genital organs

673

1.34

1.91

1.6

2.0

2.80

2.92

g/l

0.72

633

Degeneration of nervous system due to alcohol

260

1.57

1.90

1.3

2.8

2.91

2.95

g/l

0.10

233

Allergic contact dermatitis due to drugs in contact with skin

236

1.59

1.90

1.6

2.1

3.07

2.94

g/l

0.22

217

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

122

959

1.28

1.90

2.0

2.5

2.88

2.97

g/l

0.53

107

866

Recurrent dislocation of patella

259

1.55

1.90

1.5

1.8

2.88

2.81

g/l

0.24

245

Other disorders of skin and subcutaneous tissue related to radiation

3.79

1.89

1.2

1.1

3.25

3.38

g/l

—

Aneurysms, operations, SAH

270

2303

1.18

1.88

1.9

2.2

2.96

2.94

g/l

0.11

233

2057

Dislocation of lens

167

1.71

1.87

2.9

2.7

2.90

3.08

g/l

0.51

154

Other diseases of peritoneum

535

1.38

1.87

1.6

2.6

2.82

2.97

g/l

0.58

482

Burn and corrosion of wrist and hand

309

1.50

1.87

1.6

2.1

3.05

2.89

g/l

0.41

283

Pre-eclampsia

223

1872

1.20

1.86

2.6

2.1

2.83

2.87

g/l

0.23

205

1716

Crohn disease (strict definition, all UC cases excluded)

442

1.41

1.85

1.6

2.3

3.05

2.93

g/l

0.39

408

Acute lymphadenitis

501

1.39

1.85

2.5

2.4

3.11

2.93

g/l

0.60

458

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

550

0.65

1.84

2.0

2.2

2.76

2.98

g/l

0.78

507

Degeneration of the brain due to alcohol

263

1.55

1.82

1.3

2.8

2.91

2.97

g/l

0.14

237

Use of peginterferon beta-1a

3.14

1.82

2.0

1.0

2.29

2.73

g/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

223

1.60

1.82

1.7

2.5

3.09

3.05

g/l

0.07

194

Other drug-induced secondary parkinsonism

109

1.89

1.81

1.9

2.1

2.59

3.05

g/l

0.83

Abrasion of teeth

502

4482

1.12

1.81

2.5

2.3

2.73

2.92

g/l

4.68

450

4045

Dentofacial anomalies [including malocclusion]

973

7199

1.09

1.78

2.2

2.78

2.91

g/l

3.83

871

6538

Postpartum hemorraghe, parous women as controls

151

1577

0.81

1.77

1.9

2.0

2.70

2.77

g/l

0.49

136

1478

Separation of retinal layers (serosa)

439

1.40

1.75

2.3

2.6

2.92

2.94

g/l

0.04

402

Congenital varicose veins

2.75

1.74

2.4

2.0

2.90

2.92

g/l

—

Acute nasopharyngitis (common cold)

145

1168

1.24

1.74

1.8

2.0

2.79

2.94

g/l

1.23

133

1080

Dysplasia of cervi uteri

278

1727

1.17

1.73

2.2

2.0

2.81

2.96

g/l

2.03

254

1553

Malignant neoplasm of breast, HER2-negative

600

3539

1.11

1.73

1.9

1.4

3.06

2.92

g/l

2.61

518

3100

Colorectal neuroendocrine tumor and carcinoma

118

1.81

1.73

3.5

1.4

2.75

2.91

g/l

0.58

108

Bitten or struck by other mammals

136

1097

1.25

1.72

2.5

2.4

2.97

2.92

g/l

0.26

127

1008

Postpartum hemorraghe, all women as controls

151

1815

0.82

1.72

1.9

2.70

2.81

g/l

1.06

136

1703

Other congenital malformations of the digestive system

421

1.40

1.70

1.5

2.6

2.97

2.95

g/l

0.04

381

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

333

1.46

1.70

1.6

2.3

2.63

2.97

g/l

2.45

310

Erectile dysfunction

146

1192

1.24

1.69

2.3

2.4

2.98

2.93

g/l

0.27

131

1060

Lesion of radial nerve

375

1.43

1.69

2.1

2.3

2.97

3.00

g/l

0.05

335

Non-small cell lung cancer, squamous, helper endpoint

656

0.69

1.68

1.9

2.4

3.44

3.01

g/l

1.96

570

Other female pelvic inflammatory diseases

222

1884

1.18

1.68

1.7

2.3

2.91

2.94

g/l

0.17

176

1686

Polypectomy (DHB20)

103

808

1.29

1.67

2.7

2.4

2.84

2.97

g/l

0.84

736

Acute alcohol intoxication

395

3501

1.13

1.64

1.4

2.4

3.00

2.91

g/l

1.08

349

3183

Leiomyoma of uterus

955

4996

1.09

1.64

2.2

2.93

2.95

g/l

0.12

827

4433

Other ulcerative colitis

539

1.35

1.64

1.3

2.4

2.91

2.89

g/l

0.06

491

Other and unspecified disease of Bartholin gland

328

1.45

1.63

1.3

2.4

2.96

2.99

g/l

0.08

302

Other sideroblastic anaemias

2.42

1.62

1.1

1.5

3.24

3.06

g/l

—

Cytomegaloviral hepatitis

2.82

1.61

1.7

2.2

3.43

3.02

g/l

—

Outcome of delivery

138

690

1.24

1.61

1.7

1.9

2.81

2.85

g/l

0.21

131

653

Arthropod-borne viral fevers and viral haemorrhagic fevers

1163

0.78

1.60

3.4

2.4

2.88

2.95

g/l

0.34

1063

Alcohol withdrawal state with delirium

105

831

1.27

1.60

1.2

2.4

2.97

2.93

g/l

0.18

764

Other and unspecified disorders of orbit

2.28

1.60

1.3

2.8

3.21

2.89

g/l

0.44

Pedestrian injured in transport accident

751

1.29

1.60

1.4

2.3

2.98

2.96

g/l

0.05

682

Dementia in other diseases classified elsewhere

638

1.32

1.60

1.7

2.5

2.96

3.02

g/l

0.20

565

Nonsuppurative otitis media

239

1772

1.17

1.58

1.9

2.1

2.93

2.95

g/l

0.06

221

1615

Cysts of oral region, not elsewhere classified

630

1.31

1.57

2.6

2.5

2.95

2.91

g/l

0.12

575

Use of memantine

459

4234

0.89

1.57

1.9

2.3

2.94

3.02

g/l

0.90

343

3642

Use of other anti-dementia drugs

459

4234

0.89

1.57

1.9

2.3

2.94

3.02

g/l

0.90

343

3642

Other or unspecified paralytic strabismus

2.08

1.57

1.0

2.6

2.84

2.88

g/l

0.07

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

424

1.38

1.57

2.7

1.8

2.87

2.91

g/l

0.12

395

Unspecified dementia

146

1587

0.82

1.55

1.9

2.3

2.90

3.08

g/l

1.20

120

1368

Perforation of tympanic membrane

144

1186

1.22

1.54

2.0

2.3

2.72

2.97

g/l

2.63

130

1067

Brain meningioma, including Hilmo

607

1.31

1.53

2.2

1.4

3.03

2.94

g/l

0.30

520

Pedal cyclist injured in noncollision transport accidents

148

1223

1.22

1.53

1.7

2.3

2.86

2.97

g/l

0.77

126

1124

Chromophobe cell carcinoma of kidney

2.14

1.53

2.3

1.2

2.79

2.98

g/l

0.26

Macular hole

105

838

1.27

1.52

1.9

2.6

2.95

2.97

g/l

0.06

750

Erythema intertrigo

250

1.50

1.52

2.1

3.1

2.95

3.03

g/l

0.17

224

Thyroiditis, unspecified

154

1.65

1.52

1.3

1.7

3.17

2.97

g/l

0.24

143

Alzheimer’s disease (Early onset), excluding more controls

440

0.66

1.52

1.3

2.3

3.02

3.16

g/l

0.30

379

Dronedarone medication

333

1.43

1.52

1.9

2.4

3.13

3.03

g/l

0.23

294

Endometriosis of ovary

217

1811

1.17

1.51

1.7

2.2

2.78

3.01

g/l

3.13

188

1622

Other maternal disorders predominantly related to pregnancy

595

4100

0.91

1.51

2.2

2.84

2.89

g/l

0.61

543

3735

Occupational exposure to risk-factors

393

0.63

1.51

4.2

2.7

2.08

2.93

g/l

3.66

359

Other and unspecified abdominal hernia

504

1.34

1.51

1.3

2.1

2.85

2.99

g/l

0.62

454

conjunctival haemorrhage

127

1036

1.24

1.51

2.5

2.4

2.83

2.96

g/l

0.88

115

929

Other disorders of Eustachian tube

300

1.45

1.51

1.4

2.2

3.02

2.96

g/l

0.13

276

Parkinson's disease, including avohilmo

290

2539

1.15

1.51

1.9

2.3

2.99

2.97

g/l

0.15

241

2224

Pilonidal cyst

678

1.29

1.50

1.9

2.1

3.13

2.90

g/l

1.21

636

Malignant neoplasm of bronchus and lung, including Hilmo

370

2750

1.13

1.50

2.2

1.5

3.34

2.94

g/l

10.82

331

2400

Palindromic rheumatism

1.84

1.49

1.4

1.6

2.85

2.77

g/l

0.12

Obstructed labour due to malposition and malpresentation of fetus

146

1641

0.83

1.49

1.5

1.9

2.85

2.84

g/l

0.03

140

1535

Examination and encounter for administrative purposes

436

1.36

1.48

2.8

2.7

3.03

3.09

g/l

0.20

395

Diseases of middle ear and mastoid

776

5851

1.09

1.48

2.4

2.1

2.87

2.91

g/l

0.51

709

5277

Hereditary lymphedema

2.88

1.46

1.0

1.3

3.18

3.19

g/l

—

L01XE Protein kinase inhibitors

727

1.28

1.46

3.1

2.7

3.37

2.97

g/l

2.19

661

Right hemicolectomy

100

798

1.26

1.46

3.1

2.5

3.09

3.03

g/l

0.25

714

Other disorders of conjunctiva

234

2023

1.16

1.46

2.6

2.3

2.78

2.96

g/l

2.16

209

1804

Other intracranial haemorrhages

396

1.38

1.45

1.7

2.5

3.10

3.02

g/l

0.18

345

Malignant neoplasm of liver and intrahepatic bile ducts

345

1.41

1.45

2.0

1.4

2.99

3.01

g/l

0.06

296

Lichen sclerosus et atrophicus

154

1287

1.20

1.44

2.1

2.92

3.00

g/l

0.40

139

1126

Pregnancy, childbirth and the puerperium

386

2260

0.89

1.43

1.8

2.1

3.04

3.06

g/l

0.17

345

1918

Vascular dementia (other)

1.83

1.43

1.8

2.6

3.23

3.15

g/l

0.09

Other acantholytic disorders

2.32

1.41

1.4

2.9

2.90

2.99

g/l

—

Maternal care for other known or suspected fetal problems

128

986

0.82

1.41

1.5

1.8

2.68

2.80

g/l

0.83

123

930

Oral lichen planus, including avohilmo , including avohilmo

102

820

1.25

1.40

2.1

2.6

2.91

2.94

g/l

0.12

740

Malignant neoplasm of stomach, including Hilmo

731

1.27

1.39

1.3

1.4

3.17

3.00

g/l

0.71

629

Nontoxic single thyroid nodule

108

875

1.24

1.39

2.4

2.84

2.97

g/l

0.71

789

Tuberculosis, IBD comorbidity

118

966

1.23

1.38

2.0

2.3

3.00

3.01

g/l

0.04

848

Other peripheral vertigo

147

1230

1.20

1.38

1.8

2.6

2.88

2.95

g/l

0.39

125

1107

Convalescence

556

1.30

1.37

2.1

2.68

2.95

g/l

1.89

504

Congenital obstruction of the pelviureteric junction

1.91

1.36

4.4

2.3

3.14

2.91

g/l

0.47

Antepartum haemorrhage, not elsewhere classified

556

1.30

1.36

2.2

1.8

2.83

2.82

g/l

0.05

527

Renal cell carcinoma of kidney

384

1.37

1.35

2.0

1.5

3.18

3.06

g/l

0.27

324

Use of levodopa decarboxylase inhibitor

252

2208

1.15

1.34

2.1

2.4

2.95

g/l

0.02

210

1931

Neovascular glaucoma

489

1.32

1.33

2.4

2.5

3.20

3.00

g/l

0.83

432

Dystonia

621

1.28

1.32

1.2

2.4

2.63

2.95

g/l

2.59

570

Contraceptive management

407

3168

0.90

1.32

2.1

2.80

2.87

g/l

0.80

376

2940

Benign neoplasm: Orbit, unspecified

1.94

1.31

2.8

2.0

3.08

2.76

g/l

0.48

Foreign body or object entering through skin

595

1.29

1.31

2.9

2.4

2.75

2.93

g/l

0.86

548

Gonococcal infection

326

1.39

1.31

2.2

1.8

3.02

2.91

g/l

0.31

302

Dementia, including avohilmo

940

6035

1.07

1.31

2.1

2.4

2.91

3.00

g/l

1.78

749

5306

Benign neoplasm: Lip

251

1.45

1.31

3.1

2.3

2.88

2.96

g/l

0.17

221

Pleural plaque without asbestos

553

1.30

1.7

2.5

3.01

3.04

g/l

0.09

486

Melanocytic naevi of lip

1.82

1.29

1.2

2.1

2.93

3.05

g/l

0.21

Cauda equina syndrome

122

1.67

1.29

2.2

1.7

2.92

2.89

g/l

0.04

114

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

200

1728

1.16

1.29

2.5

2.3

2.93

2.94

g/l

0.09

177

1576

Malignant neoplasm of stomach

606

1.28

1.2

1.4

3.11

3.04

g/l

0.20

522

Varus deformity, not elsewhere classified

107

1.71

1.28

1.4

2.1

2.18

2.79

g/l

2.24

Benign neoplasm: Larynx

380

1.36

1.27

2.6

2.5

2.71

2.96

g/l

1.23

341

Conductive hearing loss, unspecified

118

976

1.22

1.27

2.1

2.3

2.93

2.97

g/l

0.15

104

887

Benign mammary dysplasia

215

1871

1.15

1.27

2.5

2.3

2.91

3.00

g/l

0.65

186

1649

Injuries involving multiple body regions

354

1.37

1.26

2.4

3.15

2.96

g/l

0.74

323

Chondromalacia

295

1.41

1.26

1.4

2.1

3.00

2.87

g/l

0.25

279

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

1.97

1.26

1.5

2.4

2.84

2.97

g/l

0.22

Nonspecific lymphadenitis

564

1.28

1.25

1.8

2.1

2.91

2.89

g/l

0.05

525

Residual foreign body in soft tissue

450

1.32

1.25

2.0

2.3

2.82

2.94

g/l

0.35

411

Labour and delivery complicated by fetal stress [distress]

131

1026

0.83

1.24

1.6

1.7

2.81

2.79

g/l

0.09

125

965

Non-small cell lung cancer, including Hilmo

255

2117

1.14

1.24

2.1

1.4

3.40

2.93

g/l

9.67

228

1837

Benign neoplasm: Endocrine pancreas

1.85

1.24

1.9

2.5

2.69

3.05

g/l

1.02

Alzheimer’s disease (Atypical or mixed)

138

1620

0.84

1.23

1.7

2.3

2.93

3.09

g/l

0.81

108

1380

Presbycusis

273

2398

1.13

1.22

2.3

2.94

3.10

g/l

1.93

223

2068

Foreign body in alimentary tract

602

1.27

1.22

1.4

2.5

2.98

2.95

g/l

0.10

549

Amblyopia ex anopsia

331

1.37

1.21

1.4

2.2

2.84

2.98

g/l

0.43

304

Endometriosis diagnosis and infertility diagnosis occurring together

103

845

1.22

1.20

1.6

2.1

2.71

2.85

g/l

0.74

793

Inguinal hernia, bilateral

176

1517

1.17

1.20

2.9

2.3

2.88

2.92

g/l

0.20

155

1353

Unspecified jaundice

587

1.27

1.18

1.6

2.5

3.23

3.03

g/l

0.87

523

Tuberculosis, wide

122

1021

1.20

1.18

2.0

2.5

3.01

3.03

g/l

0.08

899

Recurrent and persistent haematuria

1.76

1.17

1.5

2.3

3.14

3.00

g/l

0.21

Benign neoplasm of male genital organs

249

1.42

1.17

1.4

2.8

2.64

2.92

g/l

1.40

223

Car occupant injured in other and unspecified transport accidents

227

1996

1.14

1.16

2.0

2.2

2.81

2.94

g/l

1.52

202

1825

Ulcerative rectosigmoiditis

101

831

1.22

1.16

2.0

2.4

2.99

2.91

g/l

0.36

767

Gonococcal infection

317

1.37

1.16

2.2

1.8

3.05

2.92

g/l

0.40

295

Benign neoplasm: other/unspecified salivary gland

326

1.37

1.16

1.6

2.6

3.06

3.01

g/l

0.16

290

Parkinson's disease, strict definition

256

2272

1.13

1.15

1.9

2.4

2.98

2.96

g/l

0.11

216

1993

Chalazion

154

1318

1.17

1.15

2.8

2.4

2.76

2.96

g/l

1.87

136

1199

Vertigo of central origin

183

1.50

1.15

1.7

2.6

2.56

3.01

g/l

1.43

160

Peritonsillar abscess

245

2168

1.13

1.14

2.8

2.2

2.88

2.91

g/l

0.21

226

1984

Tuberculosis of other organs, strict

310

1.37

1.14

2.2

2.6

3.17

3.12

g/l

0.07

270

LSIL lesion of the cervix uteri, vagina or vulva

142

1209

1.18

1.13

2.6

2.1

2.87

g/l

0.01

132

1117

Injury of muscle and tendon at shoulder and upper arm level

594

5502

1.08

1.13

2.3

2.86

2.93

g/l

1.03

536

4967

Presbyopia

672

1.24

1.12

1.5

2.3

2.87

2.92

g/l

0.14

621

Papillary adenocarcinoma of thyroid gland

538

1.27

1.12

2.0

1.3

2.75

2.89

g/l

0.57

480

Sequelae of injuries of upper limb

129

1091

1.19

1.12

2.6

2.5

2.78

2.94

g/l

0.94

112

999

Glaucoma secondary to other eye disorders

503

1.28

1.12

2.4

2.8

3.20

3.00

g/l

0.82

447

Benign neoplasm of brain and other parts of central nervous system

763

1.23

1.12

2.0

2.5

2.88

2.97

g/l

0.41

691

Perforation of oesophagus

1.87

1.12

1.1

2.5

2.87

3.00

g/l

0.27

Maternal care related to the fetus and amniotic cavity and possible delivery problems

400

2582

0.91

1.11

2.5

2.0

2.76

2.87

g/l

1.61

375

2368

Parkinson's disease

272

2430

1.12

1.11

1.9

2.3

3.01

2.97

g/l

0.29

228

2137

Disturbances of smell and taste

486

1.29

1.11

3.2

3.0

2.97

2.98

g/l

0.03

441

Schizoaffective disorder

700

1.23

1.11

1.8

2.3

2.95

2.91

g/l

0.13

650

Malignant neoplasm of head and neck

121

1019

1.19

1.11

2.4

1.4

2.83

2.93

g/l

0.58

108

892

All dysplastic lesions of the vulva

451

1.30

1.10

1.3

2.3

3.01

2.97

g/l

0.11

419

Inguinal or femoral hernia, bilateral

178

1548

1.16

1.10

2.8

2.3

2.87

2.92

g/l

0.26

157

1380

Other factor of the environment

120

1.61

1.10

2.8

1.7

2.95

3.03

g/l

0.13

111

2.44

1.10

3.0

2.9

2.22

2.64

g/l

—

Pleural plaque

176

1531

1.16

1.09

2.2

2.3

2.84

2.93

g/l

0.72

151

1342

Effects of foreign body entering through natural orifice

334

3019

1.11

1.09

2.3

2.80

2.93

g/l

1.56

304

2758

Contact with machinery

115

1364

0.84

1.09

2.3

2.71

2.91

g/l

1.47

102

1247

Dementia due to Parkinsons disease, excluding more controls

236

1.41

1.08

1.3

2.5

3.08

3.16

g/l

0.13

206

Small plaque parapsoriasis

2.20

1.08

1.6

2.3

3.19

3.27

g/l

—

Colorectal cancer

375

3337

1.10

1.08

2.4

1.4

3.04

2.95

g/l

1.02

324

2905

Lack of expected normal physiological development

2.19

1.08

1.0

1.1

2.93

3.05

g/l

—

Malignant neoplasm of nasal cavity and sinuses

1.83

1.06

6.6

1.3

2.57

2.95

g/l

0.99

Unspecified mental disorder

546

5053

1.08

1.06

1.9

2.2

2.90

2.91

g/l

0.15

485

4576

Dislocation, sprain and strain of joints and ligaments of knee

829

7174

1.07

1.05

1.9

2.3

2.86

2.89

g/l

0.52

742

6542

Other fall from one level to another

298

2683

1.11

1.05

2.1

2.3

2.90

2.94

g/l

0.29

268

2437

Carcinoma in situ of skin of lip

2.00

1.05

1.1

1.5

3.80

3.13

g/l

—

Benign neoplasm: Choroid

815

1.21

1.05

1.6

2.6

2.70

2.96

g/l

1.53

738

Pregnancy with abortive outcome

959

4712

1.06

1.04

1.8

2.3

2.93

2.95

g/l

0.22

853

4151

Endometriosis ASRM stages 1,2

192

1685

1.14

1.04

1.4

2.0

2.71

2.90

g/l

1.95

167

1546

Malignant neoplasm of hypopharynx, including Hilmo

1.80

1.02

1.3

1.2

3.05

3.08

g/l

0.03

Sensorineural hearing loss

1412

9139

1.05

1.02

2.4

2.3

2.82

2.98

g/l

7.48

1204

8179

Other vitreous opacities

466

1.28

1.02

3.5

2.7

2.61

2.91

g/l

1.55

420

Benign neoplasm: Other parts of oropharynx

107

1.62

1.01

2.8

1.9

2.42

3.03

g/l

2.63

Gastrointestinal stromal tumor and sarcoma

123

1.57

1.01

1.3

1.4

3.26

3.00

g/l

0.30

108

Hereditary corneal dystrophies

431

1.29

1.01

1.4

2.7

3.08

3.00

g/l

0.21

388

Inflammatory diseases of prostate (prostatitis)

192

1691

1.14

1.01

2.1

2.6

2.75

2.95

g/l

2.19

175

1511

Benign neoplasm of bone and articular cartilage

104

874

1.20

1.00

1.5

2.4

2.76

2.94

g/l

1.17

800

Embolic stroke

610

1.24

1.00

2.1

2.6

3.22

3.06

g/l

0.64

537

Glaucoma

1061

8655

1.06

1.00

2.2

2.3

2.88

2.97

g/l

2.18

922

7628

Other noninflammatory disorders of vagina

100

838

1.20

0.99

2.7

2.2

2.92

3.01

g/l

0.47

747

Other diseases of biliary tract

137

1182

1.17

0.97

2.2

2.4

3.09

2.99

g/l

0.58

123

1046

Vasomotor rhinitis (mode)

100

842

1.19

0.96

2.1

2.6

2.74

2.94

g/l

1.13

764

Aggressive periodontitis

217

1.40

0.94

2.3

2.8

3.04

2.96

g/l

0.18

199

Benign lipomatous neoplasm

459

4247

1.08

0.94

2.6

2.3

2.86

2.94

g/l

0.92

413

3809

Benign neoplasm of other and unspecified female genital organs

522

0.76

0.94

2.0

2.3

2.66

3.00

g/l

0.97

472

Malignant neoplasm of respiratory system and intrathoracic organs

347

2639

1.10

0.93

2.1

1.4

3.33

2.94

g/l

9.70

305

2301

Specific developmental disorder of motor function

2.18

0.92

1.0

2.1

2.65

3.07

g/l

—

Ankle and foot

1.66

0.92

1.4

2.2

2.58

2.96

g/l

0.65

Colon adenocarcinoma

185

1640

1.13

0.91

2.4

1.4

3.07

2.94

g/l

0.83

157

1402

Fistulae involving female genital tract

185

1.42

0.91

2.1

2.3

3.28

3.08

g/l

0.28

166

Oral leukoplakia, including avohilmo

315

1.31

0.89

1.2

2.5

3.09

2.96

g/l

0.31

287

Contact with other hot fluids

245

1.36

0.89

1.1

2.2

3.03

2.92

g/l

0.21

227

Acute drug-induced interstitial lung disorder

1.61

0.89

9.7

2.1

3.21

3.06

g/l

0.25

Use of galantamine

104

1216

0.85

0.88

1.3

2.3

2.92

3.06

g/l

0.78

1041

Malignant neoplasm of endocrine gland

767

1.19

0.88

2.4

1.4

2.80

2.92

g/l

0.64

671

Tuberculosis of other organs

264

1.34

0.87

2.0

2.5

3.22

3.15

g/l

0.09

229

Benign neoplasm: Conjunctiva

361

1.28

0.86

1.3

2.8

3.03

3.00

g/l

0.06

332

Motor disorders

2.00

0.86

1.0

2.0

2.65

3.11

g/l

—

Abnormalities of forces of labour

814

1.18

0.86

1.4

2.0

2.62

2.86

g/l

2.80

776

Lifestyle-related condition

112

1.54

0.86

3.1

1.6

2.92

2.98

g/l

0.10

102

Changes in corneal membranes

1.99

0.86

1.5

2.5

3.20

2.94

g/l

—

Foreign body entering into or through eye or natural orifice

843

1.18

0.85

2.7

2.3

3.03

2.92

g/l

0.53

776

Personal history of certain other diseases

1.57

0.85

1.2

1.6

3.08

2.99

g/l

0.15

Malignant neoplasm of thyroid gland

716

1.19

0.84

2.5

1.4

2.77

2.92

g/l

0.78

628

Calcaneal spur

113

1.52

0.83

1.2

1.7

2.97

2.90

g/l

0.09

101

Von Willebrand disease

105

1.54

0.82

2.4

2.1

2.77

2.94

g/l

0.56

All dysplastic lesions of the vagina

258

1.33

0.82

2.7

1.9

2.86

2.94

g/l

0.22

241

Mixed conductive and sensorineural hearing loss

202

1815

1.12

0.82

2.6

2.3

2.84

3.03

g/l

1.87

170

1615

Contact with other hot metals

130

1.48

0.81

1.1

2.5

3.49

2.94

g/l

1.39

116

Any dementia

788

5184

1.06

0.81

2.1

2.3

2.98

3.00

g/l

0.18

634

4514

Oligomenorrhoea

276

1.31

0.81

1.6

2.3

2.85

3.05

g/l

0.89

252

Contact with other and unspecified heat and hot substances

1.75

0.81

5.4

1.7

3.15

2.81

g/l

—

Malignant neoplasm of ovary, including Hilmo

751

0.82

0.80

3.1

1.4

3.10

2.95

g/l

0.57

646

Injury of nerves at forearm level

114

1.51

0.80

1.2

2.3

2.73

2.90

g/l

0.33

106

Acute poliomyelitis

147

0.60

0.80

1.3

2.2

3.60

3.02

g/l

—

132

Interstitial cystitis (chronic), drug-induced

1.86

0.80

1.0

1.8

2.53

3.16

g/l

—

Discharge from other and unspecified firearms

0.00

0.80

0.0

2.5

—

2.79

—

Postmenopausal atrophic vaginitis

414

2117

1.08

0.80

2.2

2.3

2.75

3.05

g/l

9.36

369

1871

Whooping cough

1.84

0.79

1.0

3.5

3.10

2.77

g/l

—

Other problems related to primary support group, including family circumstances

790

1.17

0.79

1.9

2.1

2.88

2.91

g/l

0.09

735

Other congenital malformations of respiratory system

2.27

0.78

1.0

1.3

3.86

2.84

g/l

—

Motorcycle rider injured in noncollision transport accidents

217

1.34

0.77

1.8

1.9

2.57

2.87

g/l

1.26

203

Transient global amnesia

119

1358

0.87

0.76

2.6

2.4

2.68

3.01

g/l

4.17

101

1220

Divergent concomitant strabismus

744

1.17

0.74

1.9

2.3

2.83

2.95

g/l

0.63

678

Other contact dermatitis

837

1.16

0.74

1.7

2.4

2.73

3.00

g/l

2.49

756

Accidental poisoning by and exposure to alcohol

133

0.60

0.74

1.3

2.9

2.80

2.91

g/l

—

123

Malignant neoplasm of nasal cavity and middle ear

1.64

0.74

5.9

1.3

2.50

2.93

g/l

—

Typhoid and paratyphoid fevers

1.63

0.73

1.2

1.5

3.04

g/l

—

Other complications of labour and delivery, not elsewhere classified

552

0.81

0.73

1.3

1.5

2.71

2.80

g/l

0.36

518

Use of rivastigmine

233

2543

0.91

0.72

2.1

2.3

3.07

3.05

g/l

0.09

189

2155

Acquired stenosis of external ear canal

109

1.49

0.72

1.6

1.9

3.01

2.92

g/l

0.11

Radial styloid tenosynovitis [de Quervain]

507

1.21

0.72

2.3

2.1

2.90

2.92

g/l

0.07

471

Fall on and from ladder

111

971

1.15

0.72

3.6

2.5

2.65

2.94

g/l

2.86

101

886

Heterophoria

756

1.17

0.72

2.9

2.3

2.66

2.97

g/l

3.06

694

Neuroendocrine tumor and carcinoma of rectum

1.75

0.71

4.0

1.1

2.76

2.86

g/l

—

Benign neoplasm: Scrotum

1.74

0.71

1.3

1.4

2.89

g/l

—

Other infective (teno)synovitis

1.74

0.71

1.0

1.3

2.43

2.67

g/l

—

Non-small cell lung cancer, adenocarcinoma

823

1.16

0.71

1.9

1.4

3.33

2.96

g/l

3.72

712

Seminoma of testis, including Hilmo

1.57

0.70

1.7

1.4

3.20

2.84

g/l

—

Alzheimer disease

572

4429

0.94

0.70

1.9

2.3

3.04

3.01

g/l

0.20

443

3816

Convergence insufficiency and excess

1.52

0.70

1.4

1.9

2.34

2.92

g/l

1.54

Communicating hydrocephalus

248

1.30

0.70

1.6

2.9

2.93

3.00

g/l

0.14

223

Single delivery by caesarean section

132

856

0.88

0.69

2.0

1.6

2.80

2.91

g/l

0.66

125

805

Other benign neoplasm of uterus: Other parts/unspecified

602

1.19

0.69

2.8

2.3

3.11

3.15

g/l

0.08

509

Vertical strabismus

337

1.25

0.69

1.8

2.6

2.95

3.00

g/l

0.10

304

Mild mental retardation

181

0.66

0.69

2.2

2.1

2.87

2.92

g/l

0.08

172

Thromboangiitis obliterans

1.70

0.69

1.0

3.0

2.76

3.00

g/l

—

Other and unspecified heterotropia

1.89

0.69

1.8

1.1

3.08

2.97

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

134

1191

1.13

0.69

3.1

2.4

2.86

2.97

g/l

0.60

126

1068

Ovarian dysfunction, other/unspecified

1.69

0.69

2.4

2.2

2.89

3.01

g/l

—

Disorders of globe

311

1.26

0.68

2.6

2.7

3.07

2.94

g/l

0.27

274

Malignant neoplasm of rectum

113

1281

0.88

0.68

2.4

1.4

2.92

g/l

0.01

1117

Malignant neoplasm of base of tongue, including Hilmo

0.54

0.68

4.6

1.2

2.66

2.95

g/l

—

Malignant neoplasm of hypopharynx

1.66

0.68

1.0

1.1

3.57

3.07

g/l

—

Deep bite

106

813

1.15

0.68

2.0

2.3

2.81

2.95

g/l

0.59

756

Acute appendicitis, with complications

287

2653

1.08

0.68

2.4

2.3

2.97

2.93

g/l

0.27

259

2409

Gestational diabetes (for exclusion)

254

1923

0.92

0.67

1.8

2.92

2.77

g/l

1.77

233

1811

629

1.18

0.67

2.0

2.3

2.91

3.10

g/l

0.84

526

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

117

1322

0.88

0.67

2.7

1.4

2.96

2.94

g/l

0.12

1153

Frontotemporal dementia

1.57

0.67

2.4

2.1

2.90

3.07

g/l

—

Other benign neoplasms of uterus

753

1.16

0.67

3.0

2.2

3.01

3.10

g/l

0.24

646

Abnormal findings in bronchial washings nasal secretions pleural fluid sputum throat scrapings

1.82

0.67

1.0

1.5

2.52

3.07

g/l

—

Burn and corrosion confined to eye and adnexa

188

1.34

0.67

1.6

2.4

2.97

2.87

g/l

0.20

178

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

1.62

0.66

1.1

1.2

3.24

3.00

g/l

—

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

1.62

0.66

3.3

1.1

2.59

3.05

g/l

—

Other benign neoplasms of connective and other soft tissue

133

1186

1.13

0.66

2.6

2.4

2.81

2.97

g/l

1.08

115

1074

Maternal care for known or suspected abnormality of pelvic organs

184

1381

0.91

0.65

2.6

2.0

2.77

2.85

g/l

0.47

169

1287

Gender identity disorders

1.60

0.65

1.0

1.8

2.90

2.91

g/l

—

Burns and corrosions confined to eye and internal organs

224

1.30

0.65

1.6

2.3

2.88

2.87

g/l

0.02

210

Frontotemporal dementia, wide, incl. Pick's disease

1.52

0.64

2.3

2.1

2.91

3.10

g/l

—

Bacterial meningitis

359

1.23

0.64

3.5

2.7

2.69

2.88

g/l

0.69

329

Reduction defects of lower limb

1.75

0.64

3.8

3.6

2.44

2.93

g/l

—

Alzheimer disease, including avohilmo

673

4976

0.95

0.64

1.9

2.3

3.01

3.00

g/l

0.08

535

4300

Secondary parkinsonism+Parkinsonism in other disease

333

1.24

0.63

2.8

2.7

2.79

3.03

g/l

0.87

298

Carcinoma in situ of other and unspecified sites

507

1.19

0.63

3.5

2.7

3.14

2.98

g/l

0.49

455

Disorders of adrenal gland, other and/or unspecified

1.66

0.63

1.1

2.4

2.77

3.09

g/l

—

Infections of genitourinary tract in pregnancy

890

0.86

0.62

2.2

2.91

2.96

g/l

0.16

813

Secondary parkinsonism

325

1.24

0.62

2.8

2.6

2.79

3.02

g/l

0.78

291

Exposure to other specified electric current

164

0.67

0.62

2.0

2.63

2.88

g/l

0.76

154

Unspecific neurodegenerative disorder

784

5600

0.95

0.62

2.0

2.3

2.96

3.00

g/l

0.45

608

4900

Use of dimethyl fumarate

1.61

0.61

1.0

2.3

2.51

2.62

g/l

—

Non-small cell lung cancer, squamous

554

0.83

0.61

1.9

1.4

3.44

2.97

g/l

2.21

476

Long labour

183

1716

0.91

0.60

2.3

2.0

2.77

2.84

g/l

0.44

173

1596

Other rupture of muscle

1.56

0.60

1.0

1.8

3.69

2.62

g/l

—

Intermittent heterotropia

417

1.20

0.59

2.1

2.60

3.00

g/l

2.29

381

Adenocarcinoma and papilloma adenocarcinoma of rectum

113

1266

0.89

0.59

2.7

1.4

2.95

2.94

g/l

0.04

1103

Glaucoma suspect

571

6000

0.95

0.59

2.2

2.4

2.83

2.97

g/l

2.74

501

5277

Female infertility

318

1801

1.07

0.58

1.9

2.2

2.85

2.95

g/l

1.07

291

1631

Malignant neoplasm of gallbladder

1.50

0.58

1.1

3.19

3.01

g/l

—

Necrobiosis lipoidica, not elsewhere classified

1.50

0.58

4.4

2.4

2.65

3.00

g/l

—

Unequal limb length (acquired)

1.73

0.58

1.2

2.3

2.92

2.76

g/l

—

Persistent delusional disorders

914

0.87

0.57

2.1

2.4

3.04

2.96

g/l

0.31

820

Malignant neoplasm of oral cavity, including Hilmo

503

1.18

0.57

2.5

1.4

3.01

2.97

g/l

0.13

441

LSIL lesion of the cervix uteri

868

1.13

0.56

3.2

2.1

2.80

2.87

g/l

0.42

817

Acute and transient psychotic disorders

134

1210

1.11

0.56

2.1

2.3

3.00

2.95

g/l

0.23

115

1116

L02BB Anti-androgens

134

1480

0.90

0.55

1.8

2.3

3.19

2.92

g/l

2.01

117

1289

Use of rasagiline

340

1.22

0.54

1.4

3.0

2.93

2.97

g/l

0.09

305

Supervision of high-risk pregnancy

167

917

1.10

0.53

1.7

1.8

2.72

2.85

g/l

1.16

157

864

Uterine polyps

125

1129

1.11

0.53

2.0

2.2

2.90

3.03

g/l

0.80

116

1009

Alzheimer’s disease, strict definition

437

3795

0.95

0.53

2.0

2.2

3.06

3.02

g/l

0.33

342

3266

Vestibular neuronitis

127

1149

1.11

0.52

2.1

2.5

2.95

2.94

g/l

0.02

114

1041

Malignant neoplasm of other and unspecified urinary organs

1.53

0.52

1.0

1.2

2.65

3.05

g/l

—

Malignant neoplasm of other and ill-defined digestive organs

1.46

0.52

1.3

3.50

3.21

g/l

0.33

Hypermetropia

666

1.14

0.52

2.5

2.3

2.97

3.00

g/l

0.08

606

Toxic effects of substances chiefly nonmedicinal as to source

108

1202

0.90

0.52

1.7

2.4

2.79

2.96

g/l

1.07

1103

Obstructed labour due to maternal pelvic abnormality

156

1704

0.91

0.52

2.4

2.3

2.73

2.92

g/l

1.93

141

1548

FESS (DNB20)

131

1442

0.91

0.51

2.4

2.69

2.94

g/l

2.78

117

1324

Pregnancy hypertension

442

3758

1.05

0.51

2.4

2.1

2.85

2.87

g/l

0.19

413

3413

Congenital malformations of aortic and mitral valves

370

1.19

0.51

1.9

2.4

3.02

2.92

g/l

0.28

342

Pedal cyclist injured in transport accident

284

2663

1.07

0.51

2.0

2.2

2.87

2.95

g/l

0.77

248

2426

Carcinoma in situ, bladder

454

1.18

0.51

3.8

2.7

3.07

2.97

g/l

0.23

409

Torsion of ovary, ovarian pedicle and fallopian tube

180

1.28

0.50

1.3

2.2

3.03

2.96

g/l

0.14

166

Unattended death

109

0.63

0.49

5.0

1.8

2.37

3.02

g/l

—

Cyst of Bartholin Gland

344

1.20

0.49

2.5

2.1

2.92

2.94

g/l

0.03

323

Malignant neoplasm of accessory sinuses, including Hilmo

1.54

0.49

5.0

1.3

3.47

2.85

g/l

—

Hypertrophy of breast in women and men

232

2165

1.07

0.48

1.9

2.3

2.87

2.89

g/l

0.12

207

1971

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.49

0.48

1.6

2.1

3.12

2.94

g/l

—

Use of ropinirole

467

1.16

0.47

2.3

2.9

2.98

2.99

g/l

0.02

422

Family history of malignant neoplasm

101

1119

0.90

0.46

3.1

2.1

2.93

2.92

g/l

0.04

1021

Dental pulpitis, including avohilmo

1334

8417

1.03

0.46

2.0

2.3

2.81

2.91

g/l

3.18

1233

7652

Kela-code for behavioural disturbances in mental retardation

0.59

0.46

1.8

2.0

2.14

3.02

g/l

—

Medicines for HER+ breast cancer

514

5088

0.96

0.46

2.0

2.3

3.04

2.96

g/l

0.93

441

4474

Vascular dementia (undefined)

566

1.14

0.45

2.0

2.2

3.00

3.17

g/l

0.63

479

Female infertility, cervical, vaginal, other or unspecified origin

287

1757

1.06

0.45

2.0

2.1

2.86

2.96

g/l

0.93

264

1591

Open bite that required surgery (Lefort1 or BSSO)

1.38

0.44

1.0

1.8

2.07

2.81

g/l

—

Dementia

861

5730

1.04

0.44

2.1

2.4

2.94

3.00

g/l

0.89

681

5028

Lesion of sciatic nerve

586

0.87

0.43

1.3

2.5

2.70

3.02

g/l

1.58

509

Non-allergic asthma

109

991

1.10

0.43

2.0

2.5

3.07

2.96

g/l

0.67

100

894

Subarachnoid haemorrhage

151

1395

1.09

0.43

2.0

2.3

2.97

3.00

g/l

0.10

128

1234

Complications predominantly related to the puerperium

255

2402

1.06

0.42

1.9

2.1

2.75

2.87

g/l

1.09

238

2204

Other obstructed labour

712

0.88

0.42

2.0

2.1

2.81

2.93

g/l

0.40

669

Other specified and unspecified strabismus

1.36

0.42

2.1

2.3

2.35

2.86

g/l

1.97

Obstetric embolism

0.00

0.42

0.0

1.1

—

3.58

—

Sequelae of infectious and parasitic diseases

832

1.11

0.41

2.8

2.2

3.02

2.97

g/l

0.19

749

Carcinoma in situ of middle ear and respiratory system

1.37

0.41

2.0

3.2

2.73

3.05

g/l

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.41

0.0

3.0

—

2.69

—

Other articular cartilage disorders

231

1.22

0.41

2.6

2.2

2.76

2.82

g/l

0.14

211

Bicuspidal aortic valve syndrome

342

1.17

0.41

2.0

2.5

2.94

2.88

g/l

0.15

317

Other and unspecified disorders of skin and subcutaneous tissue

757

1.11

0.41

1.7

2.5

2.69

2.96

g/l

1.11

688

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

747

6113

0.97

0.41

2.3

2.2

2.87

2.90

g/l

0.34

681

5497

Alzheimer’s disease (Atypical or mixed), excluding more controls

128

937

1.09

0.40

1.8

2.3

2.87

3.18

g/l

2.17

102

808

Infliximab

1.35

0.39

1.1

1.8

3.05

2.86

g/l

0.32

Other and unspecified injuries of shoulder and upper arm

297

1.18

0.39

1.3

2.6

2.94

3.04

g/l

0.13

266

Diabetes mellitus in pregnancy

219

1492

0.94

0.39

1.5

1.8

2.90

2.79

g/l

0.92

202

1407

Polyhydramnios

270

0.81

0.39

1.4

1.8

2.57

2.89

g/l

1.29

255

Malignant neoplasm of other and ill-defined sites, including Hilmo

169

1.25

0.39

1.3

3.33

3.06

g/l

0.35

143

L02BA Anti-estrogens

225

2120

1.06

0.39

1.9

2.3

3.14

2.94

g/l

2.00

196

1888

Excessive vomiting in pregnancy

636

1.12

0.39

2.3

2.2

2.73

2.92

g/l

0.93

596

Primary open-angle glaucoma

550

5516

0.96

0.39

2.2

2.3

2.84

3.00

g/l

3.13

471

4769

Use of selegiline

599

1.12

0.38

2.2

2.5

2.88

3.01

g/l

0.48

534

Other congenital malformations of limb(s)

1.40

0.38

1.0

1.8

3.52

2.79

g/l

—

Pterygium

364

1.16

0.38

2.1

2.6

2.76

2.93

g/l

0.41

329

Circumscribed brain atrophy

271

1.19

0.38

2.0

2.8

2.81

3.05

g/l

0.80

242

Mental retardation, excluding more controls

227

1.20

0.38

1.7

2.5

2.92

2.95

g/l

0.08

208

L02BG Aromatase inhibitors

429

4462

0.96

0.37

2.1

2.4

3.04

2.98

g/l

0.66

369

3912

Primary open-angle glaucoma, strict

443

4600

0.96

0.37

2.2

2.3

2.84

2.99

g/l

2.30

379

3973

Hypothermia

198

1.22

0.36

1.2

3.1

2.89

2.98

g/l

0.19

176

Pedal cyclist injured in collision with motor vehicle

278

0.82

0.36

1.3

2.2

2.94

2.96

g/l

0.02

259

Caught, crushed, jammed or pinched in or between objects

450

1.14

0.36

1.5

2.3

2.72

2.92

g/l

0.89

415

Dislocation, sprain and strain of joints and ligaments of head

328

1.16

0.36

1.3

1.9

2.60

2.90

g/l

1.15

302

Other corneal oedema

1.33

0.36

2.7

1.9

2.77

3.01

g/l

—

Pathological resorption of teeth

347

1.16

0.36

1.1

2.5

2.90

2.95

g/l

0.10

321

Other abnormal products of conception

268

1683

1.05

0.36

1.8

2.1

2.80

2.83

g/l

0.21

254

1574

Benign neoplasm: Skin of trunk

470

1.13

0.35

3.1

2.5

2.78

2.93

g/l

0.59

427

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

101

928

1.09

0.35

1.9

2.2

3.01

2.90

g/l

0.43

846

Postpartum haemorrhage due to retained placenta

785

0.90

0.35

2.0

1.8

2.74

2.73

g/l

0.02

742

Malignant neoplasm of pancreas, including Hilmo

104

1127

0.92

0.34

2.1

1.4

3.10

2.92

g/l

1.18

980

Erosion and ectropion of cervix uteri

349

1.15

0.34

3.5

2.2

3.07

3.12

g/l

0.13

313

Other appendicitis

102

940

1.09

0.34

3.0

2.4

2.86

2.95

g/l

0.60

865

Benign neoplasm: Bladder

109

1.29

0.34

2.1

3.0

2.62

3.01

g/l

1.07

Malignant neoplasm of bronchus and lung

291

2305

1.05

0.33

2.0

1.4

3.38

2.95

g/l

10.39

255

1999

Follow-up care involving plastic surgery

388

1.14

0.32

1.5

1.9

2.82

2.89

g/l

0.16

351

Universal erythroderma, KELA reimbursement

146

1.24

0.32

1.3

2.3

2.65

3.05

g/l

1.34

132

Nontraumatic intracranial haemmorrhage

322

3084

1.05

0.32

2.4

2.2

3.04

2.97

g/l

0.51

282

2704

Sequelae of other and unspecified infectious and parasitic diseases

503

1.12

0.31

2.6

2.1

3.05

2.91

g/l

0.41

462

Struck by thrown, projected or falling objec

465

1.12

0.31

1.2

2.5

2.70

2.92

g/l

0.94

429

Left ventricular outflow tract obstruction, narrow definition

427

1.13

0.31

1.9

2.4

3.15

2.92

g/l

0.74

393

Other menopausal disorders

378

2046

1.04

0.31

2.1

2.2

2.79

3.02

g/l

5.40

344

1830

Seminoma of testis

1.35

0.31

1.9

1.4

2.99

2.85

g/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

820

0.91

0.31

3.1

2.4

2.98

2.94

g/l

0.17

745

Other specified and unspecified disorders of lens

129

1.25

0.31

1.8

2.9

2.65

3.18

g/l

—

117

Anomalies of dental arch relationship, including avohilmo

187

1595

1.06

0.30

1.9

2.3

2.75

2.92

g/l

1.34

161

1477

Arthropathy in Crohn disease

1.32

0.30

1.1

2.3

2.60

2.73

g/l

0.22

Malignant neoplasm of penis, including Hilmo

1.26

0.29

3.6

1.4

3.16

2.97

g/l

—

Generalized epilepsy, strict definition

157

1.21

0.29

1.4

2.2

2.62

2.90

g/l

0.51

148

Carcinoma in situ of cervix uteri

678

1.09

0.29

2.2

2.1

2.92

2.91

g/l

0.02

634

Poor fetal growth

698

1.09

0.29

1.7

1.8

2.73

2.79

g/l

0.26

658

Benign neoplasm: Skin of other and unspecified parts of face

156

1474

1.06

0.28

3.7

2.4

2.75

2.98

g/l

1.74

131

1320

Other specified/unspecified diseases of inner ear

1.28

0.28

1.8

2.0

2.58

3.09

g/l

—

Valgus deformity, not elsewhere classified

1.28

0.28

1.1

1.6

2.59

2.87

g/l

—

Respiratory tuberculosis, not confirmed

543

0.90

0.28

2.4

2.6

2.81

3.04

g/l

1.01

475

Myocardial infarction, unclassifiable

370

3419

0.96

0.27

1.8

2.3

3.11

2.99

g/l

1.33

323

2948

Hydatidiform mole

120

0.75

0.27

5.7

2.0

2.42

2.91

g/l

—

114

Primary angle-closure glaucoma

605

0.91

0.27

2.6

2.7

2.97

3.03

g/l

0.13

533

Retained placenta and membranes, without haemorrhage

116

1236

0.94

0.27

2.0

2.1

2.75

2.92

g/l

1.13

108

1134

Wilms' tumor, including Hilmo

1.20

0.26

1.0

1.2

3.95

3.00

g/l

—

Short Achilles tendon (acquired)

246

0.85

0.26

3.1

2.5

2.14

2.94

g/l

4.10

227

Medical treatment for female infertility

133

1400

0.94

0.26

1.7

1.8

2.73

2.78

g/l

0.24

125

1317

Schizophrenia or delusion

389

3765

1.03

0.26

1.9

2.2

2.96

2.92

g/l

0.33

336

3428

Stenosis and insufficiency of lacrimal passages

132

1246

1.06

0.26

2.3

2.5

2.78

2.99

g/l

1.75

114

1104

Cholesteatoma of middle ear

665

0.91

0.26

1.8

2.5

2.99

3.02

g/l

0.12

596

Ethmoidectomy

142

1500

0.95

0.26

2.8

2.3

2.73

2.94

g/l

1.96

128

1376

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

511

4321

1.03

0.25

2.3

2.1

2.87

2.88

g/l

0.17

476

3903

Pedestrian injured in collision with car, pick-up truck or van

245

1.15

0.25

1.1

2.3

3.09

3.03

g/l

0.08

221

Suppurative otitis media, unspecified

223

0.85

0.24

1.5

2.2

3.14

3.00

g/l

0.20

200

Inflammatory disease of cervix uteri

787

0.93

0.24

1.4

2.3

2.72

3.00

g/l

1.93

706

Fourth [trochlear] nerve palsy

244

0.86

0.24

1.5

2.7

2.78

3.01

g/l

0.42

219

Disorders of acoustic nerve

331

1.12

0.24

2.9

2.4

2.96

3.02

g/l

0.14

297

Maltreatment syndromes

350

1.12

0.24

2.1

1.8

2.85

2.84

g/l

0.02

333

Antenatal screening

182

974

1.05

0.24

2.0

1.8

2.84

2.87

g/l

0.17

177

920

Malignant neoplasm of breast, HER-negative

247

2518

0.96

0.23

1.9

1.4

3.06

2.97

g/l

0.66

211

2163

malignant neoplasm of female genital organs

189

1962

0.96

0.23

1.7

1.4

3.09

2.99

g/l

0.58

167

1681

Deep endometriosis

1031

0.94

0.22

1.5

2.2

2.68

3.00

g/l

2.88

925

Hypertrophy of breast

189

1812

1.04

0.22

1.5

2.2

2.87

2.90

g/l

0.14

168

1653

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

107

1011

1.06

0.22

2.1

2.5

2.74

2.94

g/l

1.49

917

Melanocytic naevi of eyelid, including canthus

107

1.22

0.22

1.3

2.2

3.25

2.93

g/l

1.06

Toxic effect of pesticides

0.00

0.22

0.0

1.0

—

3.18

—

Medullary carcinoma of thyroid gland

0.00

0.22

0.0

1.0

—

3.26

—

Ascariasis

0.00

0.22

0.0

1.3

—

3.01

—

Myiasis

0.00

0.22

0.0

5.2

—

2.86

—

Helminthiases

163

1.17

0.21

2.7

2.0

2.72

2.89

g/l

0.40

147

Malignant neoplasm of placenta, including Hilmo

0.00

0.21

0.0

1.0

—

2.86

—

Supernumerary ureter

0.00

0.21

0.0

1.0

—

3.12

—

Chronic diseases of tonsils and adenoids

1112

6910

1.02

0.21

1.9

2.3

2.85

2.93

g/l

1.60

1025

6253

Other congenital malformations of spinal cord

0.00

0.21

0.0

1.2

—

2.91

—

Disorder of visual pathways, unspecified

0.00

0.21

0.0

1.7

—

2.81

—

Need for immunization against certain single viral diseases

0.00

0.21

0.0

1.5

—

2.71

—

False labour

215

1394

0.96

0.21

1.7

1.9

2.63

2.84

g/l

3.34

207

1317

Unicornuate uterus

0.00

0.21

0.0

1.0

—

2.83

—

Birth injury to peripheral nervous system

0.00

0.21

0.0

3.3

—

2.78

—

Constitutional tall stature

0.00

0.21

0.0

1.0

—

3.08

—

Mumps

251

0.87

0.21

1.4

2.3

2.74

2.88

g/l

0.26

228

Other congenital musculoskeletal deformities

0.00

0.21

0.0

1.0

—

2.76

—

Foreign body in respiratory tract

537

1.08

0.21

2.6

2.4

3.03

2.94

g/l

0.34

487

Benign neoplasm: Bronchus and lung

155

0.83

0.20

1.5

2.1

3.36

3.00

g/l

0.63

141

Benign neoplasm: Pineal gland

0.00

0.20

0.0

1.1

—

2.61

—

Calculus of lower urinary tract

732

1.07

0.20

2.1

2.6

3.08

2.97

g/l

0.46

655

Alzheimer’s disease (Late onset)

413

3564

0.97

0.20

2.0

2.3

3.07

3.03

g/l

0.22

320

3057

Congenital malformations of breast

108

1.21

0.20

1.0

2.1

2.96

2.84

g/l

0.29

103

Impacted teeth

107

1003

0.95

0.19

1.4

1.8

2.94

2.87

g/l

0.29

100

938

Pneumoconiosis due to dust containing silica

1.18

0.19

2.2

2.7

3.35

2.84

g/l

—

Malignant neoplasm of brain, including Hilmo

510

1.08

0.19

2.5

1.4

2.81

2.94

g/l

0.66

450

Non-small cell lung cancer

148

1406

1.05

0.19

1.9

1.4

3.40

2.92

g/l

7.17

130

1204

Crossbite

409

1.09

0.19

1.1

2.0

2.79

2.90

g/l

0.29

388

Intracerebral haemorrhage

199

1919

1.04

0.19

2.6

2.3

3.04

3.01

g/l

0.19

179

1668

Respiratory tuberculosis

725

1.06

0.18

2.0

2.6

2.93

3.02

g/l

0.36

638

Respiratory tuberculosis, confirmed and not-confirmed

725

1.06

0.18

2.0

2.6

2.93

3.02

g/l

0.36

638

Schizophrenia, schizotypal and delusional disorders

390

3804

1.03

0.18

1.9

2.2

2.96

2.92

g/l

0.37

337

3464

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS